"CLINGEN GENE DISEASE VALIDITY CURATIONS","","","","","","","","",""
"FILE CREATED: 2022-01-26","","","","","","","","",""
"WEBPAGE: https://search.clinicalgenome.org/kb/gene-validity","","","","","","","","",""
"+++++++++++","++++++++++++++","+++++++++++++","++++++++++++++++++","+++++++++","+++++++++","++++++++++++++","+++++++++++++","+++++++++++++++++++","+++++++++++++++++++"
"GENE SYMBOL","GENE ID (HGNC)","DISEASE LABEL","DISEASE ID (MONDO)","MOI","SOP","CLASSIFICATION","ONLINE REPORT","CLASSIFICATION DATE","GCEP"
"+++++++++++","++++++++++++++","+++++++++++++","++++++++++++++++++","+++++++++","+++++++++","++++++++++++++","+++++++++++++","+++++++++++++++++++","+++++++++++++++++++"
"A2ML1","HGNC:23336","Noonan syndrome","MONDO:0018997","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d910a9d8-516e-443d-acba-8d61f7574792-2018-06-07T160000.000Z","2018-06-07T16:00:00.000Z","RASopathy"
"AARS1","HGNC:20","undetermined early-onset epileptic encephalopathy","MONDO:0018614","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ac62fe65-ee56-4146-9fe4-00dc1db2d958-2018-11-20T170000.000Z","2018-11-20T17:00:00.000Z","Epilepsy"
"AASS","HGNC:17366","hyperlysinemia","MONDO:0009388","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_92e04f9e-f03e-4295-baac-e9fb6b48a258-2020-06-29T174543.477Z","2020-06-29T17:45:43.477Z","Aminoacidopathy"
"ABCC4","HGNC:55","qualitative platelet defect","MONDO:0001197","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2828abac-5b4a-4dad-a703-10c0daf35dbd-2021-08-25T170551.779Z","2021-08-25T17:05:51.779Z","Hemostasis Thrombosis"
"ABCC9","HGNC:60","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8be22ebc-f0f5-4de5-9c2a-382ebd02c533-2020-11-13T170000.000Z","2020-11-13T17:00:00.000Z","Dilated Cardiomyopathy"
"ABCD1","HGNC:61","adrenoleukodystrophy","MONDO:0018544","XL","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_815e0f84-b530-4fd2-81a9-02e02bf352ee-2020-12-18T170000.000Z","2020-12-18T17:00:00.000Z","Peroxisomal Disorders"
"ABCD3","HGNC:67","congenital bile acid synthesis defect 5","MONDO:0014564","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f8d82e6f-8ee8-4944-898b-165916c13cac-2020-03-06T170000.000Z","2020-03-06T17:00:00.000Z","Peroxisomal Disorders"
"ABCG5","HGNC:13886","sitosterolemia","MONDO:0008863","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c52c7403-8975-4a3f-8796-a966e977f708-2020-07-10T160000.000Z","2020-07-10T16:00:00.000Z","Hemostasis Thrombosis"
"ABCG8","HGNC:13887","sitosterolemia","MONDO:0008863","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_af59edc2-1148-4dca-b804-192639017b65-2020-07-14T202806.911Z","2020-07-14T20:28:06.911Z","Hemostasis Thrombosis"
"ABHD12","HGNC:15868","PHARC syndrome","MONDO:0012984","AR","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ccd68c20-2024-4239-be51-26697e19a6b4-2018-06-28T164515.791Z","2018-06-28T16:45:15.791Z","Hearing Loss"
"ACAD8","HGNC:87","isobutyryl-CoA dehydrogenase deficiency","MONDO:0012648","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0d260f0e-df71-420a-9281-92e4bddcddbb-2019-04-26T160000.000Z","2019-04-26T16:00:00.000Z","Aminoacidopathy"
"ACAD9","HGNC:21497","acyl-CoA dehydrogenase 9 deficiency","MONDO:0012624","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5fad1866-75ce-470f-984c-e64bb7e11168-2018-03-27T160000.000Z","2018-03-27T16:00:00.000Z","Fatty Acid Oxidation Disorders"
"ACADL","HGNC:88","long chain acyl-CoA dehydrogenase deficiency","MONDO:0020531","AR","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d95637bf-c628-4d23-a0d5-656db55a09a4-2021-01-25T194827.344Z","2021-01-25T19:48:27.344Z","Fatty Acid Oxidation Disorders"
"ACADM","HGNC:89","medium chain acyl-CoA dehydrogenase deficiency","MONDO:0008721","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fb987774-0e5b-4466-924f-6f19fccc6599-2018-01-23T170000.000Z","2018-01-23T17:00:00.000Z","Fatty Acid Oxidation Disorders"
"ACADS","HGNC:90","short chain acyl-CoA dehydrogenase deficiency","MONDO:0008722","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c6bc94e9-cdf2-4efb-b654-004541efc344-2018-01-23T170000.000Z","2018-01-23T17:00:00.000Z","Fatty Acid Oxidation Disorders"
"ACADSB","HGNC:91","2-methylbutyryl-CoA dehydrogenase deficiency","MONDO:0012392","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8bfa3857-c96c-40ac-b4c1-2cf04fd4eb4f-2019-03-22T160000.000Z","2019-03-22T16:00:00.000Z","Aminoacidopathy"
"ACADVL","HGNC:92","very long chain acyl-CoA dehydrogenase deficiency","MONDO:0008723","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_130ca053-9f40-4fd5-b89c-b9b374694fda-2018-02-20T170000.000Z","2018-02-20T17:00:00.000Z","Fatty Acid Oxidation Disorders"
"ACAT1","HGNC:93","beta-ketothiolase deficiency","MONDO:0008760","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_99bcab0a-de59-479d-8fe6-8b76cbce90ee-2018-05-22T160000.000Z","2018-05-22T16:00:00.000Z","Fatty Acid Oxidation Disorders"
"ACAT2","HGNC:94","acetyl-CoA acetyltransferase-2 deficiency","MONDO:0013548","Undetermined","SOP7","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7cb46678-6e33-4d34-86ba-fdf59e59fb80-2021-01-25T194853.212Z","2021-01-25T19:48:53.212Z","Fatty Acid Oxidation Disorders"
"ACBD5","HGNC:23338","acyl-CoA binding domain containing protein 5 deficiency","MONDO:0100112","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8ac052f6-de8d-4c14-adf2-bbecb624defd-2020-06-05T160000.000Z","2020-06-05T16:00:00.000Z","Peroxisomal Disorders"
"ACOX1","HGNC:119","peroxisomal acyl-CoA oxidase deficiency","MONDO:0009919","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_96026ae4-050d-4eb5-849c-178c703a556e-2019-12-06T170000.000Z","2019-12-06T17:00:00.000Z","Peroxisomal Disorders"
"ACSF3","HGNC:27288","combined malonic and methylmalonic acidemia","MONDO:0013661","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b215e20c-7781-49a0-b473-9219cb07e0b9-2020-10-09T160000.000Z","2020-10-09T16:00:00.000Z","Aminoacidopathy"
"ACSL4","HGNC:3571","non-syndromic X-linked intellectual disability","MONDO:0019181","XL","SOP5","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9507","2017-10-20T00:00:00","Intellectual Disability and Autism"
"ACTA1","HGNC:129","alpha-actinopathy","MONDO:0100084","SD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9a8d04be-c08f-444b-b9cd-cd7de2e282c2-2020-01-13T170000.000Z","2020-01-13T17:00:00.000Z","Congenital Myopathies"
"ACTA1","HGNC:129","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP7","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f2459efe-385d-4056-b7e3-3a4a0c0d5edd-2020-05-01T124447.908Z","2020-05-01T12:44:47.908Z","Hypertrophic Cardiomyopathy"
"ACTA2","HGNC:130","familial thoracic aortic aneurysm and aortic dissection","MONDO:0019625","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8249","2016-09-27T00:00:00","Heritable Thoracic Aortic Aneurysm and Dissection"
"ACTB","HGNC:132","ACTB-associated syndromic thrombocytopenia","MONDO:0100433","AD","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9cee7fd2-09f7-41dc-9742-542917d856b0-2021-12-07T215708.078Z","2021-12-07T21:57:08.078Z","Hemostasis Thrombosis"
"ACTB","HGNC:132","Baraitser-Winter cerebrofrontofacial syndrome","MONDO:0017579","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fa13dfad-ab93-4521-874a-5ede8f608fe4-2021-10-26T165835.977Z","2021-10-26T16:58:35.977Z","Brain Malformations"
"ACTC1","HGNC:143","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2f62793b-0015-46eb-bb51-bddbae25ba0d-2021-06-23T201616.296Z","2021-06-23T20:16:16.296Z","Hypertrophic Cardiomyopathy"
"ACTC1","HGNC:143","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3e9b4048-3003-4180-b891-fcf10d25a814-2020-08-12T160000.000Z","2020-08-12T16:00:00.000Z","Dilated Cardiomyopathy"
"ACTC1","HGNC:143","arrhythmogenic right ventricular cardiomyopathy","MONDO:0016587","AD","SOP7","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_748d4255-ef43-4b42-b9f1-1cdbc50de763-2019-03-15T160000.000Z","2019-03-15T16:00:00.000Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"ACTG1","HGNC:144","Baraitser-winter syndrome 2","MONDO:0013812","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9969a221-1ce9-44c6-8ab7-2ad5f7ccd5ab-2019-01-07T170000.000Z","2019-01-07T17:00:00.000Z","Hearing Loss"
"ACTG1","HGNC:144","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_db9f5d19-5ebc-4a1a-a4c3-79ff27f69a0e-2019-01-07T170000.000Z","2019-01-07T17:00:00.000Z","Hearing Loss"
"ACTN1","HGNC:163","platelet-type bleeding disorder 15","MONDO:0014078","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_215f3113-cfb6-44cc-a68b-1eb6539c9fa0-2020-11-25T170000.000Z","2020-11-25T17:00:00.000Z","Hemostasis Thrombosis"
"ACTN2","HGNC:164","intrinsic cardiomyopathy","MONDO:0000591","AD","SOP5","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6710e329-d391-4355-85a5-02d03f8791a3-2018-08-06T130831.379Z","2018-08-06T13:08:31.379Z","Hypertrophic Cardiomyopathy"
"ACVRL1","HGNC:175","telangiectasia, hereditary hemorrhagic, type 2","MONDO:0010880","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fbbb72c5-84a0-4096-8d49-6df506cfee0e-2019-08-28T160000.000Z","2019-08-28T16:00:00.000Z","Hemostasis Thrombosis"
"ACY1","HGNC:177","aminoacylase 1 deficiency","MONDO:0012368","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_67196825-d32f-4070-9c15-debaa2287b73-2020-09-25T160000.000Z","2020-09-25T16:00:00.000Z","Aminoacidopathy"
"ADA","HGNC:186","adenosine deaminase deficiency","MONDO:0007064","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_664ba77c-3db6-47da-941e-316ac819432a-2020-11-19T170000.000Z","2020-11-19T17:00:00.000Z","SCID-CID"
"ADAMTS13","HGNC:1366","congenital thrombotic thrombocytopenic purpura","MONDO:0010122","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6442c328-21be-482d-9ea9-ce694c1a5dd9-2020-03-25T160000.000Z","2020-03-25T16:00:00.000Z","Hemostasis Thrombosis"
"ADAR","HGNC:225","Leigh syndrome","MONDO:0009723","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_03f538b5-43af-4699-9ddb-264077de21c9-2020-08-27T164642.352Z","2020-08-27T16:46:42.352Z","Mitochondrial Diseases"
"ADCY1","HGNC:232","hearing loss, autosomal recessive","MONDO:0019588","AR","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8152","2017-05-10T00:00:00","Hearing Loss"
"ADGRV1","HGNC:17416","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1f3dc96a-8fd3-4d30-98fd-1b1cf264e818-2019-03-19T160000.000Z","2019-03-19T16:00:00.000Z","Hearing Loss"
"ADGRV1","HGNC:17416","Usher syndrome type 2","MONDO:0016484","AR","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_992d2cd7-5305-4278-9601-3e59ac1a8770-2017-02-15T170000.000Z","2017-02-15T17:00:00.000Z","Hearing Loss"
"ADK","HGNC:257","adenosine kinase deficiency","MONDO:0100255","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c2319ca2-652d-411e-ab6d-5b7fb7e185ea-2021-04-08T160000.000Z","2021-04-08T16:00:00.000Z","Aminoacidopathy"
"ADNP","HGNC:15766","ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder","MONDO:0014379","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_837200e1-ed55-415b-bd9e-6649e4abab1d-2020-01-15T170000.000Z","2020-01-15T17:00:00.000Z","Intellectual Disability and Autism"
"ADSL","HGNC:291","adenylosuccinate lyase deficiency","MONDO:0007068","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d282f565-84e4-4a47-9acc-77ee31bbe9f6-2020-09-07T160000.000Z","2020-09-07T16:00:00.000Z","Intellectual Disability and Autism"
"AFF2","HGNC:3776","FRAXE intellectual disability","MONDO:0010659","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9508","2017-10-20T00:00:00","Intellectual Disability and Autism"
"AGPS","HGNC:327","rhizomelic chondrodysplasia punctata","MONDO:0015776","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aba640e2-c95d-414b-8c72-d22769e4366a-2019-10-04T202742.154Z","2019-10-04T20:27:42.154Z","Peroxisomal Disorders"
"AGTR2","HGNC:338","X-linked complex neurodevelopmental disorder","MONDO:0100148","XL","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d7cfa2a0-e6a7-49b8-a773-b32a1dfbcd57-2020-06-02T160000.000Z","2020-06-02T16:00:00.000Z","Intellectual Disability and Autism"
"AHCY","HGNC:343","hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase","MONDO:0013404","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d9b3a56b-b188-44d1-9983-a059895c0ba1-2020-06-29T174601.333Z","2020-06-29T17:46:01.333Z","Aminoacidopathy"
"AHDC1","HGNC:25230","AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome","MONDO:0014358","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_59a6c010-95ac-4813-9cf4-5ff60fa5c7e9-2021-11-16T170000.000Z","2021-11-16T17:00:00.000Z","Intellectual Disability and Autism"
"AHI1","HGNC:21575","Joubert syndrome 3","MONDO:0012078","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d0d8d22f-cea6-4f4f-bc71-e85303dccac1-2021-10-26T143345.589Z","2021-10-26T14:33:45.589Z","Brain Malformations"
"AICDA","HGNC:13203","hyper-IgM syndrome type 2","MONDO:0011528","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b34c451d-03a1-42dd-a439-599428b0eb38-2021-09-17T121716.866Z","2021-09-17T12:17:16.866Z","Antibody Deficiencies GCEP"
"AIFM1","HGNC:8768","X-linked hereditary sensory and autonomic neuropathy with hearing loss","MONDO:0010378","XL","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7afc3bb-7fce-45fd-a275-87277e22b1eb-2018-07-09T160000.000Z","2018-07-09T16:00:00.000Z","Hearing Loss"
"AIFM1","HGNC:8768","Leigh syndrome","MONDO:0009723","XL","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e917f93b-01ef-42e3-bf8d-b50a91f83f9c-2021-06-14T135732.582Z","2021-06-14T13:57:32.582Z","Mitochondrial Diseases"
"AK2","HGNC:362","reticular dysgenesis","MONDO:0009973","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aba98528-8032-4dd4-bd1d-5381b102323c-2021-05-20T150257.066Z","2021-05-20T15:02:57.066Z","SCID-CID"
"AKAP9","HGNC:379","long QT syndrome","MONDO:0002442","AD","SOP8","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_786eac72-8014-4fdf-b279-10a5faaa09b8-2020-12-15T002607.349Z","2020-12-15T00:26:07.349Z","Long QT Syndrome"
"AKT3","HGNC:393","overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes","MONDO:0100283","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_52b1df18-387f-4c38-a655-682e4d2eb378-2021-07-29T213439.431Z","2021-07-29T21:34:39.431Z","Brain Malformations"
"AKT3","HGNC:393","microcephaly","MONDO:0001149","AD","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6e3b524c-5d27-43d6-a0db-4f8f7cf1f872-2021-10-26T150030.155Z","2021-10-26T15:00:30.155Z","Brain Malformations"
"ALDH18A1","HGNC:9722","P5CS deficiency","MONDO:0100126","SD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7bfbe962-beb3-4553-9909-a83a3aac2d55-2021-05-18T211134.377Z","2021-05-18T21:11:34.377Z","Aminoacidopathy"
"ALDH4A1","HGNC:406","hyperprolinemia type 2","MONDO:0009401","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5edc3f72-31e0-47f8-bcec-e3e5b81c97ae-2020-10-23T171643.432Z","2020-10-23T17:16:43.432Z","Aminoacidopathy"
"ALDH5A1","HGNC:408","succinic semialdehyde dehydrogenase deficiency","MONDO:0010083","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c3e57466-df2f-4045-b374-010dbd334bfc-2021-04-27T160000.000Z","2021-04-27T16:00:00.000Z","Intellectual Disability and Autism"
"ALDH6A1","HGNC:7179","methylmalonate semialdehyde dehydrogenase deficiency","MONDO:0013579","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_57ca1521-9336-4769-bc55-240089dab917-2019-09-27T160000.000Z","2019-09-27T16:00:00.000Z","Aminoacidopathy"
"ALDH7A1","HGNC:877","pyridoxine-dependent epilepsy","MONDO:0009945","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7a982307-d8bd-43d1-b356-ef7ee6f32045-2019-07-26T160000.000Z","2019-07-26T16:00:00.000Z","Aminoacidopathy"
"ALG13","HGNC:30881","developmental and epileptic encephalopathy","MONDO:0100062","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f14dd634-ec5c-48cc-a375-e3cfd0c6e832-2018-04-19T160000.000Z","2018-04-19T16:00:00.000Z","Epilepsy"
"ALG8","HGNC:23161","polycystic liver disease 3 with or without kidney cysts","MONDO:0054743","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_13259bf6-e954-4159-b247-c9685638e537-2020-07-29T160000.000Z","2020-07-29T16:00:00.000Z","Kidney Cystic and Ciliopathy Disorders"
"ALG9","HGNC:15672","ALG9-associated autosomal dominant polycystic kidney disease","MONDO:0700000","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_38d817af-0a28-4453-a00f-ffccadbd9936-2020-08-26T160000.000Z","2020-08-26T16:00:00.000Z","Kidney Cystic and Ciliopathy Disorders"
"ALK","HGNC:427","neuroblastoma, susceptibility to, 3","MONDO:0013083","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ba9f692d-9b6d-4d46-8bfa-009ec20ae538-2019-11-21T193244.183Z","2019-11-21T19:32:44.183Z","Hereditary Cancer"
"ALMS1","HGNC:428","Alstrom syndrome","MONDO:0008763","AR","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_6238","2017-02-10T00:00:00","Hearing Loss"
"ALPK3","HGNC:17574","hypertrophic cardiomyopathy","MONDO:0005045","AR","SOP4","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8763","2017-02-07T16:00:00","Hypertrophic Cardiomyopathy"
"ALPL","HGNC:438","obsolete adult hypophosphatasia","MONDO:0007798","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_03912003-38e1-45cc-a005-099e00dd3eec-2021-05-19T070000.000Z","2021-05-19T07:00:00.000Z","Skeletal Disorders"
"ALPL","HGNC:438","obsolete childhood hypophosphatasia","MONDO:0009428","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_354366d0-a7f6-472d-a7b2-4b16f6e328ac-2019-01-21T200000.000Z","2019-01-21T20:00:00.000Z","Skeletal Disorders"
"ALPL","HGNC:438","obsolete childhood hypophosphatasia","MONDO:0009428","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_52e23281-c9c5-42fe-a089-2652c3b849f8-2021-03-03T080000.000Z","2021-03-03T08:00:00.000Z","Skeletal Disorders"
"ALPL","HGNC:438","obsolete infantile hypophosphatasia","MONDO:0009427","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_64fd43a0-1c7d-4f34-906c-570d800492bc-2021-06-02T205406.157Z","2021-06-02T20:54:06.157Z","Skeletal Disorders"
"AMACR","HGNC:451","alpha-methylacyl-CoA racemase deficiency","MONDO:0013681","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3fb8a3ea-cf06-4788-841f-e787f3780a49-2020-03-06T170000.000Z","2020-03-06T17:00:00.000Z","Peroxisomal Disorders"
"AMT","HGNC:473","glycine encephalopathy","MONDO:0011612","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a85e1b07-b975-4c92-b592-7b3e8d35805a-2019-05-24T160000.000Z","2019-05-24T16:00:00.000Z","Aminoacidopathy"
"ANK1","HGNC:492","hereditary spherocytosis","MONDO:0019350","AR","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_55457b0b-370e-466d-b2da-1cb8d67aecc8-2021-06-23T160000.000Z","2021-06-23T16:00:00.000Z","General Gene Curation"
"ANK1","HGNC:492","hereditary spherocytosis","MONDO:0019350","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_82460b48-c4a5-4496-92ce-6fbad632d6d7-2021-03-24T160000.000Z","2021-03-24T16:00:00.000Z","General Gene Curation"
"ANK2","HGNC:493","Brugada syndrome","MONDO:0015263","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10145","2017-11-21T00:00:00","Brugada Syndrome"
"ANK2","HGNC:493","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_097e646b-467f-4c08-95d6-958ed324562b-2020-12-15T175241.108Z","2020-12-15T17:52:41.108Z","Intellectual Disability and Autism"
"ANK2","HGNC:493","catecholaminergic polymorphic ventricular tachycardia","MONDO:0017990","AD","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c7e5e43e-1596-4c15-bf14-e9388b204e88-2021-01-20T170000.000Z","2021-01-20T17:00:00.000Z","Catecholaminergic Polymorphic Ventricular Tachycardia"
"ANK3","HGNC:494","intellectual disability","MONDO:0001071","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_668a89e3-477d-434c-8ab4-0bc9ec3504de-2020-10-07T160000.000Z","2020-10-07T16:00:00.000Z","Intellectual Disability and Autism"
"ANKRD1","HGNC:15819","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3dcc6918-d7e7-4385-b343-bc8b8678b3a4-2020-08-12T160000.000Z","2020-08-12T16:00:00.000Z","Dilated Cardiomyopathy"
"ANKRD1","HGNC:15819","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8f241e6c-2fc8-4f23-b976-3b79d90fad3e-2020-05-01T125214.646Z","2020-05-01T12:52:14.646Z","Hypertrophic Cardiomyopathy"
"ANKRD11","HGNC:21316","KBG syndrome","MONDO:0007846","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cf3e887e-8da4-45ea-bec8-9565f8246bc9-2019-11-26T170000.000Z","2019-11-26T17:00:00.000Z","Intellectual Disability and Autism"
"ANKRD26","HGNC:29186","thrombocytopenia 2","MONDO:0008555","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e86bee2b-8353-48c2-8ea3-a6b2b26cdb2f-2019-09-25T160000.000Z","2019-09-25T16:00:00.000Z","Hemostasis Thrombosis"
"ANKS6","HGNC:26724","nephronophthisis 16","MONDO:0014158","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_62df8a40-0b65-46a4-89c8-51f26424c523-2021-08-25T160000.000Z","2021-08-25T16:00:00.000Z","Kidney Cystic and Ciliopathy Disorders"
"ANO5","HGNC:27337","autosomal recessive limb-girdle muscular dystrophy","MONDO:0015152","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cecfa828-c192-44ae-9f3f-9dd5a99a5e5a-2020-09-09T120214.822Z","2020-09-09T12:02:14.822Z","Limb Girdle Muscular Dystrophy"
"ANO6","HGNC:25240","Scott syndrome","MONDO:0009885","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c2d3c125-1938-4295-82bb-b2851a3b2c8d-2020-05-27T160000.000Z","2020-05-27T16:00:00.000Z","Hemostasis Thrombosis"
"ANXA11","HGNC:535","amyotrophic lateral sclerosis type 23","MONDO:0027694","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4dca2f56-87c6-4ac7-97bf-0889883b8e63-2021-11-12T215939.032Z","2021-11-12T21:59:39.032Z","Amyotrophic Lateral Sclerosis Spectrum Disorders"
"AP1S2","HGNC:560","X-linked syndromic intellectual disability","MONDO:0020119","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9caaaacd-e262-421c-826b-8433848721ff-2017-10-20T160000.000Z","2017-10-20T16:00:00.000Z","Intellectual Disability and Autism"
"AP3B1","HGNC:566","Hermansky-Pudlak syndrome 2","MONDO:0011997","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_00ce813c-9493-48f9-9351-b70defb71d75-2020-02-26T170000.000Z","2020-02-26T17:00:00.000Z","Hemostasis Thrombosis"
"AP3D1","HGNC:568","Hermansky-Pudlak syndrome 10","MONDO:0014885","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ec9ffa2-efda-446d-a848-e6d4d5b92fb6-2020-02-26T170000.000Z","2020-02-26T17:00:00.000Z","Hemostasis Thrombosis"
"AP4B1","HGNC:572","AP-4 deficiency syndrome","MONDO:0100176","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4436344a-e0da-4c42-b06a-cdf8a2581ce5-2021-07-26T160000.000Z","2021-07-26T16:00:00.000Z","Intellectual Disability and Autism"
"AP4E1","HGNC:573","AP-4 deficiency syndrome","MONDO:0100176","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_be93d2e7-f302-41a7-9675-032510e46ad2-2021-02-18T155050.880Z","2021-02-18T15:50:50.880Z","Intellectual Disability and Autism"
"AP4M1","HGNC:574","AP-4 deficiency syndrome","MONDO:0100176","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f49be3e4-4e1f-478b-b4e0-f41623e5b548-2021-04-07T160000.000Z","2021-04-07T16:00:00.000Z","Intellectual Disability and Autism"
"APC","HGNC:583","APC-related attenuated familial adenomatous polyposis","MONDO:0016613","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9854","2017-09-11T00:00:00","Colon Cancer"
"APOB","HGNC:603","hypercholesterolemia, autosomal dominant, type B","MONDO:0007751","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1c26b83b-409e-47c7-9c53-6ca79472d6fc-2018-11-14T180000.000Z","2018-11-14T18:00:00.000Z","General Gene Curation"
"APOB","HGNC:603","familial hypobetalipoproteinemia 1","MONDO:0014252","SD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e7382aae-83d5-4a23-b1fe-e3d6acea8584-2020-02-26T170000.000Z","2020-02-26T17:00:00.000Z","General Gene Curation"
"APPL1","HGNC:24035","monogenic diabetes","MONDO:0015967","AD","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5e2bc680-f1d4-4b65-baaa-22b4ff22b56e-2021-12-15T170000.000Z","2021-12-15T17:00:00.000Z","Monogenic Diabetes"
"AQP1","HGNC:633","pulmonary arterial hypertension","MONDO:0015924","AD","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_29eda804-13df-4fe9-bbb3-9494b11edc92-2021-01-11T145519.495Z","2021-01-11T14:55:19.495Z","Pulmonary Hypertension"
"AQP5","HGNC:638","palmoplantar keratoderma, Bothnian type","MONDO:0010849","AD","SOP5","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_77aa086c-5551-4e23-9e35-7c4ff072e238-2018-07-03T141124.777Z","2018-07-03T14:11:24.777Z","UNC Biocuration Core"
"ARG1","HGNC:663","hyperargininemia","MONDO:0008814","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0157f793-9232-4700-bbf0-dfb16270f688-2020-06-29T174101.533Z","2020-06-29T17:41:01.533Z","Aminoacidopathy"
"ARHGEF1","HGNC:681","immunodeficiency 62","MONDO:0032763","AR","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9547c192-135d-48b3-a1c0-2eca5e2608c5-2021-01-19T214711.722Z","2021-01-19T21:47:11.722Z","Antibody Deficiencies GCEP"
"ARHGEF10","HGNC:14103","autosomal dominant slowed nerve conduction velocity","MONDO:0011998","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b23121f9-57e1-48ac-a2bc-d5a293829530-2020-10-05T160423.090Z","2020-10-05T16:04:23.090Z","Charcot-Marie-Tooth"
"ARHGEF6","HGNC:685","non-syndromic X-linked intellectual disability","MONDO:0019181","XL","SOP8","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d248ef99-6ff8-43d8-a24e-dfce6b2db1c8-2020-10-20T160000.000Z","2020-10-20T16:00:00.000Z","Intellectual Disability and Autism"
"ARHGEF9","HGNC:14561","X-linked complex neurodevelopmental disorder","MONDO:0100148","XL","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9305fb2c-6cdf-492d-9dd0-8b03dd4fab1c-2019-11-21T170000.000Z","2019-11-21T17:00:00.000Z","Intellectual Disability and Autism"
"ARID1A","HGNC:11110","Coffin-Siris syndrome","MONDO:0015452","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aaf6d47a-656a-49ca-ba9e-169f25bf03e7-2021-07-07T160000.000Z","2021-07-07T16:00:00.000Z","Intellectual Disability and Autism"
"ARID1B","HGNC:18040","Coffin-Siris syndrome","MONDO:0015452","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d487e6c4-9727-4315-90a2-11338128a8e5-2019-12-04T200734.569Z","2019-12-04T20:07:34.569Z","Intellectual Disability and Autism"
"ARL13B","HGNC:25419","Joubert syndrome","MONDO:0018772","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f6c474c9-4035-498c-a902-03be50d36205-2020-06-03T210114.719Z","2020-06-03T21:01:14.719Z","Syndromic Disorders"
"ARL2BP","HGNC:17146","retinitis pigmentosa with or without situs inversus","MONDO:0014186","AR","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_afe2baae-73d8-4f77-a106-a9163dbde4ce-2018-07-03T175137.305Z","2018-07-03T17:51:37.305Z","UNC Biocuration Core"
"ARPC1B","HGNC:704","platelet abnormalities with eosinophilia and immune-mediated inflammatory disease","MONDO:0060583","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_13909f11-a592-41cc-ade9-c77a5b49b253-2020-07-22T160000.000Z","2020-07-22T16:00:00.000Z","Hemostasis Thrombosis"
"ARSL","HGNC:719","X-linked chondrodysplasia punctata 1","MONDO:0010555","XL","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2c48d88b-d100-4203-8abf-03f3199bf3e0-2020-08-25T132456.576Z","2020-08-25T13:24:56.576Z","Syndromic Disorders"
"ARX","HGNC:18060","developmental and epileptic encephalopathy","MONDO:0100062","XL","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3a5357ce-2161-4a7f-a8e1-a1dba4550e57-2019-06-04T160000.000Z","2019-06-04T16:00:00.000Z","Epilepsy"
"ARX","HGNC:18060","X-linked complex neurodevelopmental disorder","MONDO:0100148","XL","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ccf3ab49-ee8f-4980-aa04-ca13c21c124a-2020-12-01T170000.000Z","2020-12-01T17:00:00.000Z","Intellectual Disability and Autism"
"ASL","HGNC:746","argininosuccinic aciduria","MONDO:0008815","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c16021b9-f6db-4e41-90f3-4786d63a1fa3-2018-09-15T160000.000Z","2018-09-15T16:00:00.000Z","Aminoacidopathy"
"ASNS","HGNC:753","congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome","MONDO:0014258","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e1cea57d-fe02-469e-8c52-a383c3f5a0c6-2020-06-29T174449.301Z","2020-06-29T17:44:49.301Z","Aminoacidopathy"
"ASPA","HGNC:756","Canavan disease","MONDO:0010079","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_66306eff-659f-4508-a41b-1820e47e0e1d-2020-10-08T161701.633Z","2020-10-08T16:17:01.633Z","Aminoacidopathy"
"ASS1","HGNC:758","citrullinemia type I","MONDO:0008988","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5dc5ef32-81ca-478e-be42-436da3416e4d-2018-12-27T170000.000Z","2018-12-27T17:00:00.000Z","Aminoacidopathy"
"ASXL1","HGNC:18318","Bohring-Opitz syndrome","MONDO:0011510","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_31e0ce4d-aeb7-4983-9ec2-85178d7f40f0-2021-07-30T160000.000Z","2021-07-30T16:00:00.000Z","Intellectual Disability and Autism"
"ASXL2","HGNC:23805","syndromic intellectual disability","MONDO:0000508","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cedd313e-b43b-4212-840b-7d4172258b16-2021-09-28T115443.696Z","2021-09-28T11:54:43.696Z","Intellectual Disability and Autism"
"ATF6","HGNC:791","achromatopsia","MONDO:0018852","AR","SOP4","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_4842","2016-11-16T00:00:00","General Gene Curation"
"ATL3","HGNC:24526","neuropathy, hereditary sensory, type 1F","MONDO:0014286","AD","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_132d0be7-2003-43ed-a934-1cf60cf45773-2021-07-13T160000.000Z","2021-07-13T16:00:00.000Z","Charcot-Marie-Tooth"
"ATM","HGNC:795","familial ovarian cancer","MONDO:0016248","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10080","2017-07-12T00:00:00","Breast/Ovarian Cancer"
"ATM","HGNC:795","hereditary nonpolyposis colon cancer","MONDO:0018630","AD","SOP4","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9861","2017-08-28T00:00:00","Colon Cancer"
"ATM","HGNC:795","hereditary breast carcinoma","MONDO:0016419","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9908","2017-07-12T00:00:00","Breast/Ovarian Cancer"
"ATM","HGNC:795","ataxia telangiectasia","MONDO:0008840","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_02a69e27-77dc-41bd-83d2-dda9c224ee43-2021-07-27T205239.729Z","2021-07-27T20:52:39.729Z","Hereditary Cancer"
"ATP1A2","HGNC:800","familial or sporadic hemiplegic migraine","MONDO:0018925","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fe788a45-b8da-4377-acdb-5dd55fcc3130-2021-03-02T183446.232Z","2021-03-02T18:34:46.232Z","Epilepsy"
"ATP5MK","HGNC:30889","Leigh syndrome","MONDO:0009723","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ff19a86d-404a-464e-8da6-8824ce45ed20-2020-08-27T164252.070Z","2020-08-27T16:42:52.070Z","Mitochondrial Diseases"
"ATP6AP1","HGNC:868","congenital disorder of glycosylation type II","MONDO:0005501","XL","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c6bfce2b-c20c-40f9-b2f5-d81f76a328f7-2021-09-17T122311.885Z","2021-09-17T12:23:11.885Z","General Inborn Errors of Metabolism"
"ATP6AP2","HGNC:18305","ATP6AP2-related disorder","MONDO:0100146","XL","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ac33652a-dd98-46f4-ba4e-d3d5a482a22e-2020-09-14T160000.000Z","2020-09-14T16:00:00.000Z","Intellectual Disability and Autism"
"ATP6V1B1","HGNC:853","renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss","MONDO:0009968","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c74d3789-9cfc-4be3-b23d-baf610620e6c-2017-12-19T050000.000Z","2017-12-19T05:00:00.000Z","Hearing Loss"
"ATP7A","HGNC:869","Menkes disease","MONDO:0010651","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9510","2018-02-07T00:00:00","Intellectual Disability and Autism"
"ATP7B","HGNC:870","Wilson disease","MONDO:0010200","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f0ac0a41-d7d5-4377-a622-1ee9bc4ed9f3-2019-03-27T160000.000Z","2019-03-27T16:00:00.000Z","General Gene Curation"
"ATRX","HGNC:886","ATR-X-related syndrome","MONDO:0016980","XL","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5296ecdf-b709-47bd-9032-daec8b91e300-2021-09-29T160000.000Z","2021-09-29T16:00:00.000Z","Intellectual Disability and Autism"
"AUH","HGNC:890","3-methylglutaconic aciduria type 1","MONDO:0009610","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_681f6747-37ce-498e-8bb1-eddd55a90e2c-2020-06-29T174231.569Z","2020-06-29T17:42:31.569Z","Aminoacidopathy"
"AUTS2","HGNC:14262","syndromic intellectual disability","MONDO:0000508","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_582999f6-b3b4-46de-90a0-8f44e22df469-2020-09-01T160000.000Z","2020-09-01T16:00:00.000Z","Intellectual Disability and Autism"
"AXIN2","HGNC:904","oligodontia-cancer predisposition syndrome","MONDO:0012075","AD","SOP4","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8439","2017-06-08T00:00:00","Colon Cancer"
"BAG3","HGNC:939","myofibrillar myopathy","MONDO:0018943","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5466","2016-12-18T00:00:00","General Gene Curation"
"BAG3","HGNC:939","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1bec07e1-0186-4f45-bd8e-7d8a0f2547a9-2020-10-09T160000.000Z","2020-10-09T16:00:00.000Z","Dilated Cardiomyopathy"
"BAP1","HGNC:950","BAP1-related tumor predisposition syndrome","MONDO:0013692","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d70c33af-2e4f-4489-9c29-797655015b1d-2019-03-21T175713.803Z","2019-03-21T17:57:13.803Z","Hereditary Cancer"
"BARD1","HGNC:952","hereditary breast carcinoma","MONDO:0016419","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10081","2017-08-09T00:00:00","Breast/Ovarian Cancer"
"BARD1","HGNC:952","hereditary nonpolyposis colon cancer","MONDO:0018630","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8430","2017-06-08T00:00:00","Colon Cancer"
"BARD1","HGNC:952","familial ovarian cancer","MONDO:0016248","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9909","2017-08-09T00:00:00","Breast/Ovarian Cancer"
"BCAT2","HGNC:977","hypervalinemia and hyperleucine-isoleucinemia","MONDO:0100058","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b5e16ee6-88c9-4872-8681-dd7fd0156b0f-2020-07-24T172325.905Z","2020-07-24T17:23:25.905Z","Aminoacidopathy"
"BCKDHA","HGNC:986","maple syrup urine disease type 1A","MONDO:0023691","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5c89a6c7-751a-4a99-8a32-97cc33c5df7c-2018-09-14T160000.000Z","2018-09-14T16:00:00.000Z","Aminoacidopathy"
"BCKDHB","HGNC:987","maple syrup urine disease type 1B","MONDO:0023692","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0b0d314c-7355-441c-a357-72ba3e566c57-2019-02-08T170000.000Z","2019-02-08T17:00:00.000Z","Aminoacidopathy"
"BCKDK","HGNC:16902","branched-chain keto acid dehydrogenase kinase deficiency","MONDO:0013970","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f90aaad0-b56a-41dc-8d1f-9d12fc66113f-2019-01-18T170000.000Z","2019-01-18T17:00:00.000Z","Aminoacidopathy"
"BCL11A","HGNC:13221","Dias-Logan syndrome","MONDO:0014914","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9630f9a3-3f90-49c6-ae8b-6313c950b1b2-2020-09-13T171807.228Z","2020-09-13T17:18:07.228Z","Intellectual Disability and Autism"
"BCOR","HGNC:20893","microphthalmia, syndromic 2","MONDO:0010261","XL","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3da06b77-1ed0-4197-948c-a9bbf80b6ed4-2020-12-17T171347.861Z","2020-12-17T17:13:47.861Z","Syndromic Disorders"
"BCS1L","HGNC:1020","Leigh syndrome","MONDO:0009723","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3b50d7db-1144-4187-a60c-72b45adb80bd-2019-09-19T155315.896Z","2019-09-19T15:53:15.896Z","Mitochondrial Diseases"
"BCS1L","HGNC:1020","Bjornstad syndrome","MONDO:0009872","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7a26b6b5-e703-43fc-bcd0-eaff67ef8107-2018-07-09T160000.000Z","2018-07-09T16:00:00.000Z","Hearing Loss"
"BDP1","HGNC:13652","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d300a54b-171c-4445-a138-a24409e99aae-2021-03-26T160000.000Z","2021-03-26T16:00:00.000Z","Hearing Loss"
"BGN","HGNC:1044","familial thoracic aortic aneurysm and aortic dissection","MONDO:0019625","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8260","2016-12-22T00:00:00","Heritable Thoracic Aortic Aneurysm and Dissection"
"BIN1","HGNC:1052","centronuclear myopathy","MONDO:0018947","SD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1a2b9d96-97da-473d-8147-a425a5364fcb-2020-04-27T160000.000Z","2020-04-27T16:00:00.000Z","Congenital Myopathies"
"BLK","HGNC:1057","monogenic diabetes","MONDO:0015967","AD","SOP7","Refuted","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_072e29f7-db97-40d9-9280-819706203c24-2020-08-21T160000.000Z","2020-08-21T16:00:00.000Z","Monogenic Diabetes"
"BLM","HGNC:1058","Bloom syndrome","MONDO:0008876","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e0a20b67-5a62-462c-894b-76b60a66e979-2018-10-09T170000.000Z","2018-10-09T17:00:00.000Z","Hereditary Cancer"
"BLNK","HGNC:14211","agammaglobulinemia 4, autosomal recessive","MONDO:0013289","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2e1d2e1b-52a6-4371-9055-0e1cc74da39d-2021-03-16T132748.373Z","2021-03-16T13:27:48.373Z","Antibody Deficiencies GCEP"
"BLOC1S3","HGNC:20914","Hermansky-Pudlak syndrome 8","MONDO:0013560","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bdeec503-f903-4507-89e7-33c9255b5ad1-2020-09-23T160000.000Z","2020-09-23T16:00:00.000Z","Hemostasis Thrombosis"
"BLOC1S6","HGNC:8549","Hermansky-Pudlak syndrome 9","MONDO:0013606","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_984682a2-afb9-48b3-afe8-20e0f633022d-2020-09-23T160000.000Z","2020-09-23T16:00:00.000Z","Hemostasis Thrombosis"
"BMPR1A","HGNC:1076","generalized juvenile polyposis/juvenile polyposis coli","MONDO:0008276","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10029","2017-06-12T00:00:00","Colon Cancer"
"BMPR2","HGNC:1078","pulmonary arterial hypertension","MONDO:0015924","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a20ce78b-18ba-436c-877e-a08d092ac7c7-2020-12-07T172318.621Z","2020-12-07T17:23:18.621Z","Pulmonary Hypertension"
"BRAF","HGNC:1097","Noonan syndrome","MONDO:0018997","AD","SOP5","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_47cf08d5-efc6-4d42-b031-a06619873161-2018-07-24T160000.000Z","2018-07-24T16:00:00.000Z","RASopathy"
"BRAF","HGNC:1097","Noonan syndrome with multiple lentigines","MONDO:0007893","AD","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_888875a8-5654-486b-8e64-e1382ccc6650-2018-07-24T160000.000Z","2018-07-24T16:00:00.000Z","RASopathy"
"BRAF","HGNC:1097","cardiofaciocutaneous syndrome","MONDO:0015280","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a53e5a92-126f-4b00-a89b-af55d4f342ca-2018-07-24T160000.000Z","2018-07-24T16:00:00.000Z","RASopathy"
"BRAF","HGNC:1097","Costello syndrome","MONDO:0009026","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f229eceb-8f5e-4ecb-a484-7863b8dc7d19-2018-07-24T160000.000Z","2018-07-24T16:00:00.000Z","RASopathy"
"BRCA1","HGNC:1100","breast-ovarian cancer, familial, susceptibility to, 1","MONDO:0011450","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9972","2017-09-13T00:00:00","Breast/Ovarian Cancer"
"BRCA1","HGNC:1100","Fanconi anemia, complementation group S","MONDO:0054748","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aa39798d-9b6e-430d-8bc1-2a01f81f1f72-2020-05-14T003137.538Z","2020-05-14T00:31:37.538Z","Hereditary Cancer"
"BRCA2","HGNC:1101","breast-ovarian cancer, familial, susceptibility to, 2","MONDO:0012933","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8397","2017-09-13T00:00:00","Breast/Ovarian Cancer"
"BRCA2","HGNC:1101","Fanconi anemia complementation group D1","MONDO:0011584","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_48faf04b-ffc4-4163-8570-22f5c29c4064-2018-12-21T151618.437Z","2018-12-21T15:16:18.437Z","Hereditary Cancer"
"BRIP1","HGNC:20473","hereditary breast carcinoma","MONDO:0016419","AD","SOP4","Refuted","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9910","2017-05-10T00:00:00","Breast/Ovarian Cancer"
"BRIP1","HGNC:20473","familial ovarian cancer","MONDO:0016248","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9911","2016-10-12T00:00:00","Breast/Ovarian Cancer"
"BRIP1","HGNC:20473","Fanconi anemia complementation group J","MONDO:0012187","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_40aae4ea-8c9b-42a7-9d02-0f52a184712f-2019-08-18T160442.255Z","2019-08-18T16:04:42.255Z","Hereditary Cancer"
"BRSK2","HGNC:11405","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_327881a5-52fd-42bd-a500-c94514a7aed3-2021-02-03T170000.000Z","2021-02-03T17:00:00.000Z","Intellectual Disability and Autism"
"BRWD3","HGNC:17342","X-linked syndromic intellectual disability","MONDO:0020119","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b8a924e2-e76b-4363-bf38-d95fd53d6141-2018-09-20T192312.767Z","2018-09-20T19:23:12.767Z","Intellectual Disability and Autism"
"BSCL2","HGNC:15832","distal hereditary motor neuropathy","MONDO:0018894","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_02472719-c26d-40ff-8ad4-897ef7a6800a-2021-09-23T001322.660Z","2021-09-23T00:13:22.660Z","Charcot-Marie-Tooth"
"BSND","HGNC:16512","Bartter disease type 4a","MONDO:0011242","AR","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9b69acb1-93bc-4bc0-8a33-77bf64179c32-2018-07-12T205243.945Z","2018-07-12T20:52:43.945Z","Hearing Loss"
"BTD","HGNC:1122","Leigh syndrome","MONDO:0009723","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_74599afe-02f9-4225-9e50-63306f04a552-2021-06-14T140327.018Z","2021-06-14T14:03:27.018Z","Mitochondrial Diseases"
"BTD","HGNC:1122","biotinidase deficiency","MONDO:0009665","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_847f7f2b-575f-4a90-bf02-179d464e4841-2020-02-10T180000.000Z","2020-02-10T18:00:00.000Z","Hearing Loss"
"BTK","HGNC:1133","isolated growth hormone deficiency type III","MONDO:0010615","XL","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6341781b-9ba9-41b1-889a-8d65a9b3ebb7-2020-11-17T170000.000Z","2020-11-17T17:00:00.000Z","Antibody Deficiencies GCEP"
"BTK","HGNC:1133","Bruton-type agammaglobulinemia","MONDO:0010421","XL","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8dc4d594-2103-46ad-a786-f4bda9b95995-2020-10-20T160000.000Z","2020-10-20T16:00:00.000Z","Antibody Deficiencies GCEP"
"BUB1B","HGNC:1149","mosaic variegated aneuploidy syndrome 1","MONDO:0009759","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_59147f27-d5a3-4760-ba8d-0429bae3c906-2019-11-22T145326.352Z","2019-11-22T14:53:26.352Z","Hereditary Cancer"
"C1QB","HGNC:1242","C1Q deficiency","MONDO:0013343","AR","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3216","2017-01-09T00:00:00","General Gene Curation"
"C9orf72","HGNC:28337","frontotemporal dementia and/or amyotrophic lateral sclerosis 1","MONDO:0007105","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_afd5a267-72c8-4a04-8404-4c819efe61c5-2021-09-21T030209.665Z","2021-09-21T03:02:09.665Z","Amyotrophic Lateral Sclerosis Spectrum Disorders"
"CA5A","HGNC:1377","hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency","MONDO:0014332","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f7c5731a-866e-4a96-abb0-f0747f89280b-2018-09-10T160000.000Z","2018-09-10T16:00:00.000Z","Aminoacidopathy"
"CABP2","HGNC:1385","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_20de88d2-6681-4522-9e11-26cdf66a2c15-2020-02-06T170000.000Z","2020-02-06T17:00:00.000Z","Hearing Loss"
"CACNA1C","HGNC:1390","Brugada syndrome","MONDO:0015263","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10146","2017-11-21T00:00:00","Brugada Syndrome"
"CACNA1C","HGNC:1390","short QT syndrome","MONDO:0000453","AD","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_51dae85e-8745-48c1-8fb9-cabc2501d3fb-2020-08-03T160000.000Z","2020-08-03T16:00:00.000Z","Short QT Syndrome"
"CACNA1C","HGNC:1390","long QT syndrome","MONDO:0002442","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c496551d-c7a7-4e49-ad41-8cfd49840dc1-2020-04-24T160000.000Z","2020-04-24T16:00:00.000Z","Long QT Syndrome"
"CACNA1D","HGNC:1391","sinoatrial node dysfunction and deafness","MONDO:0013960","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8249f2c1-ff59-4ea2-8e7e-11256c73433e-2018-05-01T160000.000Z","2018-05-01T16:00:00.000Z","Hearing Loss"
"CACNA1H","HGNC:1395","epilepsy","MONDO:0005027","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c3208279-a38d-4b38-b4f9-3af2610c4936-2018-07-30T040000.000Z","2018-07-30T04:00:00.000Z","Epilepsy"
"CACNA2D1","HGNC:1399","Brugada syndrome 1","MONDO:0011001","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10147","2017-11-21T00:00:00","Brugada Syndrome"
"CACNA2D1","HGNC:1399","short QT syndrome","MONDO:0000453","AD","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_896733cc-c686-4279-affb-e1860fd10ca2-2020-09-05T160000.000Z","2020-09-05T16:00:00.000Z","Short QT Syndrome"
"CACNB2","HGNC:1402","Brugada syndrome 1","MONDO:0011001","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10148","2017-11-21T00:00:00","Brugada Syndrome"
"CACNB2","HGNC:1402","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP7","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e7a08ba4-6024-449c-b824-c762a85277a1-2020-04-07T023127.397Z","2020-04-07T02:31:27.397Z","Hypertrophic Cardiomyopathy"
"CACNB2","HGNC:1402","short QT syndrome","MONDO:0000453","AD","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_eaa3adbb-5e58-4e9a-a142-76c93c65b917-2020-08-03T160000.000Z","2020-08-03T16:00:00.000Z","Short QT Syndrome"
"CACNB4","HGNC:1404","epilepsy","MONDO:0005027","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d2fad131-8e91-4874-9394-8b86d6d62abb-2018-06-22T105438.082Z","2018-06-22T10:54:38.082Z","Epilepsy"
"CACNG2","HGNC:1406","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a61ad78f-0f37-4221-82f4-710275033666-2021-07-29T210333.496Z","2021-07-29T21:03:33.496Z","Intellectual Disability and Autism"
"CALM1","HGNC:1442","catecholaminergic polymorphic ventricular tachycardia","MONDO:0017990","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1ca1d8df-10fa-48ef-aea4-fb4dc6564dd0-2021-06-17T160000.000Z","2021-06-17T16:00:00.000Z","Catecholaminergic Polymorphic Ventricular Tachycardia"
"CALM1","HGNC:1442","long QT syndrome","MONDO:0002442","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4a150cd9-e16b-4992-8cc7-5ccec44b4d6b-2018-09-25T160000.000Z","2018-09-25T16:00:00.000Z","Long QT Syndrome"
"CALM2","HGNC:1445","catecholaminergic polymorphic ventricular tachycardia","MONDO:0017990","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_42d280da-accc-46f2-8832-47d5a3eeeba7-2021-06-17T160000.000Z","2021-06-17T16:00:00.000Z","Catecholaminergic Polymorphic Ventricular Tachycardia"
"CALM2","HGNC:1445","long QT syndrome","MONDO:0002442","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_86e4b783-3b60-4a1d-ab34-e61d27751ca6-2018-09-25T160000.000Z","2018-09-25T16:00:00.000Z","Long QT Syndrome"
"CALM3","HGNC:1449","catecholaminergic polymorphic ventricular tachycardia","MONDO:0017990","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1b7fc965-a109-4448-94a0-00a9b078b484-2021-06-17T160000.000Z","2021-06-17T16:00:00.000Z","Catecholaminergic Polymorphic Ventricular Tachycardia"
"CALM3","HGNC:1449","long QT syndrome","MONDO:0002442","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3cc2a1ae-5f3d-445c-b124-f3d38fdd070a-2018-09-25T160000.000Z","2018-09-25T16:00:00.000Z","Long QT Syndrome"
"CALR3","HGNC:20407","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fd8036e5-bf01-4b89-b4fc-94080d835d99-2018-08-06T131427.771Z","2018-08-06T13:14:27.771Z","Hypertrophic Cardiomyopathy"
"CAMK2G","HGNC:1463","intellectual developmental disorder 59","MONDO:0032795","AD","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_525f1ddb-a662-4baf-b877-45fc26e07b71-2021-07-30T130229.547Z","2021-07-30T13:02:29.547Z","Syndromic Disorders"
"CAPN3","HGNC:1480","limb-girdle muscular dystrophy","MONDO:0016971","SD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6f7dbd92-77a0-4fe7-9308-98ce7f4cc383-2021-06-15T185919.142Z","2021-06-15T18:59:19.142Z","Limb Girdle Muscular Dystrophy"
"CASK","HGNC:1497","X-linked syndromic intellectual disability","MONDO:0020119","XL","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ca0e703c-3fe1-44a1-8632-036554b2f158-2019-07-09T160000.000Z","2019-07-09T16:00:00.000Z","Intellectual Disability and Autism"
"CASQ2","HGNC:1513","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP7","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_07177c89-7845-4df5-ba3e-bdd415b5c8b3-2020-05-01T131734.423Z","2020-05-01T13:17:34.423Z","Hypertrophic Cardiomyopathy"
"CASQ2","HGNC:1513","catecholaminergic polymorphic ventricular tachycardia","MONDO:0017990","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_991ee32e-280d-4bea-a638-aa1b6fa6f781-2021-01-20T170000.000Z","2021-01-20T17:00:00.000Z","Catecholaminergic Polymorphic Ventricular Tachycardia"
"CASQ2","HGNC:1513","catecholaminergic polymorphic ventricular tachycardia","MONDO:0017990","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c778b145-fcfc-4252-8dd8-33f982b288e8-2021-01-20T170000.000Z","2021-01-20T17:00:00.000Z","Catecholaminergic Polymorphic Ventricular Tachycardia"
"CASR","HGNC:1514","epilepsy","MONDO:0005027","AD","SOP8","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ddebf083-3434-4401-9b6b-9ec24aceec89-2021-03-03T123827.967Z","2021-03-03T12:38:27.967Z","Epilepsy"
"CAT","HGNC:1516","acatalasia","MONDO:0013571","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7381d0cc-74d3-4dfc-bc2e-62416afbb0ee-2020-04-03T160000.000Z","2020-04-03T16:00:00.000Z","Peroxisomal Disorders"
"CBL","HGNC:1541","CBL-related disorder","MONDO:0013308","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4a1a76fd-7e23-44a7-b2fc-4495bc5d5ee6-2019-04-29T160000.000Z","2019-04-29T16:00:00.000Z","RASopathy"
"CBS","HGNC:1550","classic homocystinuria","MONDO:0009352","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a9086d29-767b-4ab8-9274-1249b5480834-2019-04-12T160000.000Z","2019-04-12T16:00:00.000Z","Aminoacidopathy"
"CC2D1A","HGNC:30237","complex neurodevelopmental disorder","MONDO:0100038","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_63def86b-765e-4f12-93a3-94ef911c3190-2020-01-08T170000.000Z","2020-01-08T17:00:00.000Z","Intellectual Disability and Autism"
"CCDC39","HGNC:25244","primary ciliary dyskinesia 14","MONDO:0013434","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_79c47f13-dd33-45e4-a170-6ff26aa2732c-2021-11-02T204310.116Z","2021-11-02T20:43:10.116Z","Motile Ciliopathy"
"CCDC40","HGNC:26090","primary ciliary dyskinesia 15","MONDO:0013435","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e9c192c6-9f74-4beb-85ba-a42199e9794a-2021-12-10T031508.185Z","2021-12-10T03:15:08.185Z","Motile Ciliopathy"
"CCDC50","HGNC:18111","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cf656dcb-6644-41bb-a29a-d7bdf54b28f7-2021-11-17T170000.000Z","2021-11-17T17:00:00.000Z","Hearing Loss"
"CCDC78","HGNC:14153","centronuclear myopathy","MONDO:0018947","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_886b45ae-232d-4635-ab94-88a0d15bbcca-2019-12-09T170000.000Z","2019-12-09T17:00:00.000Z","Congenital Myopathies"
"CD164","HGNC:1632","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e9524ca4-7d17-4691-b650-0d457531c7fd-2018-03-20T160000.000Z","2018-03-20T16:00:00.000Z","Hearing Loss"
"CD3E","HGNC:1674","severe combined immunodeficiency","MONDO:0015974","AR","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3217","2017-01-09T00:00:00","General Gene Curation"
"CD3E","HGNC:1674","immunodeficiency 18","MONDO:0014278","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_29d6bb32-65b3-4c78-9c94-da71cc591565-2021-01-26T172908.775Z","2021-01-26T17:29:08.775Z","SCID-CID"
"CD3G","HGNC:1675","combined immunodeficiency due to CD3gamma deficiency","MONDO:0014276","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8ea83aa7-473b-4670-88dd-36b1abe277f8-2021-07-15T160000.000Z","2021-07-15T16:00:00.000Z","SCID-CID"
"CD40LG","HGNC:11935","hyper-IgM syndrome type 1","MONDO:0010626","XL","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4184ad10-d95f-4027-b75d-e4e11127febf-2021-03-22T154242.503Z","2021-03-22T15:42:42.503Z","SCID-CID"
"CD79A","HGNC:1698","agammaglobulinemia 3, autosomal recessive","MONDO:0013288","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_12a6257c-c9ca-432a-ab76-b05985283381-2020-12-15T135909.057Z","2020-12-15T13:59:09.057Z","Antibody Deficiencies GCEP"
"CD79B","HGNC:1699","agammaglobulinemia 6, autosomal recessive","MONDO:0012987","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9c252b2c-2183-4e7d-8ceb-69f7a01cc1d9-2021-01-26T171006.440Z","2021-01-26T17:10:06.440Z","Antibody Deficiencies GCEP"
"CD81","HGNC:1701","immunodeficiency, common variable, 6","MONDO:0013286","AR","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e2092b4c-a8ff-4b40-bc09-17fbe33aa3e7-2021-04-29T210806.386Z","2021-04-29T21:08:06.386Z","Antibody Deficiencies GCEP"
"CDC14A","HGNC:1718","hearing impairment and infertile male syndrome","MONDO:0100069","AR","SOP5","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_144089d2-83ec-4c6c-8b43-9a4cae801d51-2020-03-11T132601.755Z","2020-03-11T13:26:01.755Z","Hearing Loss"
"CDC14A","HGNC:1718","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e869e4b1-30e2-4d9b-9b69-124903d7b307-2018-02-26T170000.000Z","2018-02-26T17:00:00.000Z","Hearing Loss"
"CDC42","HGNC:1736","macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome","MONDO:0014757","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_95177a3a-0dca-4945-8a44-f63697739cef-2021-10-27T162623.932Z","2021-10-27T16:26:23.932Z","Hemostasis Thrombosis"
"CDC73","HGNC:16783","hyperparathyroidism 2 with jaw tumors","MONDO:0007768","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a5bd498b-dc86-4f2d-a51b-48baf7017a02-2018-10-12T210249.200Z","2018-10-12T21:02:49.200Z","Hereditary Cancer"
"CDH1","HGNC:1748","hereditary nonpolyposis colon cancer","MONDO:0018630","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8433","2017-06-08T00:00:00","Colon Cancer"
"CDH1","HGNC:1748","hereditary breast carcinoma","MONDO:0016419","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8502","2017-01-25T00:00:00","Breast/Ovarian Cancer"
"CDH1","HGNC:1748","familial ovarian cancer","MONDO:0016248","AD","SOP4","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8503","2017-08-03T00:00:00","Breast/Ovarian Cancer"
"CDH1","HGNC:1748","hereditary diffuse gastric adenocarcinoma","MONDO:0007648","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_14223ff7-e6b0-4c60-bee6-df55301d2017-2018-10-11T185226.994Z","2018-10-11T18:52:26.994Z","Hereditary Cancer"
"CDH15","HGNC:1754","intellectual disability","MONDO:0001071","AD","SOP8","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9295bddb-d61c-47c2-b186-97296b9c4d94-2021-02-17T170000.000Z","2021-02-17T17:00:00.000Z","Intellectual Disability and Autism"
"CDH2","HGNC:1759","arrhythmogenic right ventricular cardiomyopathy","MONDO:0016587","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c7a03805-bf73-4d2d-9756-c666c67be119-2018-07-13T160000.000Z","2018-07-13T16:00:00.000Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"CDH23","HGNC:13733","Usher syndrome type 1","MONDO:0010168","AR","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5610","2017-01-30T00:00:00","Hearing Loss"
"CDH23","HGNC:13733","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f5799772-f233-4004-99a8-e6a0dddf0e8b-2018-05-22T040000.000Z","2018-05-22T04:00:00.000Z","Hearing Loss"
"CDH3","HGNC:1762","EEM syndrome","MONDO:0009155","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5791d618-93bf-4517-9c60-48e6490319a6-2021-08-05T160000.000Z","2021-08-05T16:00:00.000Z","Retina"
"CDK13","HGNC:1733","syndromic intellectual disability","MONDO:0000508","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c594bcfa-2b2c-425a-8285-74bae8e01da8-2021-12-31T225720.705Z","2021-12-31T22:57:20.705Z","Intellectual Disability and Autism"
"CDK16","HGNC:8749","X-linked complex neurodevelopmental disorder","MONDO:0100148","XL","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_93557c1a-c141-4833-bcbb-83fccbd7d761-2021-10-28T173157.308Z","2021-10-28T17:31:57.308Z","Intellectual Disability and Autism"
"CDK4","HGNC:1773","melanoma, cutaneous malignant, susceptibility to, 3","MONDO:0012183","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ca76579b-1432-4edc-84e8-b3332dce4ede-2020-01-13T194434.667Z","2020-01-13T19:44:34.667Z","Hereditary Cancer"
"CDKL5","HGNC:11411","CDKL5 disorder","MONDO:0100039","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a80cd86d-b085-4f35-9379-12a53ef367e2-2018-07-02T145731.072Z","2018-07-02T14:57:31.072Z","Rett and Angelman-like Disorders"
"CDKN1B","HGNC:1785","hereditary nonpolyposis colon cancer","MONDO:0018630","AR","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8434","2017-06-08T00:00:00","Colon Cancer"
"CDKN1B","HGNC:1785","multiple endocrine neoplasia type 4","MONDO:0012552","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b07f8882-dd5e-4831-9926-f8b4c2a8c265-2018-12-21T154854.477Z","2018-12-21T15:48:54.477Z","Hereditary Cancer"
"CDKN2A","HGNC:1787","melanoma-pancreatic cancer syndrome","MONDO:0011713","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0c0d2fc0-12b2-4855-b537-60394d0987dd-2019-08-14T194547.089Z","2019-08-14T19:45:47.089Z","Hereditary Cancer"
"CEACAM16","HGNC:31948","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e25cadf1-752a-495d-aaf2-30565519518a-2018-03-20T160000.000Z","2018-03-20T16:00:00.000Z","Hearing Loss"
"CEBPA","HGNC:1833","acute myeloid leukemia","MONDO:0018874","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4234367e-149b-4f13-9243-341396fb4ccf-2019-08-18T155916.225Z","2019-08-18T15:59:16.225Z","Hereditary Cancer"
"CEMIP","HGNC:29213","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_27d840d2-1f58-4d1c-9f6e-307db9f41b60-2018-07-17T160000.000Z","2018-07-17T16:00:00.000Z","Hearing Loss"
"CEP164","HGNC:29182","ciliopathy","MONDO:0005308","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_961b81f6-7ad1-49e2-b675-c035b4d8d35d-2021-10-27T160000.000Z","2021-10-27T16:00:00.000Z","Kidney Cystic and Ciliopathy Disorders"
"CEP57","HGNC:30794","mosaic variegated aneuploidy syndrome 2","MONDO:0013582","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c44921de-14cf-4907-8bef-1525329ee89c-2019-11-22T145303.972Z","2019-11-22T14:53:03.972Z","Hereditary Cancer"
"CEP78","HGNC:25740","cone-rod dystrophy and hearing loss","MONDO:0014980","AR","SOP4","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8149","2017-04-12T00:00:00","Hearing Loss"
"CFL2","HGNC:1875","nemaline myopathy 7","MONDO:0012538","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3c04b972-6797-42e7-87e8-ee97eb0bbad7-2019-11-25T150139.061Z","2019-11-25T15:01:39.061Z","Congenital Myopathies"
"CHD1L","HGNC:1916","congenital anomaly of kidney and urinary tract","MONDO:0019719","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3220","2016-11-18T00:00:00","General Gene Curation"
"CHD2","HGNC:1917","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5af80ea6-31c6-47d2-a5a5-299380f5593c-2018-07-18T125309.666Z","2018-07-18T12:53:09.666Z","Epilepsy"
"CHD7","HGNC:20626","CHARGE syndrome","MONDO:0008965","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_26ae5799-567b-431b-b981-3bc2f8635802-2018-08-23T160000.000Z","2018-08-23T16:00:00.000Z","Hearing Loss"
"CHD8","HGNC:20153","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3134b4e1-2fee-4025-99af-b2146cc2ccf8-2018-07-16T160000.000Z","2018-07-16T16:00:00.000Z","Intellectual Disability and Autism"
"CHEK1","HGNC:1925","familial ovarian cancer","MONDO:0016248","AD","SOP4","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8504","2016-10-12T00:00:00","Breast/Ovarian Cancer"
"CHEK1","HGNC:1925","hereditary breast carcinoma","MONDO:0016419","AD","SOP4","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8505","2016-10-12T00:00:00","Breast/Ovarian Cancer"
"CHEK2","HGNC:16627","hereditary breast carcinoma","MONDO:0016419","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8522","2016-12-14T00:00:00","Breast/Ovarian Cancer"
"CHEK2","HGNC:16627","familial ovarian cancer","MONDO:0016248","AD","SOP4","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8523","2016-12-14T00:00:00","Breast/Ovarian Cancer"
"CHEK2","HGNC:16627","hereditary nonpolyposis colon cancer","MONDO:0018630","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9862","2017-03-13T00:00:00","Breast/Ovarian Cancer"
"CHM","HGNC:1940","choroideremia","MONDO:0010557","XL","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d84b01d6-8b3c-4a1e-bd25-68ee6962f374-2020-10-26T124704.094Z","2020-10-26T12:47:04.094Z","Retina"
"CHRNA2","HGNC:1956","sleep-related hypermotor epilepsy","MONDO:0000030","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0f832b8a-af5a-494e-bfdb-70cc619addf1-2020-12-25T015652.186Z","2020-12-25T01:56:52.186Z","Epilepsy"
"CHRNA2","HGNC:1956","benign familial neonatal-infantile seizures","MONDO:0011140","AD","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7916abab-d963-4e9c-8913-1decc21b680c-2020-01-07T170000.000Z","2020-01-07T17:00:00.000Z","Epilepsy"
"CHRNA2","HGNC:1956","epilepsy","MONDO:0005027","AD","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ce166e6d-92ad-49fc-a3c3-e473b0cabf0d-2020-12-24T170000.000Z","2020-12-24T17:00:00.000Z","Epilepsy"
"CHRNA4","HGNC:1958","sleep-related hypermotor epilepsy","MONDO:0000030","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e3aa0108-5514-48ba-a09c-5506b2030d1f-2020-02-18T170000.000Z","2020-02-18T17:00:00.000Z","Epilepsy"
"CIB2","HGNC:24579","Usher syndrome type 1","MONDO:0010168","AR","SOP6","Refuted","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_95709038-78a4-4043-a054-9cbe245d2588-2019-02-19T170000.000Z","2019-02-19T17:00:00.000Z","Hearing Loss"
"CIB2","HGNC:24579","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d4187cb6-182f-43fc-aeec-d27297c36bdb-2018-02-20T170000.000Z","2018-02-20T17:00:00.000Z","Hearing Loss"
"CISD2","HGNC:24212","Wolfram syndrome","MONDO:0018105","AR","SOP6","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0a18d59c-c00c-4bb3-b6d6-1e59b92d1313-2018-03-27T160000.000Z","2018-03-27T16:00:00.000Z","Hearing Loss"
"CLCN4","HGNC:2022","non-syndromic X-linked intellectual disability","MONDO:0019181","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_54fbcbc8-77d7-4496-8527-1171cdd7452c-2017-10-20T160000.000Z","2017-10-20T16:00:00.000Z","Intellectual Disability and Autism"
"CLDN14","HGNC:2035","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_17528cdb-97e0-4128-92de-9e419902aa62-2018-05-01T160000.000Z","2018-05-01T16:00:00.000Z","Hearing Loss"
"CLIC2","HGNC:2063","X-linked complex neurodevelopmental disorder","MONDO:0100148","XL","SOP8","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3e8ec6b8-5189-43eb-a741-833c77e7ce91-2021-02-16T170000.000Z","2021-02-16T17:00:00.000Z","Intellectual Disability and Autism"
"CLN5","HGNC:2076","neuronal ceroid lipofuscinosis","MONDO:0016295","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a522b1d6-5ade-4749-94b8-d5426bbe5961-2021-09-08T023930.981Z","2021-09-08T02:39:30.981Z","Epilepsy"
"CLN6","HGNC:2077","neuronal ceroid lipofuscinosis","MONDO:0016295","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_09654b45-6649-4d11-b43e-aeb6d20fb86d-2020-12-01T170000.000Z","2020-12-01T17:00:00.000Z","Epilepsy"
"CLN8","HGNC:2079","neuronal ceroid lipofuscinosis","MONDO:0016295","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_68775ed0-576e-4ee7-90f2-d16329ecd7c1-2020-09-07T220116.243Z","2020-09-07T22:01:16.243Z","Epilepsy"
"CLPB","HGNC:30664","Leigh syndrome","MONDO:0009723","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_789c591d-1de7-4652-a0d1-f895b639233e-2020-11-23T201057.415Z","2020-11-23T20:10:57.415Z","Mitochondrial Diseases"
"CLPP","HGNC:2084","Perrault syndrome 3","MONDO:0013588","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_15291cb2-a541-4f88-91c8-0b441e3b64cb-2018-03-27T160000.000Z","2018-03-27T16:00:00.000Z","Hearing Loss"
"CLRN1","HGNC:12605","Usher syndrome type 3","MONDO:0016485","AR","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8400","2017-03-02T00:00:00","Hearing Loss"
"CNGB3","HGNC:2153","achromatopsia 3","MONDO:0009875","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aa7bad05-3d4d-4a69-b4e9-82f9224a77f4-2021-10-07T160000.000Z","2021-10-07T16:00:00.000Z","Retina"
"CNKSR2","HGNC:19701","X-linked complex neurodevelopmental disorder","MONDO:0100148","XL","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_420ee599-c745-43b9-b9a9-c80dfd7f68a8-2020-12-16T170000.000Z","2020-12-16T17:00:00.000Z","Intellectual Disability and Autism"
"CNNM4","HGNC:105","Jalili syndrome","MONDO:0009007","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e3cedd07-df9e-4838-8a6b-b24b2802f223-2021-08-06T154836.361Z","2021-08-06T15:48:36.361Z","Retina"
"CNOT3","HGNC:7879","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_585384c5-8958-4934-af26-4040774a644c-2021-08-24T160000.000Z","2021-08-24T16:00:00.000Z","Intellectual Disability and Autism"
"CNTNAP2","HGNC:13830","complex neurodevelopmental disorder","MONDO:0100038","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3af732e2-062d-4bb3-a3cd-2045e460dc8f-2021-06-15T160000.000Z","2021-06-15T16:00:00.000Z","Epilepsy"
"CNTNAP2","HGNC:13830","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP8","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e91dc4be-821d-4f54-acdd-755a25070eec-2021-03-16T160000.000Z","2021-03-16T16:00:00.000Z","Intellectual Disability and Autism"
"COCH","HGNC:2180","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_998da390-3e32-4b80-a733-d64d87d5357b-2018-01-05T170000.000Z","2018-01-05T17:00:00.000Z","Hearing Loss"
"COL11A2","HGNC:2187","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0665772a-ba94-4561-b597-364f7db7e4ca-2018-12-20T170000.000Z","2018-12-20T17:00:00.000Z","Hearing Loss"
"COL11A2","HGNC:2187","otospondylomegaepiphyseal dysplasia","MONDO:0008975","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_177bddd8-0566-4f80-a9f1-679ca96a7c60-2018-12-20T170000.000Z","2018-12-20T17:00:00.000Z","Hearing Loss"
"COL11A2","HGNC:2187","otospondylomegaepiphyseal dysplasia","MONDO:0008975","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_27b13a91-0a04-4393-bf1c-4f8418154c9b-2018-12-20T170000.000Z","2018-12-20T17:00:00.000Z","Hearing Loss"
"COL11A2","HGNC:2187","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_561327b9-7c55-40c3-b83c-5a3ed9d75606-2018-12-20T170000.000Z","2018-12-20T17:00:00.000Z","Hearing Loss"
"COL1A1","HGNC:2197","osteogenesis imperfecta type 2","MONDO:0008147","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0b093295-1c7c-4526-90eb-d6a9fff1cc75-2021-03-22T211103.977Z","2021-03-22T21:11:03.977Z","Skeletal Disorders"
"COL1A1","HGNC:2197","osteogenesis imperfecta type 1","MONDO:0008146","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_74914fec-a5c4-437c-8c83-66c9f1df3e6e-2021-03-16T235154.009Z","2021-03-16T23:51:54.009Z","Skeletal Disorders"
"COL1A1","HGNC:2197","osteogenesis imperfecta type 3","MONDO:0009804","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a51b8f9f-0e11-4d82-b454-15d27e974dd7-2021-06-24T204605.941Z","2021-06-24T20:46:05.941Z","Skeletal Disorders"
"COL2A1","HGNC:2200","spondyloepiphyseal dysplasia, Stanescu type","MONDO:0014701","AD","SOP4","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_4843","2016-12-01T00:00:00","General Gene Curation"
"COL2A1","HGNC:2200","spondyloepiphyseal dysplasia congenita","MONDO:0008471","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0f217fba-a78c-4f9f-ad2a-301f0d53f046-2021-06-07T170000.000Z","2021-06-07T17:00:00.000Z","Skeletal Disorders"
"COL2A1","HGNC:2200","achondrogenesis type II","MONDO:0008702","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_14640c06-c66e-4dc7-86ea-9b0850e51474-2020-10-05T170000.000Z","2020-10-05T17:00:00.000Z","Skeletal Disorders"
"COL2A1","HGNC:2200","Kniest dysplasia","MONDO:0007987","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_25a49ec9-69ab-4e51-a13a-fe1eaa50ae56-2021-12-15T183542.376Z","2021-12-15T18:35:42.376Z","Skeletal Disorders"
"COL2A1","HGNC:2200","platyspondylic dysplasia, Torrance type","MONDO:0007895","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a4c42c43-7b6a-4456-aeb1-7a00302a468b-2021-02-01T180000.000Z","2021-02-01T18:00:00.000Z","Skeletal Disorders"
"COL2A1","HGNC:2200","spondyloperipheral dysplasia-short ulna syndrome","MONDO:0010078","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d4da6e1f-5aad-4541-a3ae-76ed4782a023-2022-01-06T154807.494Z","2022-01-06T15:48:07.494Z","Skeletal Disorders"
"COL2A1","HGNC:2200","spondylometaphyseal dysplasia","MONDO:0016763","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e5315530-5b3c-42f1-b18c-1884a0b767f6-2021-06-07T160000.000Z","2021-06-07T16:00:00.000Z","Skeletal Disorders"
"COL3A1","HGNC:2201","Ehlers-Danlos syndrome, vascular type","MONDO:0017314","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ce795591-1c7c-4a52-886a-a294293c67c3-2019-02-27T170000.000Z","2019-02-27T17:00:00.000Z","General Gene Curation"
"COL4A5","HGNC:2207","Alport syndrome","MONDO:0018965","XL","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0407dc2e-1cab-4043-889d-4695b043d7b3-2019-03-19T160000.000Z","2019-03-19T16:00:00.000Z","Hearing Loss"
"COL4A6","HGNC:2208","hearing loss, X-linked 6","MONDO:0010484","XL","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d026ef00-c6f3-4aa8-a61a-b354b68fe043-2018-01-16T170000.000Z","2018-01-16T17:00:00.000Z","Hearing Loss"
"COL5A1","HGNC:2209","Ehlers-Danlos syndrome, classic type","MONDO:0007522","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3133eacb-2ef9-4463-8031-11d10f0e91b9-2021-03-24T151331.225Z","2021-03-24T15:13:31.225Z","General Gene Curation"
"COL5A2","HGNC:2210","Ehlers-Danlos syndrome, classic type","MONDO:0007522","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1901d495-d33f-4741-88fd-4b66ac43bbad-2021-03-24T184245.711Z","2021-03-24T18:42:45.711Z","General Gene Curation"
"COL6A1","HGNC:2211","collagen 6-related myopathy","MONDO:0100225","SD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_56f239a3-d5dc-4be6-a6ab-0cf9bf62133f-2021-01-22T170000.000Z","2021-01-22T17:00:00.000Z","Congenital Myopathies"
"COL6A2","HGNC:2212","collagen 6-related myopathy","MONDO:0100225","SD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5fbb3f66-4f91-4c43-9900-6aba89420a7f-2021-02-22T170000.000Z","2021-02-22T17:00:00.000Z","Congenital Myopathies"
"COL6A3","HGNC:2213","collagen 6-related myopathy","MONDO:0100225","SD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3112c174-c9ee-494d-b8ba-2ad61537e1ad-2021-05-24T160000.000Z","2021-05-24T16:00:00.000Z","Congenital Myopathies"
"COL6A3","HGNC:2213","dystonia 27","MONDO:0014627","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8a109763-6fff-4da9-b826-7c2544d3f878-2021-05-24T160000.000Z","2021-05-24T16:00:00.000Z","Congenital Myopathies"
"COL9A1","HGNC:2217","Stickler syndrome","MONDO:0019354","AR","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9807","2018-03-26T00:00:00","Heritable Thoracic Aortic Aneurysm and Dissection"
"COL9A2","HGNC:2218","Stickler syndrome","MONDO:0019354","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_697ae26e-2b07-4f87-b42c-121684c89bc0-2019-02-19T170000.000Z","2019-02-19T17:00:00.000Z","Hearing Loss"
"COL9A3","HGNC:2219","Stickler syndrome","MONDO:0019354","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a436c41e-0873-4e4c-b2f2-d56f75ca737a-2019-09-17T160000.000Z","2019-09-17T16:00:00.000Z","Hearing Loss"
"COMP","HGNC:2227","multiple epiphyseal dysplasia","MONDO:0016648","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0e93c534-284e-40eb-9076-343a825d3a46-2020-03-24T170000.000Z","2020-03-24T17:00:00.000Z","Skeletal Disorders"
"COMP","HGNC:2227","pseudoachondroplasia","MONDO:0008322","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_630905e9-0f42-452b-81fa-7fad4eae08f9-2020-02-07T180000.000Z","2020-02-07T18:00:00.000Z","Skeletal Disorders"
"COQ9","HGNC:25302","Leigh syndrome","MONDO:0009723","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cebc5501-5d36-4767-98bc-edc4ddab3527-2021-04-09T140634.407Z","2021-04-09T14:06:34.407Z","Mitochondrial Diseases"
"COX10","HGNC:2260","Leigh syndrome","MONDO:0009723","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_48794019-db9d-47c2-9977-4dc76a7d07b3-2019-05-20T182801.393Z","2019-05-20T18:28:01.393Z","Mitochondrial Diseases"
"COX15","HGNC:2263","Leigh syndrome","MONDO:0009723","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b5c8d1e1-24d0-4b88-8c04-023197db14f3-2019-05-20T183321.284Z","2019-05-20T18:33:21.284Z","Mitochondrial Diseases"
"COX4I1","HGNC:2265","Leigh syndrome","MONDO:0009723","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d56c1fe4-7711-45f4-992c-7e9586b9efc6-2021-04-09T135824.042Z","2021-04-09T13:58:24.042Z","Mitochondrial Diseases"
"COX8A","HGNC:2294","Leigh syndrome","MONDO:0009723","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_70763eb9-40f7-4f71-a64b-ab0c6ad536b0-2021-04-09T135510.592Z","2021-04-09T13:55:10.592Z","Mitochondrial Diseases"
"CPA6","HGNC:17245","epilepsy","MONDO:0005027","AD","SOP8","Refuted","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1cb32379-82a8-425d-ac80-3d740e1cc10b-2021-07-29T132527.108Z","2021-07-29T13:25:27.108Z","Epilepsy"
"CPA6","HGNC:17245","epilepsy","MONDO:0005027","AR","SOP8","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7b3ebd58-dccb-4c73-b5e4-1ec55171f2fe-2021-07-29T135909.720Z","2021-07-29T13:59:09.720Z","Epilepsy"
"CPS1","HGNC:2323","carbamoyl phosphate synthetase I deficiency disease","MONDO:0009376","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dbc4dbbe-8827-4d68-a396-8368f3801e78-2018-10-12T160000.000Z","2018-10-12T16:00:00.000Z","Aminoacidopathy"
"CPT1A","HGNC:2328","carnitine palmitoyl transferase 1A deficiency","MONDO:0009705","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dcea255c-11e4-46fd-b0f7-2de68311a75c-2018-01-23T170000.000Z","2018-01-23T17:00:00.000Z","Fatty Acid Oxidation Disorders"
"CPT1B","HGNC:2329","inherited fatty acid metabolism disorder","MONDO:0037858","Undetermined","SOP7","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cfcd80c7-d806-41cf-8c3a-7ba955919537-2021-01-25T194946.827Z","2021-01-25T19:49:46.827Z","Fatty Acid Oxidation Disorders"
"CPT2","HGNC:2330","carnitine palmitoyltransferase II deficiency","MONDO:0015515","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1a57ea10-6ca0-4311-94f1-0ad036a38ca6-2018-03-27T160000.000Z","2018-03-27T16:00:00.000Z","Fatty Acid Oxidation Disorders"
"CR2","HGNC:2336","immunodeficiency, common variable, 7","MONDO:0013862","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9153b41e-f2ef-453d-883b-187565cf4593-2021-08-03T130056.511Z","2021-08-03T13:00:56.511Z","Antibody Deficiencies GCEP"
"CRADD","HGNC:2340","syndromic intellectual disability","MONDO:0000508","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7f64ee7f-13a7-4a2d-b1a2-ad6c9e63cab3-2021-06-16T180000.000Z","2021-06-16T18:00:00.000Z","Intellectual Disability and Autism"
"CRBN","HGNC:30185","intellectual disability","MONDO:0001071","AR","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_158c9b6b-2ac8-4ee3-bd89-a57d567e675f-2021-05-21T135046.004Z","2021-05-21T13:50:46.004Z","Intellectual Disability and Autism"
"CREBBP","HGNC:2348","Rubinstein-Taybi syndrome due to CREBBP mutations","MONDO:0008393","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9554","2018-02-21T00:00:00","Intellectual Disability and Autism"
"CRH","HGNC:2355","epilepsy","MONDO:0005027","AD","SOP8","Refuted","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e1719f97-0d6c-4ed3-93bc-13cc8e1f1d6e-2021-09-21T160000.000Z","2021-09-21T16:00:00.000Z","Epilepsy"
"CRYM","HGNC:2418","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d15cf48a-3696-467a-b3c8-a45ef5a577bf-2021-09-21T160000.000Z","2021-09-21T16:00:00.000Z","Hearing Loss"
"CSPP1","HGNC:26193","Joubert syndrome 21","MONDO:0014288","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e24d1591-91b7-4c2f-bd79-d4dc8be0974d-2021-06-23T160000.000Z","2021-06-23T16:00:00.000Z","Kidney Cystic and Ciliopathy Disorders"
"CSRP3","HGNC:2472","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP5","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_130d778f-f756-4f3d-b6b2-909e40836c5a-2017-12-19T170000.000Z","2017-12-19T17:00:00.000Z","Hypertrophic Cardiomyopathy"
"CSRP3","HGNC:2472","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_beaafc90-20ef-4c81-ad8f-cfcf69d269ca-2020-11-06T165245.603Z","2020-11-06T16:52:45.603Z","Dilated Cardiomyopathy"
"CSTB","HGNC:2482","Unverricht-Lundborg syndrome","MONDO:0009698","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2926506c-5b75-4340-b821-e3ac846b6621-2020-06-16T160000.000Z","2020-06-16T16:00:00.000Z","Epilepsy"
"CSTB","HGNC:2482","developmental and epileptic encephalopathy","MONDO:0100062","AR","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_accafcd4-ba3c-4049-9285-1de877d256ec-2020-12-01T170000.000Z","2020-12-01T17:00:00.000Z","Epilepsy"
"CTCF","HGNC:13723","syndromic intellectual disability","MONDO:0000508","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f1cbcd7b-83e2-47c1-b708-c9052502e639-2021-07-21T160000.000Z","2021-07-21T16:00:00.000Z","Intellectual Disability and Autism"
"CTF1","HGNC:2499","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ef19cc13-543b-451e-b278-ec1fc04f694c-2020-08-12T040000.000Z","2020-08-12T04:00:00.000Z","Dilated Cardiomyopathy"
"CTH","HGNC:2501","cystathioninuria","MONDO:0009058","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2f5047f7-80ba-4b8f-8009-59d7130e63be-2019-06-14T160000.000Z","2019-06-14T16:00:00.000Z","Aminoacidopathy"
"CTLA4","HGNC:2505","autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency","MONDO:0014493","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e79675bd-3eef-4925-b4ef-3b7c48734f30-2021-04-28T163716.269Z","2021-04-28T16:37:16.269Z","Antibody Deficiencies GCEP"
"CTNNA1","HGNC:2509","hereditary nonpolyposis colon cancer","MONDO:0018630","AD","SOP4","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9868","2017-04-24T00:00:00","Colon Cancer"
"CTNNA3","HGNC:2511","arrhythmogenic right ventricular cardiomyopathy","MONDO:0016587","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0f1dd946-f2bb-496f-8fea-3dea303e2e76-2019-08-06T160000.000Z","2019-08-06T16:00:00.000Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"CTNNB1","HGNC:2514","severe intellectual disability-progressive spastic diplegia syndrome","MONDO:0014035","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e119aceb-a011-4811-9abd-6731c5b3d15d-2021-02-03T170000.000Z","2021-02-03T17:00:00.000Z","Intellectual Disability and Autism"
"CTSD","HGNC:2529","neuronal ceroid lipofuscinosis","MONDO:0016295","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d74b1b2a-52a3-4192-b5b4-e4fd46ffc0ba-2020-11-03T180000.000Z","2020-11-03T18:00:00.000Z","Epilepsy"
"CUL3","HGNC:2553","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fb529ace-86b5-4209-9974-9c07a1c32956-2021-01-16T030942.670Z","2021-01-16T03:09:42.670Z","Intellectual Disability and Autism"
"CUL4B","HGNC:2555","X-linked intellectual disability, Cabezas type","MONDO:0010306","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cc93f3b2-3124-40f8-a86e-c929b09c6f68-2018-02-21T050000.000Z","2018-02-21T05:00:00.000Z","Intellectual Disability and Autism"
"CYCS","HGNC:19986","thrombocytopenia 4","MONDO:0012775","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_772f2ad2-5d8c-41f6-95c4-39063daf77be-2021-06-23T170356.081Z","2021-06-23T17:03:56.081Z","Hemostasis Thrombosis"
"CYLD","HGNC:2584","Brooke-Spiegler syndrome","MONDO:0011512","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_434ddb72-ee88-47af-9fa2-8dee9fa0a388-2018-12-21T153626.610Z","2018-12-21T15:36:26.610Z","Hereditary Cancer"
"CYP4V2","HGNC:23198","Bietti crystalline corneoretinal dystrophy","MONDO:0008865","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_da577a4b-5c65-43fa-9a03-b275eaacb6eb-2021-04-01T160000.000Z","2021-04-01T16:00:00.000Z","Retina"
"DAG1","HGNC:2666","qualitative or quantitative defects of alpha-dystroglycan","MONDO:0018282","AR","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_61b73fd7-5578-447b-9482-ea64d62dae1d-2021-07-27T163613.141Z","2021-07-27T16:36:13.141Z","Limb Girdle Muscular Dystrophy"
"DBT","HGNC:2698","maple syrup urine disease","MONDO:0009563","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cfd1ebde-e447-4877-977e-f5b9fe434adc-2018-10-30T160000.000Z","2018-10-30T16:00:00.000Z","Aminoacidopathy"
"DCAF17","HGNC:25784","Woodhouse-Sakati syndrome","MONDO:0009419","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6a1d7719-4261-494d-87aa-745518580673-2021-07-27T153526.827Z","2021-07-27T15:35:26.827Z","Syndromic Disorders"
"DCDC2","HGNC:18141","ciliopathy","MONDO:0005308","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_477c8aba-eeba-43dc-a5e2-f6f84b127b8f-2021-10-13T160000.000Z","2021-10-13T16:00:00.000Z","Kidney Cystic and Ciliopathy Disorders"
"DCDC2","HGNC:18141","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_86802e37-e2a5-43b9-8538-e104859b4c55-2020-08-31T170000.000Z","2020-08-31T17:00:00.000Z","Hearing Loss"
"DCLRE1C","HGNC:17642","severe combined immunodeficiency due to DCLRE1C deficiency","MONDO:0011225","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_603e0855-2b57-4463-a9b7-1c5d70089a4f-2021-02-18T154301.245Z","2021-02-18T15:43:01.245Z","SCID-CID"
"DCX","HGNC:2714","lissencephaly spectrum disorders","MONDO:0018838","XL","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3b0d23d1-5ca6-4584-9d74-cf78ca21b0e1-2021-02-23T150911.296Z","2021-02-23T15:09:11.296Z","Brain Malformations"
"DDB2","HGNC:2718","xeroderma pigmentosum group E","MONDO:0010213","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cf2a4254-51ec-467a-9194-3962d39a6b20-2018-11-02T214938.544Z","2018-11-02T21:49:38.544Z","Hereditary Cancer"
"DDX3X","HGNC:2745","X-linked syndromic intellectual disability","MONDO:0020119","XL","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3b7c89d4-ccb2-4d4e-ad11-9d6051a40b6d-2020-05-05T160000.000Z","2020-05-05T16:00:00.000Z","Intellectual Disability and Autism"
"DDX41","HGNC:18674","DDX41-related hematologic malignancy predisposition syndrome","MONDO:0014809","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e3db8214-a39d-408d-a3c2-7b4e817b1cc1-2020-07-30T202935.621Z","2020-07-30T20:29:35.621Z","Hereditary Cancer"
"DECR1","HGNC:2753","progressive encephalopathy with leukodystrophy due to DECR deficiency","MONDO:0014464","Undetermined","SOP7","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1d25dfe8-8d0b-4b45-b04c-b315ebdceaaa-2021-01-25T194921.121Z","2021-01-25T19:49:21.121Z","Fatty Acid Oxidation Disorders"
"DEPDC5","HGNC:18423","familial focal epilepsy with variable foci","MONDO:0020310","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_82a82c75-f9a5-4f51-a15c-6513c13df57c-2018-08-24T135901.645Z","2018-08-24T13:59:01.645Z","Epilepsy"
"DES","HGNC:2770","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_91b2595a-5eb9-4ac3-aa3d-d5f99cacad84-2020-10-09T160000.000Z","2020-10-09T16:00:00.000Z","Dilated Cardiomyopathy"
"DES","HGNC:2770","myofibrillar myopathy","MONDO:0018943","SD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_93dbca4d-5b8c-42f2-b8a3-41128b417dcb-2020-08-20T182404.015Z","2020-08-20T18:24:04.015Z","Limb Girdle Muscular Dystrophy"
"DES","HGNC:2770","arrhythmogenic right ventricular cardiomyopathy","MONDO:0016587","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aef9a60b-a94f-4318-824e-e748c5c20ecb-2018-09-11T160000.000Z","2018-09-11T16:00:00.000Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"DHCR7","HGNC:2860","Smith-Lemli-Opitz syndrome","MONDO:0010035","AR","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d5ed71c9-a76b-44c0-b5c0-44d604f2e0e9-2018-09-11T163302.452Z","2018-09-11T16:33:02.452Z","Intellectual Disability and Autism"
"DHTKD1","HGNC:23537","2-aminoadipic 2-oxoadipic aciduria","MONDO:0008774","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d6dd5de3-9819-432d-996c-12a66dff277f-2020-11-03T193815.515Z","2020-11-03T19:38:15.515Z","Aminoacidopathy"
"DIABLO","HGNC:21528","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f5903c3b-b2d7-4c14-b196-37533187d807-2017-12-19T170000.000Z","2017-12-19T17:00:00.000Z","Hearing Loss"
"DIAPH1","HGNC:2876","diaph1-related sensorineural hearing loss-thrombocytopenia syndrome","MONDO:0044635","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_43c017fd-ce70-4fbe-ad30-90f216adaa7d-2018-01-05T170000.000Z","2018-01-05T17:00:00.000Z","Hearing Loss"
"DIAPH3","HGNC:15480","auditory neuropathy","MONDO:0021944","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fc54aaf6-8e1b-4c98-bcbe-e1f337f6eadc-2020-02-06T170000.000Z","2020-02-06T17:00:00.000Z","Hearing Loss"
"DICER1","HGNC:17098","pleuropulmonary blastoma","MONDO:0011014","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3212","2017-01-08T00:00:00","General Gene Curation"
"DIS3L2","HGNC:28648","Perlman syndrome","MONDO:0009965","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e68b93df-e0e7-4d46-8934-8b86064c0b37-2019-11-21T193052.781Z","2019-11-21T19:30:52.781Z","Hereditary Cancer"
"DKC1","HGNC:2890","DKC1-related disorder","MONDO:0100152","XL","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_afd6a4ca-7a1c-42ef-a9cf-bef557128f12-2020-09-13T153338.000Z","2020-09-13T15:33:38.000Z","Intellectual Disability and Autism"
"DKC1","HGNC:2890","dyskeratosis congenita, X-linked","MONDO:0010584","XL","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bb90bea1-16e7-44da-8551-91fb5fd7088a-2021-06-15T234140.163Z","2021-06-15T23:41:40.163Z","Hereditary Cancer"
"DLAT","HGNC:2896","Leigh syndrome","MONDO:0009723","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_78e45dbe-ea30-434d-9522-aa1731b9a764-2021-01-14T212056.234Z","2021-01-14T21:20:56.234Z","Mitochondrial Diseases"
"DLD","HGNC:2898","Leigh syndrome","MONDO:0009723","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_990dd96f-16ec-4c0f-a46b-ce4a647b7a50-2021-03-11T171246.198Z","2021-03-11T17:12:46.198Z","Mitochondrial Diseases"
"DLD","HGNC:2898","pyruvate dehydrogenase E3 deficiency","MONDO:0009529","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a9dfbbc2-cede-491e-9db0-fc5719fbc729-2019-03-08T170000.000Z","2019-03-08T17:00:00.000Z","Aminoacidopathy"
"DLG3","HGNC:2902","non-syndromic X-linked intellectual disability","MONDO:0019181","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e73a08f0-ff3a-4328-9020-89102296e405-2018-08-24T164248.949Z","2018-08-24T16:42:48.949Z","Intellectual Disability and Autism"
"DLGAP2","HGNC:2906","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_efeafdd5-9105-470f-b332-8c7a3dd65078-2021-10-14T160000.000Z","2021-10-14T16:00:00.000Z","Intellectual Disability and Autism"
"DMD","HGNC:2928","progressive muscular dystrophy","MONDO:0016106","XL","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b528435f-dc16-45e0-9f0f-2da3f293ab4c-2021-04-09T185212.943Z","2021-04-09T18:52:12.943Z","Limb Girdle Muscular Dystrophy"
"DMGDH","HGNC:24475","dimethylglycine dehydrogenase deficiency","MONDO:0011610","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b181250b-bc72-43b7-adec-5b85860b1a62-2019-06-28T160000.000Z","2019-06-28T16:00:00.000Z","Aminoacidopathy"
"DMXL2","HGNC:2938","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_746b46e8-0621-4879-80a1-4fb1679975be-2020-02-06T170000.000Z","2020-02-06T17:00:00.000Z","Hearing Loss"
"DNAH11","HGNC:2942","primary ciliary dyskinesia 7","MONDO:0012748","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_84088c46-0763-4ed6-9352-530d846e8b24-2021-10-25T190427.941Z","2021-10-25T19:04:27.941Z","Motile Ciliopathy"
"DNAH5","HGNC:2950","primary ciliary dyskinesia 3","MONDO:0012085","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4390dba1-012d-4e08-a841-ffc08ebdc737-2022-01-07T190607.723Z","2022-01-07T19:06:07.723Z","Motile Ciliopathy"
"DNAJB11","HGNC:14889","polycystic kidney disease 6 with or without polycystic liver disease","MONDO:0054842","AD","SOP7","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dbbe08a1-2f13-445d-9492-d1f070e66c0c-2021-02-26T152748.643Z","2021-02-26T15:27:48.643Z","Kidney Cystic and Ciliopathy Disorders"
"DNAJC12","HGNC:28908","hyperphenylalaninemia due to DNAJC12 deficiency","MONDO:0044304","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_500ad0d5-2871-4b25-a96f-0c0816524a4b-2021-01-11T184823.935Z","2021-01-11T18:48:23.935Z","Aminoacidopathy"
"DNAJC19","HGNC:30528","3-methylglutaconic aciduria type 5","MONDO:0012435","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fa7f8087-632d-4044-9e20-722085c3b42c-2021-09-24T024347.391Z","2021-09-24T02:43:47.391Z","General Inborn Errors of Metabolism"
"DNAJC5","HGNC:16235","adult neuronal ceroid lipofuscinosis","MONDO:0019260","AD","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_67f55ef1-b312-4aac-bc04-67beb2405b4f-2021-07-30T052005.845Z","2021-07-30T05:20:05.845Z","Epilepsy"
"DNM1","HGNC:2972","developmental and epileptic encephalopathy","MONDO:0100062","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_31f598a3-7efd-4e43-83f3-587e98924260-2016-12-13T170000.000Z","2016-12-13T17:00:00.000Z","Epilepsy"
"DNM1L","HGNC:2973","Leigh syndrome","MONDO:0009723","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0a922695-f136-44f8-ab1a-6581e0efafec-2021-06-30T144517.300Z","2021-06-30T14:45:17.300Z","Mitochondrial Diseases"
"DNM1L","HGNC:2973","encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1","MONDO:0013726","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_320f4ab3-19c3-458e-9e81-0f380cbfebbd-2020-08-05T160000.000Z","2020-08-05T16:00:00.000Z","Peroxisomal Disorders"
"DNM1L","HGNC:2973","Leigh syndrome","MONDO:0009723","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c22e9c6b-f04d-4d56-acb3-baa308c596b7-2021-06-30T144120.695Z","2021-06-30T14:41:20.695Z","Mitochondrial Diseases"
"DNM2","HGNC:2974","Charcot-Marie-Tooth disease","MONDO:0015626","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7bc54e5d-eed5-4d40-9e0d-143bfeb88cac-2020-10-27T131827.010Z","2020-10-27T13:18:27.010Z","Charcot-Marie-Tooth"
"DNM2","HGNC:2974","autosomal dominant centronuclear myopathy","MONDO:0008048","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e4156721-f6b9-482c-b610-97753f3f722d-2019-12-20T170000.000Z","2019-12-20T17:00:00.000Z","Congenital Myopathies"
"DNMT1","HGNC:2976","autosomal dominant cerebellar ataxia, deafness and narcolepsy","MONDO:0011397","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_6235","2017-02-10T00:00:00","Hearing Loss"
"DOCK7","HGNC:19190","developmental and epileptic encephalopathy","MONDO:0100062","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0b6ed421-950b-4862-bade-dc545555ac29-2021-07-28T192512.688Z","2021-07-28T19:25:12.688Z","Epilepsy"
"DPP6","HGNC:3010","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP8","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3d41cebe-5490-419d-882d-4f3c6856be07-2021-05-05T160000.000Z","2021-05-05T16:00:00.000Z","Intellectual Disability and Autism"
"DSC2","HGNC:3036","familial isolated arrhythmogenic right ventricular dysplasia","MONDO:0016342","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_74238dee-a847-4f27-9d30-3050c7bf9bf2-2018-09-14T160000.000Z","2018-09-14T16:00:00.000Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"DSG2","HGNC:3049","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7df1018-593f-481f-9dd0-77ce3ea829a6-2020-08-07T160000.000Z","2020-08-07T16:00:00.000Z","Dilated Cardiomyopathy"
"DSG2","HGNC:3049","arrhythmogenic right ventricular cardiomyopathy","MONDO:0016587","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f679611d-6e25-45f9-aac3-4a8ad37b1592-2018-09-14T160000.000Z","2018-09-14T16:00:00.000Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"DSP","HGNC:3052","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_432cd4f9-e73e-480b-9f1a-c43b3a17e1d4-2020-08-12T160000.000Z","2020-08-12T16:00:00.000Z","Dilated Cardiomyopathy"
"DSP","HGNC:3052","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP7","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_83a9ea83-5dec-4496-a5d8-9b5fdf9373d7-2020-04-07T022432.190Z","2020-04-07T02:24:32.190Z","Hypertrophic Cardiomyopathy"
"DSP","HGNC:3052","arrhythmogenic cardiomyopathy with woolly hair and keratoderma","MONDO:0011581","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b23da580-269c-4e5d-8f13-91dbe7ea6a57-2019-07-12T160000.000Z","2019-07-12T16:00:00.000Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"DSPP","HGNC:3054","dentinogenesis imperfecta","MONDO:0018849","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_39f5492a-97a3-49a6-929d-f24f23b51217-2018-04-17T160000.000Z","2018-04-17T16:00:00.000Z","Hearing Loss"
"DST","HGNC:1090","hereditary sensory and autonomic neuropathy type 6","MONDO:0013839","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d90c7de8-a72a-4c54-bab8-fe9d4aef0409-2021-12-14T170000.000Z","2021-12-14T17:00:00.000Z","Charcot-Marie-Tooth"
"DTNA","HGNC:3057","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cdac9dca-0cc7-4cca-9af7-d2767d917fd4-2020-08-12T160000.000Z","2020-08-12T16:00:00.000Z","Dilated Cardiomyopathy"
"DTNBP1","HGNC:17328","Hermansky-Pudlak syndrome 7","MONDO:0013559","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_785a39b1-9c7b-4745-94b6-be6a9376ac97-2021-02-24T170000.000Z","2021-02-24T17:00:00.000Z","Hemostasis Thrombosis"
"DYRK1A","HGNC:3091","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b336707e-f3a5-4554-9b37-0d29621b3562-2020-07-15T195802.528Z","2020-07-15T19:58:02.528Z","Intellectual Disability and Autism"
"DYSF","HGNC:3097","autosomal recessive limb-girdle muscular dystrophy","MONDO:0015152","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_94042756-2e7a-4cfa-812c-1b88b703eeea-2020-05-01T193204.280Z","2020-05-01T19:32:04.280Z","Limb Girdle Muscular Dystrophy"
"EARS2","HGNC:29419","Leigh syndrome","MONDO:0009723","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_774e378c-2636-41ad-be48-a2c00328ab9c-2020-03-19T190729.531Z","2020-03-19T19:07:29.531Z","Mitochondrial Diseases"
"ECHS1","HGNC:3151","Leigh syndrome","MONDO:0009723","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1d443f3c-fe02-4104-9e92-ca1c73b85a81-2021-04-09T142601.823Z","2021-04-09T14:26:01.823Z","Mitochondrial Diseases"
"ECHS1","HGNC:3151","mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency","MONDO:0014563","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dad38816-be17-4d59-bbfd-3e79221911a4-2018-10-09T160000.000Z","2018-10-09T16:00:00.000Z","Fatty Acid Oxidation Disorders"
"EDN3","HGNC:3178","Waardenburg syndrome type 4B","MONDO:0013201","AD","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_04e39ada-cd77-43f0-98f3-7b4a37668a96-2018-05-30T142540.938Z","2018-05-30T14:25:40.938Z","Hearing Loss"
"EDN3","HGNC:3178","Waardenburg syndrome type 4B","MONDO:0013201","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7f88c34c-a093-4fc8-b84a-49c7d2dd327f-2018-05-08T160000.000Z","2018-05-08T16:00:00.000Z","Hearing Loss"
"EDNRB","HGNC:3180","Waardenburg syndrome type 4A","MONDO:0010192","AD","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_73ee9727-60c1-40fd-830f-08c2b513d2ee-2018-05-08T160000.000Z","2018-05-08T16:00:00.000Z","Hearing Loss"
"EDNRB","HGNC:3180","Waardenburg syndrome type 4A","MONDO:0010192","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d7abbd45-7915-437b-849b-dea876bfc2f5-2018-05-08T160000.000Z","2018-05-08T16:00:00.000Z","Hearing Loss"
"EEF1A2","HGNC:3192","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_17551147-b62c-47a9-a12a-f425c23d90ff-2019-03-19T160000.000Z","2019-03-19T16:00:00.000Z","Epilepsy"
"EFEMP1","HGNC:3218","Doyne honeycomb retinal dystrophy","MONDO:0007471","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2859008e-eeb1-4af4-8a6e-1bf5372bb3ab-2021-08-05T160000.000Z","2021-08-05T16:00:00.000Z","Retina"
"EFEMP2","HGNC:3219","familial thoracic aortic aneurysm and aortic dissection","MONDO:0019625","AR","SOP4","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8267","2016-12-22T00:00:00","Heritable Thoracic Aortic Aneurysm and Dissection"
"EFHC1","HGNC:16406","epilepsy","MONDO:0005027","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a2338bd8-c9ea-464b-8281-84472771a657-2018-07-27T160000.000Z","2018-07-27T16:00:00.000Z","Epilepsy"
"EFNB1","HGNC:3226","craniofrontonasal syndrome","MONDO:0010570","XL","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_31ffbd0b-5c6b-4396-a84c-9330d81e4a08-2020-10-26T154650.453Z","2020-10-26T15:46:50.453Z","Craniofacial Malformations"
"EGFR","HGNC:3236","non-small cell lung carcinoma","MONDO:0005233","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_49342c73-96d7-45ba-9c90-d2d5e5710636-2020-07-30T202207.418Z","2020-07-30T20:22:07.418Z","Hereditary Cancer"
"EGR2","HGNC:3239","Charcot-Marie-Tooth disease","MONDO:0015626","SD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a6e83e27-0c9a-4475-92f5-745303931858-2021-11-17T033516.468Z","2021-11-17T03:35:16.468Z","Charcot-Marie-Tooth"
"EHMT1","HGNC:24650","Kleefstra syndrome","MONDO:0012455","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_db91a861-6a88-4848-b6d5-4772bdef52ff-2018-06-07T183128.103Z","2018-06-07T18:31:28.103Z","Intellectual Disability and Autism"
"ELANE","HGNC:3309","neutropenia","MONDO:0001475","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_259c43d2-b114-43bd-9e4e-a7beeb644323-2020-05-14T000924.456Z","2020-05-14T00:09:24.456Z","Hereditary Cancer"
"ELMOD3","HGNC:26158","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_86999665-43b6-4824-b5e5-81b2a6dd8034-2021-11-17T170000.000Z","2021-11-17T17:00:00.000Z","Hearing Loss"
"ELMOD3","HGNC:26158","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_95f5efe3-e0d1-4cef-b475-7ff1cd3c417c-2021-11-17T170000.000Z","2021-11-17T17:00:00.000Z","Hearing Loss"
"EN2","HGNC:3343","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP8","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_91eb2fc6-864c-4a4a-9b2d-0b2bdd695999-2021-02-16T170000.000Z","2021-02-16T17:00:00.000Z","Intellectual Disability and Autism"
"ENG","HGNC:3349","generalized juvenile polyposis/juvenile polyposis coli","MONDO:0008276","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9859","2017-12-11T00:00:00","Colon Cancer"
"ENG","HGNC:3349","hereditary hemorrhagic telangiectasia","MONDO:0019180","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d4d13b4a-f97b-45d0-9b82-07bcb6685a0a-2019-08-28T160000.000Z","2019-08-28T16:00:00.000Z","Hemostasis Thrombosis"
"EPCAM","HGNC:11529","hereditary breast carcinoma","MONDO:0016419","AD","SOP4","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8527","2017-04-12T00:00:00","Breast/Ovarian Cancer"
"EPCAM","HGNC:11529","colorectal cancer, hereditary nonpolyposis, type 8","MONDO:0013196","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9852","2017-09-11T00:00:00","Colon Cancer"
"EPHX1","HGNC:3401","hereditary nonpolyposis colon cancer","MONDO:0018630","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8431","2016-11-08T00:00:00","Colon Cancer"
"EPM2A","HGNC:3413","Lafora disease","MONDO:0009697","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f970ced6-0164-41ed-9e1f-1fb9f892bca6-2020-05-23T190000.000Z","2020-05-23T19:00:00.000Z","Epilepsy"
"EPS8","HGNC:3420","autosomal recessive nonsyndromic hearing loss 102","MONDO:0014428","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7a6bd2bf-8ede-45cb-a1c1-65ee5221b440-2020-02-06T171614.553Z","2020-02-06T17:16:14.553Z","Hearing Loss"
"EPS8L2","HGNC:21296","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e0022ad7-8497-4139-94a7-2546ba482c88-2020-02-05T170000.000Z","2020-02-05T17:00:00.000Z","Hearing Loss"
"ERBB4","HGNC:3432","amyotrophic lateral sclerosis type 19","MONDO:0014223","AD","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fdd26ab6-0c1f-4322-9f70-cad651bb789f-2021-09-30T143144.993Z","2021-09-30T14:31:44.993Z","Amyotrophic Lateral Sclerosis Spectrum Disorders"
"ERCC2","HGNC:3434","xeroderma pigmentosum group D","MONDO:0010212","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_91d0c244-d958-4358-8b92-cefefbce3843-2018-11-02T214605.275Z","2018-11-02T21:46:05.275Z","Hereditary Cancer"
"ERCC3","HGNC:3435","xeroderma pigmentosum group B","MONDO:0012531","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bf09deab-9612-4b13-8bb7-4c2a25dde868-2018-11-02T213956.524Z","2018-11-02T21:39:56.524Z","Hereditary Cancer"
"ERCC4","HGNC:3436","xeroderma pigmentosum group F","MONDO:0010215","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_89544dc5-2d3b-4b7f-b835-3fec714bf7a5-2019-08-14T194406.189Z","2019-08-14T19:44:06.189Z","Hereditary Cancer"
"ERCC5","HGNC:3437","xeroderma pigmentosum group G","MONDO:0010216","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fc08c954-8ded-449b-8f67-e4f044b26cda-2018-11-02T215619.763Z","2018-11-02T21:56:19.763Z","Hereditary Cancer"
"ERF","HGNC:3444","craniosynostosis 4","MONDO:0010929","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1954ba97-532a-4ef3-9d62-c4ebfd252084-2021-06-12T062024.684Z","2021-06-12T06:20:24.684Z","Craniofacial Malformations"
"ERLIN1","HGNC:16947","amyotrophic lateral sclerosis","MONDO:0004976","AR","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d668c62f-b002-4015-a629-ecbebed40e59-2021-07-27T160919.089Z","2021-07-27T16:09:19.089Z","Amyotrophic Lateral Sclerosis Spectrum Disorders"
"ESCO2","HGNC:27230","Roberts-SC phocomelia syndrome","MONDO:0100253","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4020105e-bc43-4365-9540-9a8f77b37fae-2021-07-30T142327.055Z","2021-07-30T14:23:27.055Z","Syndromic Disorders"
"ESPN","HGNC:13281","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7c63a581-ad69-4f18-b68b-d1b2cef5e699-2018-02-27T170000.000Z","2018-02-27T17:00:00.000Z","Hearing Loss"
"ESPN","HGNC:13281","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9bdbd958-1ad2-447a-9ccd-ed86f308577a-2018-09-20T200322.775Z","2018-09-20T20:03:22.775Z","Hearing Loss"
"ESRRB","HGNC:3473","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_03c875bb-70aa-4652-a7f2-35df1065165b-2018-04-24T160000.000Z","2018-04-24T16:00:00.000Z","Hearing Loss"
"ETFA","HGNC:3481","multiple acyl-CoA dehydrogenase deficiency","MONDO:0009282","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3d6848e7-6e9e-4545-9f97-69480face058-2018-05-22T160000.000Z","2018-05-22T16:00:00.000Z","Fatty Acid Oxidation Disorders"
"ETFB","HGNC:3482","multiple acyl-CoA dehydrogenase deficiency","MONDO:0009282","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d9a8d844-c82a-4258-bd48-10e2d977273e-2020-12-16T181720.992Z","2020-12-16T18:17:20.992Z","Fatty Acid Oxidation Disorders"
"ETFDH","HGNC:3483","multiple acyl-CoA dehydrogenase deficiency","MONDO:0009282","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_062e336e-cfda-45f7-b509-cd44a5079034-2018-05-22T160000.000Z","2018-05-22T16:00:00.000Z","Fatty Acid Oxidation Disorders"
"ETHE1","HGNC:23287","Leigh syndrome","MONDO:0009723","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d29d908d-ea85-4eb4-a6a5-400c95511c9a-2019-04-08T161759.443Z","2019-04-08T16:17:59.443Z","Mitochondrial Diseases"
"ETV6","HGNC:3495","thrombocytopenia 5","MONDO:0014536","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_92a8c1cb-91c1-45cd-adbe-4180b1f6da7d-2020-01-22T170000.000Z","2020-01-22T17:00:00.000Z","Hemostasis Thrombosis"
"EXO1","HGNC:3511","hereditary nonpolyposis colon cancer","MONDO:0018630","AD","SOP4","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8432","2017-06-08T00:00:00","Colon Cancer"
"EXT1","HGNC:3512","exostoses, multiple, type 1","MONDO:0007585","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0ced1387-c0a8-4f03-bd70-1595cb7683fd-2018-06-04T192029.946Z","2018-06-04T19:20:29.946Z","Hereditary Cancer"
"EXT2","HGNC:3513","exostoses, multiple, type 2","MONDO:0007586","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9e6829ce-3e0b-44c5-a214-756f33b1e948-2018-12-21T153126.680Z","2018-12-21T15:31:26.680Z","Hereditary Cancer"
"EYA1","HGNC:3519","branchio-oto-renal syndrome","MONDO:0007029","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dca41ef6-ee63-4b1f-93d3-8b114dafcc58-2018-08-30T144802.507Z","2018-08-30T14:48:02.507Z","Hearing Loss"
"EYA4","HGNC:3522","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_21c75059-bd7b-48ef-a828-28ffebe52ca0-2018-01-05T170000.000Z","2018-01-05T17:00:00.000Z","Hearing Loss"
"EYA4","HGNC:3522","dilated cardiomyopathy 1J","MONDO:0011541","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5e0a0bad-1f7a-402e-af19-a80453653b86-2020-11-30T170000.000Z","2020-11-30T17:00:00.000Z","Dilated Cardiomyopathy"
"F10","HGNC:3528","congenital factor X deficiency","MONDO:0009212","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4adcc848-b354-4975-801f-4b55bbca64ad-2019-11-27T170000.000Z","2019-11-27T17:00:00.000Z","Hemostasis Thrombosis"
"F11","HGNC:3529","congenital factor XI deficiency","MONDO:0012897","SD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a57ba9d9-45c5-48bc-b939-7593f67a86ed-2019-10-23T160000.000Z","2019-10-23T16:00:00.000Z","Hemostasis Thrombosis"
"F12","HGNC:3530","congenital factor XII deficiency","MONDO:0009315","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_50bbe8d0-4feb-43c7-8573-9d7f85c82e54-2020-01-22T170000.000Z","2020-01-22T17:00:00.000Z","Hemostasis Thrombosis"
"F12","HGNC:3530","hereditary angioedema type 3","MONDO:0012526","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f40992c9-1172-4528-ab53-95108094d4b6-2020-01-23T173048.307Z","2020-01-23T17:30:48.307Z","Hemostasis Thrombosis"
"F13A1","HGNC:3531","factor XIII, A subunit, deficiency of","MONDO:0013187","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dd9321a7-f45d-419e-94ce-101ab545a847-2020-07-22T160000.000Z","2020-07-22T16:00:00.000Z","Hemostasis Thrombosis"
"F13B","HGNC:3534","factor XIII, b subunit, deficiency of","MONDO:0013190","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_403b3588-323c-4103-9207-cc9c8be12281-2020-07-22T160000.000Z","2020-07-22T16:00:00.000Z","Hemostasis Thrombosis"
"F2","HGNC:3535","thrombophilia due to thrombin defect","MONDO:0008559","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6389b3a3-ef86-4588-9be8-eb79dcb8d3cd-2020-06-24T160000.000Z","2020-06-24T16:00:00.000Z","Hemostasis Thrombosis"
"F2","HGNC:3535","congenital prothrombin deficiency","MONDO:0013361","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6ba9c4b9-9984-4d31-a9ae-bf638838f201-2020-06-24T160000.000Z","2020-06-24T16:00:00.000Z","Hemostasis Thrombosis"
"F5","HGNC:3542","thrombophilia due to activated protein C resistance","MONDO:0008560","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ab28e09c-08ff-4149-a536-3cdb9cc4099f-2019-09-30T160000.000Z","2019-09-30T16:00:00.000Z","Hemostasis Thrombosis"
"F5","HGNC:3542","congenital factor V deficiency","MONDO:0009210","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_beaa3af3-7d91-4d53-b081-de0e660c16c6-2020-03-25T160000.000Z","2020-03-25T16:00:00.000Z","Hemostasis Thrombosis"
"F7","HGNC:3544","factor VII deficiency","MONDO:0002244","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_43fb4e99-e97a-4d9c-af11-79c2b09ecd2e-2019-07-24T160000.000Z","2019-07-24T16:00:00.000Z","Hemostasis Thrombosis"
"F8","HGNC:3546","hemophilia A","MONDO:0010602","XL","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d4578f11-b635-45f4-8034-310fca5fe960-2019-07-24T160000.000Z","2019-07-24T16:00:00.000Z","Hemostasis Thrombosis"
"F9","HGNC:3551","hemophilia B","MONDO:0010604","XL","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3d56d08d-48d0-4523-b433-dbd44c5b9e45-2019-05-22T190226.728Z","2019-05-22T19:02:26.728Z","Hemostasis Thrombosis"
"F9","HGNC:3551","thrombophilia, X-linked, due to factor 9 defect","MONDO:0010432","XL","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9b3a7f2c-a07a-4a10-b1f7-78642ebdaa5d-2020-06-24T160000.000Z","2020-06-24T16:00:00.000Z","Hemostasis Thrombosis"
"FAH","HGNC:3579","tyrosinemia type I","MONDO:0010161","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_39c50699-f422-4bae-89ac-af13ef7cb8cc-2020-06-29T174149.440Z","2020-06-29T17:41:49.440Z","Aminoacidopathy"
"FAN1","HGNC:29170","hereditary nonpolyposis colon cancer","MONDO:0018630","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9863","2017-10-23T00:00:00","Colon Cancer"
"FANCA","HGNC:3582","Fanconi anemia complementation group A","MONDO:0009215","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ceecf6ee-6700-40e5-a0d3-f7891805daac-2018-12-21T152348.098Z","2018-12-21T15:23:48.098Z","Hereditary Cancer"
"FANCC","HGNC:3584","Fanconi anemia complementation group C","MONDO:0009213","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cf4881c3-15b3-4e10-bd24-2da80433863b-2018-12-21T152145.877Z","2018-12-21T15:21:45.877Z","Hereditary Cancer"
"FANCD2","HGNC:3585","Fanconi anemia complementation group D2","MONDO:0009214","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5f0c260f-52d2-4225-9044-608f066ccfb2-2021-06-15T231506.767Z","2021-06-15T23:15:06.767Z","Hereditary Cancer"
"FANCE","HGNC:3586","Fanconi anemia complementation group E","MONDO:0010953","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6da55a6e-2cf8-499c-b842-b5a435dbff3f-2020-05-14T001745.604Z","2020-05-14T00:17:45.604Z","Hereditary Cancer"
"FANCF","HGNC:3587","Fanconi anemia complementation group F","MONDO:0011325","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_60719ed8-36fa-4d11-93b2-8036133510a6-2021-02-03T225456.822Z","2021-02-03T22:54:56.822Z","Hereditary Cancer"
"FANCG","HGNC:3588","Fanconi anemia complementation group G","MONDO:0013565","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1913bd10-1355-4067-93b6-9068924d77df-2018-12-21T151935.075Z","2018-12-21T15:19:35.075Z","Hereditary Cancer"
"FANCI","HGNC:25568","Fanconi anemia complementation group I","MONDO:0012186","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a103db2f-a8b3-403b-993a-ac4215c118df-2021-06-15T233841.081Z","2021-06-15T23:38:41.081Z","Hereditary Cancer"
"FANCL","HGNC:20748","Fanconi anemia complementation group L","MONDO:0013566","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_93d0cb5f-4859-4b28-b647-3f8226fe5921-2020-07-30T203845.671Z","2020-07-30T20:38:45.671Z","Hereditary Cancer"
"FAR1","HGNC:26222","fatty acyl-CoA reductase 1 deficiency","MONDO:0014510","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_91f6f864-5d07-4891-94b5-7f73bd71752c-2020-04-17T160000.000Z","2020-04-17T16:00:00.000Z","Peroxisomal Disorders"
"FARS2","HGNC:21062","Leigh syndrome","MONDO:0009723","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2cf7594a-d934-4b6c-8052-94066d608c5a-2019-11-25T144756.827Z","2019-11-25T14:47:56.827Z","Mitochondrial Diseases"
"FBN1","HGNC:3603","familial thoracic aortic aneurysm and aortic dissection","MONDO:0019625","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8251","2017-01-23T00:00:00","Heritable Thoracic Aortic Aneurysm and Dissection"
"FBN1","HGNC:3603","Marfan syndrome","MONDO:0007947","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d3fc0bea-4d6e-449e-885c-b204e6a0b2bf-2019-03-04T170000.000Z","2019-03-04T17:00:00.000Z","General Gene Curation"
"FBN2","HGNC:3604","familial thoracic aortic aneurysm and aortic dissection","MONDO:0019625","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8268","2016-12-22T00:00:00","Heritable Thoracic Aortic Aneurysm and Dissection"
"FBXL4","HGNC:13601","Leigh syndrome","MONDO:0009723","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fed67104-182c-48f2-85c0-ecb05cd6dd72-2020-11-23T193117.246Z","2020-11-23T19:31:17.246Z","Mitochondrial Diseases"
"FERMT3","HGNC:23151","leukocyte adhesion deficiency 3","MONDO:0013016","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_df792161-5efb-45f7-91ed-5fe76045fa06-2019-08-28T160000.000Z","2019-08-28T16:00:00.000Z","Hemostasis Thrombosis"
"FGA","HGNC:3661","congenital fibrinogen deficiency","MONDO:0018060","SD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d34ded98-dbf7-4dc7-bea4-803db1857bf8-2020-01-22T170000.000Z","2020-01-22T17:00:00.000Z","Hemostasis Thrombosis"
"FGB","HGNC:3662","congenital fibrinogen deficiency","MONDO:0018060","SD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_638c1588-9674-4bc3-a39c-2fc8f8b0ef09-2020-01-22T170000.000Z","2020-01-22T17:00:00.000Z","Hemostasis Thrombosis"
"FGD1","HGNC:3663","Aarskog-Scott syndrome, X-linked","MONDO:0010589","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9513","2017-12-06T00:00:00","Intellectual Disability and Autism"
"FGD4","HGNC:19125","Charcot-Marie-Tooth disease","MONDO:0015626","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e0aae8cd-9d57-4d8c-83ae-ed968cf186bc-2020-04-14T131822.010Z","2020-04-14T13:18:22.010Z","Charcot-Marie-Tooth"
"FGF3","HGNC:3681","deafness with labyrinthine aplasia, microtia, and microdontia","MONDO:0012541","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5ca11e8c-6703-4be5-a8c2-82e6dcc865e4-2019-05-21T160000.000Z","2019-05-21T16:00:00.000Z","Hearing Loss"
"FGFR1","HGNC:3688","Pfeiffer syndrome type 1","MONDO:0019659","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4fef65d0-f73c-45fe-968e-86073674cb7e-2021-05-21T224433.397Z","2021-05-21T22:44:33.397Z","Craniofacial Malformations"
"FGFR1","HGNC:3688","osteoglophonic dwarfism","MONDO:0008150","AD","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d958e743-2ca0-4bb9-a198-364dd58005c3-2021-03-22T203501.315Z","2021-03-22T20:35:01.315Z","Craniofacial Malformations"
"FGFR1","HGNC:3688","Hartsfield-Bixler-Demyer syndrome","MONDO:0014196","AD","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec5034c6-70cb-4ba3-bbb9-f65f6cad393d-2021-03-16T235509.401Z","2021-03-16T23:55:09.401Z","Craniofacial Malformations"
"FGFR2","HGNC:3689","apert syndrome","MONDO:0007041","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2aa63602-d820-4fee-893b-b807e7b62f28-2021-12-14T221137.192Z","2021-12-14T22:11:37.192Z","Craniofacial Malformations"
"FGFR2","HGNC:3689","Crouzon syndrome","MONDO:0007405","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c2cfa70a-750f-4357-98b9-f5c30ca4dc26-2021-12-23T165345.170Z","2021-12-23T16:53:45.170Z","Craniofacial Malformations"
"FGFR3","HGNC:3690","achondroplasia","MONDO:0007037","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3221","2016-12-01T00:00:00","General Gene Curation"
"FGFR3","HGNC:3690","thanatophoric dysplasia type 1","MONDO:0008546","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_db0459d9-c5cc-455d-a6b2-e6ea81511336-2021-12-23T221850.458Z","2021-12-23T22:18:50.458Z","Skeletal Disorders"
"FGG","HGNC:3694","congenital fibrinogen deficiency","MONDO:0018060","SD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9ef37f0f-a5ae-402c-b319-7f7d731ecbb1-2020-01-23T173301.596Z","2020-01-23T17:33:01.596Z","Hemostasis Thrombosis"
"FH","HGNC:3700","hereditary leiomyomatosis and renal cell cancer","MONDO:0007888","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_59e42ccd-2b0b-441c-8529-6eb1e9dde330-2020-05-14T002334.007Z","2020-05-14T00:23:34.007Z","Hereditary Cancer"
"FIG4","HGNC:16873","Charcot-Marie-Tooth disease","MONDO:0015626","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cbc44812-5fe4-4e11-ac89-58e4175d4463-2021-09-23T003544.594Z","2021-09-23T00:35:44.594Z","Charcot-Marie-Tooth"
"FKRP","HGNC:17997","muscular dystrophy-dystroglycanopathy","MONDO:0018276","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6cb46400-ca4b-48cd-aaf7-dd493f0d2971-2020-08-11T185912.538Z","2020-08-11T18:59:12.538Z","Limb Girdle Muscular Dystrophy"
"FKTN","HGNC:3622","muscular dystrophy-dystroglycanopathy","MONDO:0018276","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_54e23f1a-3b1b-49ef-aa02-6b46374b1546-2020-07-01T150411.449Z","2020-07-01T15:04:11.449Z","Limb Girdle Muscular Dystrophy"
"FLAD1","HGNC:24671","myopathy with abnormal lipid metabolism","MONDO:0009703","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_769764bf-09c5-4a7d-8501-5fcf154fcdda-2020-12-16T181902.981Z","2020-12-16T18:19:02.981Z","Fatty Acid Oxidation Disorders"
"FLCN","HGNC:27310","Birt-Hogg-Dube syndrome","MONDO:0007607","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c96620e8-f9c9-41a0-a979-31fb9928abb6-2018-06-04T191544.022Z","2018-06-04T19:15:44.022Z","Hereditary Cancer"
"FLI1","HGNC:3749","bleeding disorder, platelet-type, 21","MONDO:0054577","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dd0eaa15-3ee7-4db7-9920-c380757ece33-2021-04-28T160000.000Z","2021-04-28T16:00:00.000Z","Hemostasis Thrombosis"
"FLNA","HGNC:3754","familial thoracic aortic aneurysm and aortic dissection","MONDO:0019625","XL","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8274","2016-12-22T00:00:00","Heritable Thoracic Aortic Aneurysm and Dissection"
"FLNA","HGNC:3754","periventricular nodular heterotopia","MONDO:0020341","XL","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_80bc6280-7c21-4168-8a98-93c31fead5d7-2020-12-27T231155.213Z","2020-12-27T23:11:55.213Z","Intellectual Disability and Autism"
"FLNC","HGNC:3756","myofibrillar myopathy 5","MONDO:0012289","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10057","2017-12-12T16:00:00","Hypertrophic Cardiomyopathy"
"FLNC","HGNC:3756","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_edb5197f-05dc-42a4-a497-fff472985c6b-2020-11-06T170000.000Z","2020-11-06T17:00:00.000Z","Dilated Cardiomyopathy"
"FMO3","HGNC:3771","trimethylaminuria","MONDO:0011182","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_18ed3960-c745-46f1-aecc-155e713d6ef5-2020-08-14T184718.502Z","2020-08-14T18:47:18.502Z","Aminoacidopathy"
"FMR1","HGNC:3775","fragile X syndrome","MONDO:0010383","XL","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e491d278-7123-434c-8de3-46e16afb4037-2019-06-03T160000.000Z","2019-06-03T16:00:00.000Z","Intellectual Disability and Autism"
"FNIP1","HGNC:29418","FNIP1-associated syndrome","MONDO:0100432","AR","SOP8","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_25c930ed-965b-47ae-b9c2-7157b06cb868-2021-12-06T131417.148Z","2021-12-06T13:14:17.148Z","Antibody Deficiencies GCEP"
"FOLR1","HGNC:3791","neurodegenerative syndrome due to cerebral folate transport deficiency","MONDO:0013110","AR","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_22c12588-dc55-4e90-827a-d7a6349e38a9-2018-04-27T164924.579Z","2018-04-27T16:49:24.579Z","Intellectual Disability and Autism"
"FOXC1","HGNC:3800","anterior segment dysgenesis 3","MONDO:0024456","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b2271229-84ea-4aff-81b4-3428c173ed7b-2021-12-15T031246.818Z","2021-12-15T03:12:46.818Z","Glaucoma and Neuro-Ophthalmology"
"FOXE3","HGNC:3808","familial thoracic aortic aneurysm and aortic dissection","MONDO:0019625","AD","SOP4","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8261","2016-06-15T00:00:00","Heritable Thoracic Aortic Aneurysm and Dissection"
"FOXG1","HGNC:3811","FOXG1 disorder","MONDO:0100040","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3f14c6c5-b051-4c94-b9c6-3b80771eed22-2018-07-02T140827.839Z","2018-07-02T14:08:27.839Z","Rett and Angelman-like Disorders"
"FOXI1","HGNC:3815","syndromic genetic hearing loss","MONDO:0019589","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0bb41557-8ccc-4084-b4b0-d4ede42d8f36-2018-02-27T050000.000Z","2018-02-27T05:00:00.000Z","Hearing Loss"
"FOXI1","HGNC:3815","enlarged vestibular aqueduct syndrome","MONDO:0023069","AR","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d3a6b8fa-01d1-4f32-a45e-9c9582e14280-2018-09-10T194701.454Z","2018-09-10T19:47:01.454Z","Hearing Loss"
"FOXN1","HGNC:12765","T-cell immunodeficiency, congenital alopecia, and nail dystrophy","MONDO:0011132","SD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4518c986-fb1d-4f9a-a24a-ab38891a0162-2021-11-05T181626.460Z","2021-11-05T18:16:26.460Z","SCID-CID"
"FOXP1","HGNC:3823","intellectual disability-severe speech delay-mild dysmorphism syndrome","MONDO:0013352","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_db1c240c-7ffb-4a95-92ad-da9e8af2adc6-2019-05-09T162756.956Z","2019-05-09T16:27:56.956Z","Intellectual Disability and Autism"
"FOXP2","HGNC:13875","specific language disorder","MONDO:0016226","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b13348d1-1248-4507-aa29-60559e6b410e-2019-05-21T160000.000Z","2019-05-21T16:00:00.000Z","Intellectual Disability and Autism"
"FOXRED1","HGNC:26927","Leigh syndrome","MONDO:0009723","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c74ba0cb-ccef-4a19-9fef-ef9996f72290-2019-10-16T143453.574Z","2019-10-16T14:34:53.574Z","Mitochondrial Diseases"
"FTSJ1","HGNC:13254","non-syndromic X-linked intellectual disability","MONDO:0019181","XL","SOP5","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9515","2018-01-17T00:00:00","Intellectual Disability and Autism"
"FUS","HGNC:4010","amyotrophic lateral sclerosis type 6","MONDO:0011951","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b2e8f55b-371e-438f-8923-73ca9b7ec034-2021-10-12T183601.087Z","2021-10-12T18:36:01.087Z","Amyotrophic Lateral Sclerosis Spectrum Disorders"
"FXN","HGNC:3951","Friedreich ataxia","MONDO:0100339","AR","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec3f674b-1e71-4254-a0f9-f8909becff59-2017-12-22T170000.000Z","2017-12-22T17:00:00.000Z","Hypertrophic Cardiomyopathy"
"FYB1","HGNC:4036","thrombocytopenia 3","MONDO:0010120","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0e4e83fb-516b-43f8-a0af-687b9d938f74-2021-12-15T183305.227Z","2021-12-15T18:33:05.227Z","Hemostasis Thrombosis"
"GAA","HGNC:4065","glycogen storage disease II","MONDO:0009290","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0554320e-6a8f-4c39-be7f-99959a8341ee-2019-01-23T170000.000Z","2019-01-23T17:00:00.000Z","General Gene Curation"
"GABRA1","HGNC:4075","developmental and epileptic encephalopathy","MONDO:0100062","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_60478d36-384e-4246-ba8a-730755d6f216-2019-05-21T160000.000Z","2019-05-21T16:00:00.000Z","Epilepsy"
"GABRB3","HGNC:4083","developmental and epileptic encephalopathy","MONDO:0100062","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a9327dac-6f76-4881-8a23-ef2b210f92e7-2019-02-05T170000.000Z","2019-02-05T17:00:00.000Z","Epilepsy"
"GABRG2","HGNC:4087","epilepsy","MONDO:0005027","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3a3176e9-ac0c-41fe-ae40-0750726c33d8-2020-01-21T170000.000Z","2020-01-21T17:00:00.000Z","Epilepsy"
"GAD1","HGNC:4092","obsolete early infantile epileptic encephalopathy","MONDO:0016021","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_20fdee08-81b0-4957-a18a-8f622e0ab054-2021-05-13T152239.014Z","2021-05-13T15:22:39.014Z","Aminoacidopathy"
"GALNT12","HGNC:19877","colorectal cancer, susceptibility to, 1","MONDO:0012132","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8435","2017-06-08T00:00:00","Colon Cancer"
"GAMT","HGNC:4136","guanidinoacetate methyltransferase deficiency","MONDO:0012999","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f0a84d45-57f8-4763-b1c5-7a283cef5f71-2019-01-25T170000.000Z","2019-01-25T17:00:00.000Z","Aminoacidopathy"
"GANAB","HGNC:4138","polycystic kidney disease 3 with or without polycystic liver disease","MONDO:0010916","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e6392961-a64a-4818-903a-0bf88b32e736-2020-09-09T160000.000Z","2020-09-09T16:00:00.000Z","Kidney Cystic and Ciliopathy Disorders"
"GATA1","HGNC:4170","GATA1-Related X-Linked Cytopenia","MONDO:0100089","XL","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ad980194-b275-4bbb-b3df-73c1a50d3eac-2020-05-27T160000.000Z","2020-05-27T16:00:00.000Z","Hemostasis Thrombosis"
"GATA2","HGNC:4171","GATA2 deficiency with susceptibility to MDS/AML","MONDO:0042982","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7c0449f7-e20b-4610-95ad-896eee265492-2019-08-18T160000.000Z","2019-08-18T16:00:00.000Z","Hereditary Cancer"
"GATA3","HGNC:4172","hypoparathyroidism-deafness-renal disease syndrome","MONDO:0007797","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_afb6e0d5-81a5-439a-a498-9edc8505a367-2019-06-18T160000.000Z","2019-06-18T16:00:00.000Z","Hearing Loss"
"GATAD1","HGNC:29941","dilated cardiomyopathy","MONDO:0005021","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_56933afb-863f-46f5-884d-17522adb31a8-2020-09-04T160000.000Z","2020-09-04T16:00:00.000Z","Dilated Cardiomyopathy"
"GATM","HGNC:4175","AGAT deficiency","MONDO:0012996","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d63bfeff-882d-400f-af17-277a702fd09b-2019-03-08T170000.000Z","2019-03-08T17:00:00.000Z","Aminoacidopathy"
"GBA","HGNC:4177","Gaucher disease","MONDO:0018150","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fbc5a876-f97e-4f9c-be99-664e2f6c8470-2020-06-24T160000.000Z","2020-06-24T16:00:00.000Z","General Gene Curation"
"GCDH","HGNC:4189","glutaryl-CoA dehydrogenase deficiency","MONDO:0009281","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_33a2c95e-a057-4b93-b97e-27b6597516e5-2019-11-08T170000.000Z","2019-11-08T17:00:00.000Z","Aminoacidopathy"
"GCH1","HGNC:4193","GTP cyclohydrolase I deficiency","MONDO:0100184","SD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ed6c1e6c-5856-48aa-aa8f-47328e6b09eb-2020-12-11T200937.286Z","2020-12-11T20:09:37.286Z","Aminoacidopathy"
"GCK","HGNC:4195","monogenic diabetes","MONDO:0015967","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c7291ae0-3356-4c7b-832a-edae5176739f-2020-05-13T160000.000Z","2020-05-13T16:00:00.000Z","Monogenic Diabetes"
"GDAP1","HGNC:15968","Charcot-Marie-Tooth disease","MONDO:0015626","SD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c6d93637-02f5-4f5d-b7a9-17356f084149-2020-07-28T144211.873Z","2020-07-28T14:42:11.873Z","Charcot-Marie-Tooth"
"GDF2","HGNC:4217","pulmonary arterial hypertension","MONDO:0015924","AD","SOP8","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2d2e83fa-0af1-450f-af9c-5c61d4bc3106-2021-01-23T144300.291Z","2021-01-23T14:43:00.291Z","Pulmonary Hypertension"
"GDI1","HGNC:4226","non-syndromic X-linked intellectual disability","MONDO:0019181","XL","SOP5","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8afc42b0-6c5e-460b-87d1-035c051fe7ca-2018-05-24T225528.461Z","2018-05-24T22:55:28.461Z","Intellectual Disability and Autism"
"GEN1","HGNC:26881","hereditary breast carcinoma","MONDO:0016419","AD","SOP4","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8691","2017-12-13T00:00:00","Breast/Ovarian Cancer"
"GEN1","HGNC:26881","familial ovarian cancer","MONDO:0016248","AD","SOP4","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8692","2017-01-11T00:00:00","Breast/Ovarian Cancer"
"GFI1B","HGNC:4238","platelet-type bleeding disorder 17","MONDO:0008553","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_62841ea9-5bd8-4250-ab41-31d7cf82d2e3-2019-11-27T170000.000Z","2019-11-27T17:00:00.000Z","Hemostasis Thrombosis"
"GFM1","HGNC:13780","Leigh syndrome","MONDO:0009723","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_154a8f96-7062-49c7-9aaa-b23a98655f40-2019-12-19T185108.232Z","2019-12-19T18:51:08.232Z","Mitochondrial Diseases"
"GFM2","HGNC:29682","Leigh syndrome","MONDO:0009723","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0736b760-ca37-4d0a-93a4-c71bbb8cd41a-2019-12-19T185449.252Z","2019-12-19T18:54:49.252Z","Mitochondrial Diseases"
"GGCX","HGNC:4247","vitamin K-dependent clotting factors, combined deficiency of, type 1","MONDO:0010187","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_87ceae1d-b329-4c29-b6f2-8a94a127204e-2021-02-24T175200.635Z","2021-02-24T17:52:00.635Z","Hemostasis Thrombosis"
"GIPC3","HGNC:18183","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e5feebe1-59a9-4e28-ad85-aec5cad6b54e-2017-08-22T160000.000Z","2017-08-22T16:00:00.000Z","Hearing Loss"
"GJA1","HGNC:4274","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP6","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9e428d8c-42a2-430b-babd-8beceb26197e-2018-01-16T170000.000Z","2018-01-16T17:00:00.000Z","Hearing Loss"
"GJB1","HGNC:4283","Charcot-Marie-Tooth disease X-linked dominant 1","MONDO:0010549","XL","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fcacd858-2376-4cc0-983a-156145e36595-2020-01-14T170000.000Z","2020-01-14T17:00:00.000Z","Charcot-Marie-Tooth"
"GJB2","HGNC:4284","hearing loss, autosomal recessive","MONDO:0019588","AR","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8399","2017-03-02T00:00:00","Hearing Loss"
"GJB2","HGNC:4284","syndromic genetic hearing loss","MONDO:0019589","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9d7b8505-4def-4b99-a8a2-853c07e9969e-2018-06-26T160000.000Z","2018-06-26T16:00:00.000Z","Hearing Loss"
"GJB3","HGNC:4285","erythrokeratodermia variabilis","MONDO:0017851","AD","SOP6","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1d48c959-31d8-44e2-985c-c48921e8f08a-2018-03-05T050000.000Z","2018-03-05T05:00:00.000Z","Hearing Loss"
"GJB3","HGNC:4285","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f83e013a-685f-405b-89d6-a8e80aefaf6e-2018-08-23T165315.195Z","2018-08-23T16:53:15.195Z","Hearing Loss"
"GJB6","HGNC:4288","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP5","Refuted","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f281869c-25e5-44ad-94e7-c7d6374755fd-2018-09-10T180132.444Z","2018-09-10T18:01:32.444Z","Hearing Loss"
"GJB6","HGNC:4288","Clouston syndrome","MONDO:0007510","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ff18d307-80a8-44b8-8b1a-e26e8a7d912a-2018-04-17T160000.000Z","2018-04-17T16:00:00.000Z","Hearing Loss"
"GK","HGNC:4289","inborn glycerol kinase deficiency","MONDO:0010613","XL","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b8965e78-8d6a-4b8a-af2d-e05097d791e0-2022-01-14T174134.555Z","2022-01-14T17:41:34.555Z","General Inborn Errors of Metabolism"
"GLA","HGNC:4296","Fabry disease","MONDO:0010526","XL","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_eb4bb6f4-89de-4586-af6b-3f218b8cb4dc-2019-01-23T170000.000Z","2019-01-23T17:00:00.000Z","General Gene Curation"
"GLDC","HGNC:4313","glycine encephalopathy","MONDO:0011612","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_14d991f3-25f3-40c9-aacd-c1a008d9eaea-2019-02-06T170000.000Z","2019-02-06T17:00:00.000Z","Aminoacidopathy"
"GLIS2","HGNC:29450","nephronophthisis 7","MONDO:0012680","AR","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c51be76f-59d3-4884-9df3-4416686848ab-2021-05-26T160000.000Z","2021-05-26T16:00:00.000Z","Kidney Cystic and Ciliopathy Disorders"
"GLS","HGNC:4331","glutaminase deficiency","MONDO:0600001","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1eedd351-1520-4354-9608-cf8d56ce9bd9-2021-07-09T170141.305Z","2021-07-09T17:01:41.305Z","Aminoacidopathy"
"GLS","HGNC:4331","infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development","MONDO:0032685","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c0a699ec-3d67-4e18-a0da-464c2832c4ec-2021-07-09T170349.643Z","2021-07-09T17:03:49.643Z","Aminoacidopathy"
"GLUD1","HGNC:4335","hyperinsulinism-hyperammonemia syndrome","MONDO:0011717","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_924bd593-ba5a-49a5-bb71-8224271a713b-2020-11-13T170000.000Z","2020-11-13T17:00:00.000Z","Aminoacidopathy"
"GLUL","HGNC:4341","congenital brain dysgenesis due to glutamine synthetase deficiency","MONDO:0012393","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d71d7866-437d-48bd-8a98-21e67abdd917-2020-06-29T174523.991Z","2020-06-29T17:45:23.991Z","Aminoacidopathy"
"GNAI1","HGNC:4384","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ea8128fc-f085-492a-b0ef-f37d994bb01b-2021-03-17T160000.000Z","2021-03-17T16:00:00.000Z","Intellectual Disability and Autism"
"GNAO1","HGNC:4389","movement disorder","MONDO:0005395","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_418a5a18-3d0e-4cef-84b4-74c5accc0df1-2019-02-19T170000.000Z","2019-02-19T17:00:00.000Z","Epilepsy"
"GNAO1","HGNC:4389","developmental and epileptic encephalopathy","MONDO:0100062","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b56856e2-8e6f-4f01-a6bd-1642fee71e5b-2018-12-18T170000.000Z","2018-12-18T17:00:00.000Z","Epilepsy"
"GNB4","HGNC:20731","Charcot-Marie-Tooth disease","MONDO:0015626","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a8cecdd7-06d8-4697-8cd9-32900c366371-2020-04-14T132010.930Z","2020-04-14T13:20:10.930Z","Charcot-Marie-Tooth"
"GNE","HGNC:23657","isolated hereditary giant platelet disorder","MONDO:0016361","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_335d18ae-50ef-49a8-abb2-79799833b544-2020-08-26T160000.000Z","2020-08-26T16:00:00.000Z","Hemostasis Thrombosis"
"GNMT","HGNC:4415","glycine N-methyltransferase deficiency","MONDO:0011698","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cafb0200-f6cf-482d-9ffb-69ae7bc43669-2019-05-10T160000.000Z","2019-05-10T16:00:00.000Z","Aminoacidopathy"
"GNPAT","HGNC:4416","rhizomelic chondrodysplasia punctata","MONDO:0015776","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ba96f922-5ec9-4404-b2e4-66c31c2dcda6-2020-02-07T170000.000Z","2020-02-07T17:00:00.000Z","Peroxisomal Disorders"
"GP1BA","HGNC:4439","Bernard-Soulier syndrome","MONDO:0009276","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7e3aa94f-1e87-4806-bc47-2f8c40e3d1bc-2020-05-27T160000.000Z","2020-05-27T16:00:00.000Z","Hemostasis Thrombosis"
"GP1BA","HGNC:4439","pseudo-von Willebrand disease","MONDO:0008332","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8fef91aa-8c41-4044-b601-da24c2bab351-2020-05-27T160000.000Z","2020-05-27T16:00:00.000Z","Hemostasis Thrombosis"
"GP1BB","HGNC:4440","Bernard-Soulier syndrome","MONDO:0009276","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2064876d-ea54-4ace-be76-f700cfefbf90-2019-06-06T160000.000Z","2019-06-06T16:00:00.000Z","Hemostasis Thrombosis"
"GP6","HGNC:14388","platelet-type bleeding disorder 11","MONDO:0013623","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_76262cf5-f2cd-4466-b542-bf2334a96c73-2019-10-23T160000.000Z","2019-10-23T16:00:00.000Z","Hemostasis Thrombosis"
"GP9","HGNC:4444","Bernard-Soulier syndrome","MONDO:0009276","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_af66eb15-10fe-4c2b-bff2-b8c8bf813174-2019-11-27T170000.000Z","2019-11-27T17:00:00.000Z","Hemostasis Thrombosis"
"GPC3","HGNC:4451","Simpson-Golabi-Behmel syndrome","MONDO:0010731","XL","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5b8b02d6-1d60-4b4c-bb8a-b976907087c7-2019-12-31T175422.159Z","2019-12-31T17:54:22.159Z","Intellectual Disability and Autism"
"GPD1L","HGNC:28956","Brugada syndrome 1","MONDO:0011001","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10149","2017-11-21T00:00:00","Brugada Syndrome"
"GPSM2","HGNC:29501","Chudley-McCullough syndrome","MONDO:0011411","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cd40cf49-a25c-450b-be6b-b80eef958f4c-2018-05-01T160000.000Z","2018-05-01T16:00:00.000Z","Hearing Loss"
"GPT2","HGNC:18062","glutamate pyruvate transaminase 2 deficiency","MONDO:0014567","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_42a70a83-40da-4acc-b6a3-9ef3942abd14-2021-10-05T115427.845Z","2021-10-05T11:54:27.845Z","General Inborn Errors of Metabolism"
"GREM1","HGNC:2001","hereditary mixed polyposis syndrome","MONDO:0011023","AD","SOP4","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8444","2016-10-11T00:00:00","Colon Cancer"
"GRHL2","HGNC:2799","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a2ca9952-b611-4e6f-bbf8-aa5175248d01-2020-05-01T160000.000Z","2020-05-01T16:00:00.000Z","Hearing Loss"
"GRIA3","HGNC:4573","X-linked complex neurodevelopmental disorder","MONDO:0100148","XL","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_25f94660-0a8d-4f3a-8f6c-dde1b38a8ab7-2019-11-06T170000.000Z","2019-11-06T17:00:00.000Z","Intellectual Disability and Autism"
"GRIN1","HGNC:4584","complex neurodevelopmental disorder","MONDO:0100038","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_22693f82-fde1-4123-9cfb-6ec27e0c1ac6-2019-03-07T170000.000Z","2019-03-07T17:00:00.000Z","Epilepsy"
"GRIN1","HGNC:4584","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b98e5df5-8f39-4fd6-9715-bb8da7dc1806-2018-11-20T050000.000Z","2018-11-20T05:00:00.000Z","Epilepsy"
"GRIN2A","HGNC:4585","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0c405372-b99b-42fc-836d-65d7c0cbd279-2019-07-16T160000.000Z","2019-07-16T16:00:00.000Z","Epilepsy"
"GRIN2B","HGNC:4586","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ff8d9346-2ab7-4ef1-9071-9b8ae4178174-2019-03-19T170000.000Z","2019-03-19T17:00:00.000Z","Epilepsy"
"GRIN2D","HGNC:4588","infantile epilepsy syndrome","MONDO:0020071","AD","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a52befb3-e9e0-46f1-9abf-8ead03151230-2018-07-06T123456.418Z","2018-07-06T12:34:56.418Z","Epilepsy"
"GRK1","HGNC:10013","Oguchi disease","MONDO:0019152","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b6e159cb-c02a-417c-9c60-a9b66db41c73-2021-01-07T170000.000Z","2021-01-07T17:00:00.000Z","Retina"
"GRXCR1","HGNC:31673","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4becaf23-4b72-4dd1-a5aa-4deccbb394ea-2018-04-24T040000.000Z","2018-04-24T04:00:00.000Z","Hearing Loss"
"GRXCR2","HGNC:33862","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_207f12b7-3148-4a8f-88f8-f78ac5bb294c-2021-03-26T155748.643Z","2021-03-26T15:57:48.643Z","Hearing Loss"
"GSDME","HGNC:2810","autosomal dominant nonsyndromic hearing loss","MONDO:0019587","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9b0a844b-f968-48e0-8940-35584eb3454b-2018-07-19T185513.195Z","2018-07-19T18:55:13.195Z","Hearing Loss"
"GSS","HGNC:4624","inherited glutathione synthetase deficiency","MONDO:0017909","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_69a8e645-0e10-4ea9-8545-212ce9b0dcbf-2019-04-26T160000.000Z","2019-04-26T16:00:00.000Z","Aminoacidopathy"
"GSTZ1","HGNC:4643","maleylacetoacetate isomerase deficiency","MONDO:0060527","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8c287e0b-88be-4fbb-82a6-a8c70d430506-2019-03-22T160000.000Z","2019-03-22T16:00:00.000Z","Aminoacidopathy"
"GTPBP3","HGNC:14880","Leigh syndrome","MONDO:0009723","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0d1b0a47-e62d-48dd-8e0d-f2b1aff014a7-2020-02-12T203256.857Z","2020-02-12T20:32:56.857Z","Mitochondrial Diseases"
"HAAO","HGNC:4796","vertebral, cardiac, renal, and limb defects syndrome 1","MONDO:0060554","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_89484d6b-0af1-4b77-9dcb-95c18331e3b7-2020-07-10T160000.000Z","2020-07-10T16:00:00.000Z","Aminoacidopathy"
"HACD1","HGNC:9639","congenital myopathy","MONDO:0019952","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_10c52aaf-cd58-4448-bac7-12b653bfa962-2021-06-28T160000.000Z","2021-06-28T16:00:00.000Z","Congenital Myopathies"
"HADH","HGNC:4799","hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency","MONDO:0009278","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c2f238b9-4eb5-426c-a27a-ecb7b468d9e4-2018-06-26T160000.000Z","2018-06-26T16:00:00.000Z","Fatty Acid Oxidation Disorders"
"HADHA","HGNC:4801","long chain 3-hydroxyacyl-CoA dehydrogenase deficiency","MONDO:0012173","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c8a5e15b-21f7-49cc-987c-5f3585742bbe-2018-02-12T170000.000Z","2018-02-12T17:00:00.000Z","Fatty Acid Oxidation Disorders"
"HADHB","HGNC:4803","mitochondrial trifunctional protein deficiency","MONDO:0012172","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_65cb0124-8476-422c-924f-15fac7c95592-2018-05-08T160000.000Z","2018-05-08T16:00:00.000Z","Fatty Acid Oxidation Disorders"
"HAL","HGNC:4806","histidinemia","MONDO:0009345","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c5764eb8-2aad-419e-be57-99f8c6859ebb-2020-09-25T165635.220Z","2020-09-25T16:56:35.220Z","Aminoacidopathy"
"HARS1","HGNC:4816","Usher syndrome type 3","MONDO:0016485","AR","SOP5","Refuted","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ca3372fa-f205-44e5-8bd9-6c64c40ebd93-2018-05-24T195734.534Z","2018-05-24T19:57:34.534Z","Hearing Loss"
"HARS2","HGNC:4817","Perrault syndrome 2","MONDO:0013972","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5c5ed5f6-4068-4e15-a195-6098e4ee2093-2018-05-15T160000.000Z","2018-05-15T16:00:00.000Z","Hearing Loss"
"HCFC1","HGNC:4839","X-linked intellectual disability","MONDO:0100284","XL","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_023defeb-36f4-4e54-ba8f-e2c9537e933c-2021-03-17T160000.000Z","2021-03-17T16:00:00.000Z","Intellectual Disability and Autism"
"HCN4","HGNC:16882","Brugada syndrome 1","MONDO:0011001","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10150","2017-11-21T00:00:00","Brugada Syndrome"
"HCN4","HGNC:16882","familial thoracic aortic aneurysm and aortic dissection","MONDO:0019625","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8262","2016-12-22T00:00:00","Heritable Thoracic Aortic Aneurysm and Dissection"
"HDAC8","HGNC:13315","Cornelia de Lange syndrome","MONDO:0016033","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7d29159-4c90-488e-a4e1-b006d70ae762-2018-09-11T142539.606Z","2018-09-11T14:25:39.606Z","Intellectual Disability and Autism"
"HEXA","HGNC:4878","Tay-Sachs disease","MONDO:0010100","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1f7530b5-af31-40f9-ac18-a1b4d404285a-2020-05-27T160000.000Z","2020-05-27T16:00:00.000Z","General Gene Curation"
"HGD","HGNC:4892","alkaptonuria","MONDO:0008753","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5186836d-d9c6-4829-a0c9-59548460d6f2-2020-06-29T174125.541Z","2020-06-29T17:41:25.541Z","Aminoacidopathy"
"HGF","HGNC:4893","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8828a306-1262-4bbf-9661-f3d13d0f44a7-2018-01-16T170000.000Z","2018-01-16T17:00:00.000Z","Hearing Loss"
"HIBCH","HGNC:4908","Leigh syndrome","MONDO:0009723","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_079ed613-0c28-494f-9852-9baf495f26ba-2021-06-14T142317.786Z","2021-06-14T14:23:17.786Z","Mitochondrial Diseases"
"HIBCH","HGNC:4908","3-hydroxyisobutyryl-CoA hydrolase deficiency","MONDO:0009603","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_26621ace-7c6b-4a1c-8286-02c4cb8a1544-2019-11-07T222437.403Z","2019-11-07T22:24:37.403Z","Aminoacidopathy"
"HINT1","HGNC:4912","Charcot-Marie-Tooth disease","MONDO:0015626","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_170aae71-9b16-49b1-be29-44f98db2f72e-2021-03-22T201109.360Z","2021-03-22T20:11:09.360Z","Charcot-Marie-Tooth"
"HLCS","HGNC:4976","holocarboxylase synthetase deficiency","MONDO:0009666","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ad306285-9588-48e3-a6fa-183db3f01fe9-2021-02-26T171131.548Z","2021-02-26T17:11:31.548Z","Aminoacidopathy"
"HMGCL","HGNC:5005","3-hydroxy-3-methylglutaric aciduria","MONDO:0009520","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f4d084e5-a740-4bfd-a850-d6db900d4a4e-2018-06-26T160000.000Z","2018-06-26T16:00:00.000Z","Fatty Acid Oxidation Disorders"
"HMGCS2","HGNC:5008","3-hydroxy-3-methylglutaryl-CoA synthase deficiency","MONDO:0011614","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b3f49254-4635-4961-83b9-31c7ebc7f159-2018-05-22T160000.000Z","2018-05-22T16:00:00.000Z","Fatty Acid Oxidation Disorders"
"HMX1","HGNC:5017","oculoauricular syndrome","MONDO:0012802","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ebf66ec9-77a4-4e48-83a4-970639ad5373-2021-05-06T160000.000Z","2021-05-06T16:00:00.000Z","Retina"
"HNF1A","HGNC:11621","monogenic diabetes","MONDO:0015967","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2f6d71c6-6595-49bf-a50e-fce726b22088-2018-10-05T160000.000Z","2018-10-05T16:00:00.000Z","Monogenic Diabetes"
"HNF1B","HGNC:11630","renal cysts and diabetes syndrome","MONDO:0007669","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4174ea0a-6901-4070-ad93-d92614fd55c0-2021-01-19T170000.000Z","2021-01-19T17:00:00.000Z","Monogenic Diabetes"
"HNF4A","HGNC:5024","monogenic diabetes","MONDO:0015967","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_98cb808e-02d3-4378-8e6b-9b1b2883cc65-2019-02-27T170000.000Z","2019-02-27T17:00:00.000Z","Monogenic Diabetes"
"HNRNPA2B1","HGNC:5033","amyotrophic lateral sclerosis","MONDO:0004976","AD","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1ffe711b-1ff6-4b11-b329-c0f820904764-2021-12-15T185159.600Z","2021-12-15T18:51:59.600Z","Amyotrophic Lateral Sclerosis Spectrum Disorders"
"HNRNPK","HGNC:5044","neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-hip dysplasia syndrome","MONDO:0018681","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f1adc74c-9bbc-48fc-bbbf-1159c0944108-2021-12-20T170000.000Z","2021-12-20T17:00:00.000Z","Intellectual Disability and Autism"
"HOMER2","HGNC:17513","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9158c2a6-f11b-47b4-ac7d-45471f7255a1-2020-08-31T170000.000Z","2020-08-31T17:00:00.000Z","Hearing Loss"
"HOXA1","HGNC:5099","syndromic intellectual disability","MONDO:0000508","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1e0e605f-c82a-4e34-b913-8dc6b72b4881-2019-06-19T160000.000Z","2019-06-19T16:00:00.000Z","Intellectual Disability and Autism"
"HOXA11","HGNC:5101","radioulnar synostosis with amegakaryocytic thrombocytopenia 1","MONDO:0024558","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_48ef111f-28fc-4970-a0ca-8387e9ec2d0e-2021-04-28T181451.054Z","2021-04-28T18:14:51.054Z","Hemostasis Thrombosis"
"HPD","HGNC:5147","hawkinsinuria","MONDO:0007700","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6819b0ea-9f21-4f91-ae92-133d97fcf87b-2020-06-26T171501.409Z","2020-06-26T17:15:01.409Z","Aminoacidopathy"
"HPD","HGNC:5147","tyrosinemia type III","MONDO:0010162","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_89eb4236-9243-490b-bc73-fb3b99675eb9-2020-06-29T173606.841Z","2020-06-29T17:36:06.841Z","Aminoacidopathy"
"HPDL","HGNC:28242","Leigh syndrome","MONDO:0009723","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d1a484ba-cba2-4a63-8c81-7a8a41c93f9c-2021-06-30T215754.231Z","2021-06-30T21:57:54.231Z","Mitochondrial Diseases"
"HPRT1","HGNC:5157","Lesch-Nyhan syndrome","MONDO:0010298","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9597","2018-03-07T00:00:00","Intellectual Disability and Autism"
"HPS1","HGNC:5163","Hermansky-Pudlak syndrome 1","MONDO:0008748","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f6d44a89-527f-4864-a1e1-dcd0a17000ca-2019-07-22T142842.174Z","2019-07-22T14:28:42.174Z","Hemostasis Thrombosis"
"HPS3","HGNC:15597","Hermansky-Pudlak syndrome 3","MONDO:0013555","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_80370671-df62-4330-89f4-216d350e5958-2020-02-26T170000.000Z","2020-02-26T17:00:00.000Z","Hemostasis Thrombosis"
"HPS4","HGNC:15844","Hermansky-Pudlak syndrome 4","MONDO:0013556","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3649fe18-730d-4d46-ad60-b70d421abc02-2020-05-27T160000.000Z","2020-05-27T16:00:00.000Z","Hemostasis Thrombosis"
"HPS6","HGNC:18817","Hermansky-Pudlak syndrome 6","MONDO:0013558","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_602ae8f1-9e7f-4cc6-bf70-d572d98828c5-2020-11-25T170000.000Z","2020-11-25T17:00:00.000Z","Hemostasis Thrombosis"
"HRAS","HGNC:5173","Costello syndrome","MONDO:0009026","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6a40ab43-3c9f-45c0-9ec0-0371d6f0d5c8-2018-07-24T160000.000Z","2018-07-24T16:00:00.000Z","RASopathy"
"HRAS","HGNC:5173","Noonan syndrome-like disorder with loose anagen hair","MONDO:0011899","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_94630309-c540-48b3-a27f-0ee1891091c1-2018-07-25T160000.000Z","2018-07-25T16:00:00.000Z","RASopathy"
"HRG","HGNC:5181","hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency","MONDO:0013143","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a2604a64-e36e-4512-83a7-e8202ccdb593-2021-12-15T173040.572Z","2021-12-15T17:30:40.572Z","Hemostasis Thrombosis"
"HSD17B10","HGNC:4800","HSD10 mitochondrial disease","MONDO:0010327","XL","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9232b352-a845-4404-8a98-34cb6ad6ff0e-2018-10-09T160000.000Z","2018-10-09T16:00:00.000Z","Fatty Acid Oxidation Disorders"
"HSD17B4","HGNC:5213","d-bifunctional protein deficiency","MONDO:0009855","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b992de69-49b3-496d-a83a-5bcc427fdf98-2020-04-17T160000.000Z","2020-04-17T16:00:00.000Z","Peroxisomal Disorders"
"HSD17B4","HGNC:5213","Perrault syndrome","MONDO:0017312","AR","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dbc9308c-2310-4e0a-9354-667dbd3c7d5d-2018-05-30T124549.495Z","2018-05-30T12:45:49.495Z","Hearing Loss"
"HSPB8","HGNC:30171","autosomal dominant distal hereditary motor neuropathy","MONDO:0015362","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_044a2465-8e0a-44ff-8d00-1ec3a76183c8-2021-03-22T201855.441Z","2021-03-22T20:18:55.441Z","Charcot-Marie-Tooth"
"HTT","HGNC:4851","Huntington disease","MONDO:0007739","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_617c18ee-9476-4bc0-b403-20bc55150c7c-2021-11-08T193955.489Z","2021-11-08T19:39:55.489Z","General Gene Curation"
"HUWE1","HGNC:30892","non-syndromic X-linked intellectual disability","MONDO:0019181","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9518","2017-10-20T00:00:00","Intellectual Disability and Autism"
"IARS2","HGNC:29685","Leigh syndrome","MONDO:0009723","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_50877212-c671-406b-8cb6-195c7369a96c-2019-11-25T154442.667Z","2019-11-25T15:44:42.667Z","Mitochondrial Diseases"
"IDS","HGNC:5389","mucopolysaccharidosis type 2","MONDO:0010674","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_753ba7a6-cef5-4665-81e9-306e11c618c5-2018-02-21T170000.000Z","2018-02-21T17:00:00.000Z","Intellectual Disability and Autism"
"IDUA","HGNC:5391","mucopolysaccharidosis type 1","MONDO:0001586","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_042f8964-a8e1-4880-b873-73460088e8bf-2020-05-27T160000.000Z","2020-05-27T16:00:00.000Z","General Gene Curation"
"IFT122","HGNC:13556","cranioectodermal dysplasia 1","MONDO:0021093","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6e4b420a-5df1-4c3c-aca8-a5359de25a5d-2021-10-21T040941.926Z","2021-10-21T04:09:41.926Z","Syndromic Disorders"
"IGBP1","HGNC:5461","corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome","MONDO:0010333","XL","SOP8","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dbeb1651-add0-4a44-87ad-a56c7864f076-2021-02-02T170000.000Z","2021-02-02T17:00:00.000Z","Intellectual Disability and Autism"
"IGHM","HGNC:5541","autosomal recessive agammaglobulinemia 1","MONDO:0020729","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_51719b80-54fb-4a55-a63c-7d7a943da1e3-2021-06-15T120659.636Z","2021-06-15T12:06:59.636Z","Antibody Deficiencies GCEP"
"IGKC","HGNC:5716","recurrent infections associated with rare immunoglobulin isotypes deficiency","MONDO:0013576","AR","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_017e48b4-45d1-4bba-b51c-0f372dbe3a6d-2021-05-18T160657.607Z","2021-05-18T16:06:57.607Z","Antibody Deficiencies GCEP"
"IGLL1","HGNC:5870","agammaglobulinemia 2, autosomal recessive","MONDO:0013287","AR","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b483cc35-0599-4313-b71a-835cb1096ca5-2021-12-21T133220.444Z","2021-12-21T13:32:20.444Z","Antibody Deficiencies GCEP"
"IKZF5","HGNC:14283","thrombocytopenia 7","MONDO:0030867","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b3d7d24b-1fb8-4951-9508-b27035a000a0-2021-05-26T160000.000Z","2021-05-26T16:00:00.000Z","Hemostasis Thrombosis"
"IL1RAPL1","HGNC:5996","non-syndromic X-linked intellectual disability","MONDO:0019181","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3b5db6b4-94fa-46d1-88a7-bbf382f3a1c6-2021-03-15T135028.460Z","2021-03-15T13:50:28.460Z","Intellectual Disability and Autism"
"IL2RG","HGNC:6010","T-B+ severe combined immunodeficiency due to gamma chain deficiency","MONDO:0010315","XL","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e4a8be06-e082-47c7-b005-956b51424fd2-2021-04-22T191103.318Z","2021-04-22T19:11:03.318Z","SCID-CID"
"IL7R","HGNC:6024","severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive","MONDO:0012163","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6bab0c36-592e-439c-bedf-4ec095fd47e8-2021-06-22T164843.040Z","2021-06-22T16:48:43.040Z","SCID-CID"
"ILDR1","HGNC:28741","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e5e1a608-edc3-405c-805f-a7ed162c2bbc-2017-11-21T170000.000Z","2017-11-21T17:00:00.000Z","Hearing Loss"
"ILK","HGNC:6040","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_540f2706-1c1a-452e-b5b9-334728b11e40-2020-09-04T160000.000Z","2020-09-04T16:00:00.000Z","Dilated Cardiomyopathy"
"INF2","HGNC:23791","Charcot-Marie-Tooth disease dominant intermediate E","MONDO:0013758","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5215f2cf-99c9-405a-b221-18f412abd1f0-2021-03-22T202012.410Z","2021-03-22T20:20:12.410Z","Charcot-Marie-Tooth"
"INO80","HGNC:26956","immunodeficiency, common variable, 1","MONDO:0011864","AR","SOP8","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_16d9f828-f6fa-4e35-bc23-c9f1b1138b9a-2021-01-22T014826.188Z","2021-01-22T01:48:26.188Z","Antibody Deficiencies GCEP"
"INPP5E","HGNC:21474","Joubert syndrome 1","MONDO:0008944","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a5fb970a-8747-4c3e-8465-d8cb007c1428-2021-09-08T160000.000Z","2021-09-08T16:00:00.000Z","Kidney Cystic and Ciliopathy Disorders"
"INS","HGNC:6081","monogenic diabetes","MONDO:0015967","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9c21ba4d-785f-486f-84f8-511b9c89c137-2020-05-13T160000.000Z","2020-05-13T16:00:00.000Z","Monogenic Diabetes"
"INS","HGNC:6081","monogenic diabetes","MONDO:0015967","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c5224322-637e-40a8-89eb-d44e01536f25-2020-05-13T160000.000Z","2020-05-13T16:00:00.000Z","Monogenic Diabetes"
"INVS","HGNC:17870","nephronophthisis 2","MONDO:0011190","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6bdaee2a-144d-4bdf-a5c7-78001b991174-2021-02-24T170000.000Z","2021-02-24T17:00:00.000Z","Kidney Cystic and Ciliopathy Disorders"
"IQSEC2","HGNC:29059","X-linked complex neurodevelopmental disorder","MONDO:0100148","XL","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0916cda1-5213-4f88-9835-34c3931526a2-2019-06-05T160000.000Z","2019-06-05T16:00:00.000Z","Intellectual Disability and Autism"
"IRF2BP2","HGNC:21729","immunodeficiency, common variable, 14","MONDO:0054691","AD","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_025487e5-9447-4c7b-88ad-f650103e09cf-2021-03-16T125403.252Z","2021-03-16T12:54:03.252Z","Antibody Deficiencies GCEP"
"ITGA2B","HGNC:6138","platelet-type bleeding disorder 16","MONDO:0008552","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_380c4fb9-aa51-4d34-9349-7938667612b7-2021-06-23T160000.000Z","2021-06-23T16:00:00.000Z","Hemostasis Thrombosis"
"ITGA2B","HGNC:6138","Glanzmann thrombasthenia","MONDO:0100326","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9fa894f5-f9e4-4b6d-bdde-eeb7ad9507e2-2019-09-04T040000.000Z","2019-09-04T04:00:00.000Z","Hemostasis Thrombosis"
"ITGB3","HGNC:6156","Glanzmann thrombasthenia","MONDO:0100326","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e16b727e-c4c6-4d1d-8e66-8acab2b605fa-2019-08-28T040000.000Z","2019-08-28T04:00:00.000Z","Hemostasis Thrombosis"
"ITGB3","HGNC:6156","platelet-type bleeding disorder 16","MONDO:0008552","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_eda416fa-6e15-40df-bfd0-46a111e99ba0-2020-09-23T160000.000Z","2020-09-23T16:00:00.000Z","Hemostasis Thrombosis"
"ITK","HGNC:6171","lymphoproliferative syndrome 1","MONDO:0013081","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_63552229-5e8c-4a94-b428-ec9a56a0aa5f-2019-11-21T193148.945Z","2019-11-21T19:31:48.945Z","Hereditary Cancer"
"ITPR1","HGNC:6180","spinocerebellar ataxia type 29","MONDO:0007298","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8b938bea-6fcb-46e1-9435-99303d59740e-2021-11-03T160000.000Z","2021-11-03T16:00:00.000Z","Intellectual Disability and Autism"
"ITPR1","HGNC:6180","aniridia-cerebellar ataxia-intellectual disability syndrome","MONDO:0008795","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a848b265-8aa3-41ee-83cc-9287afe0f9d0-2021-11-03T160000.000Z","2021-11-03T16:00:00.000Z","Intellectual Disability and Autism"
"IVD","HGNC:6186","isovaleric acidemia","MONDO:0009475","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_05f5d468-2f46-44f3-ba67-c4e708d2954f-2019-05-10T160000.000Z","2019-05-10T16:00:00.000Z","Aminoacidopathy"
"JAK3","HGNC:6193","T-B+ severe combined immunodeficiency due to JAK3 deficiency","MONDO:0010938","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_669dcacf-8423-4507-a36c-feab049737b3-2020-12-18T200520.841Z","2020-12-18T20:05:20.841Z","SCID-CID"
"JPH2","HGNC:14202","dilated cardiomyopathy","MONDO:0005021","SD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_242181ea-8909-4b38-a6bd-9a6552935c74-2020-10-09T160000.000Z","2020-10-09T16:00:00.000Z","Dilated Cardiomyopathy"
"JPH2","HGNC:14202","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP5","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_378a727d-0c5b-4563-9c96-ac18a2902742-2017-07-18T160000.000Z","2017-07-18T16:00:00.000Z","Hypertrophic Cardiomyopathy"
"JUP","HGNC:6207","arrhythmogenic right ventricular cardiomyopathy","MONDO:0016587","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_691f4a61-de71-48e7-8f01-559c71ee089a-2018-07-27T160000.000Z","2018-07-27T16:00:00.000Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"KARS1","HGNC:6215","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f5239ac3-1506-4b0e-9055-632ba895ca0c-2018-08-24T121834.618Z","2018-08-24T12:18:34.618Z","Hearing Loss"
"KAT6A","HGNC:13013","syndromic intellectual disability","MONDO:0000508","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_86ec74ba-6b12-42ea-bc06-58af4fd6b7a4-2021-10-05T160000.000Z","2021-10-05T16:00:00.000Z","Intellectual Disability and Autism"
"KAT6B","HGNC:17582","RASopathy","MONDO:0021060","AD","SOP6","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fb3c40d8-3aea-45bf-949e-c3ba7d96a6b4-2019-02-04T170000.000Z","2019-02-04T17:00:00.000Z","RASopathy"
"KATNAL2","HGNC:25387","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_eddbdd3e-2f6b-4b55-a951-988ee214b08b-2020-05-20T160000.000Z","2020-05-20T16:00:00.000Z","Intellectual Disability and Autism"
"KBTBD13","HGNC:37227","nemaline myopathy 6","MONDO:0012237","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ff2f157e-741b-447d-a6c5-1d003e2e98e1-2020-06-22T142022.592Z","2020-06-22T14:20:22.592Z","Congenital Myopathies"
"KCNA2","HGNC:6220","undetermined early-onset epileptic encephalopathy","MONDO:0018614","AD","SOP5","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10049","2017-10-20T00:00:00","Epilepsy"
"KCNA2","HGNC:6220","infantile epilepsy syndrome","MONDO:0020071","AD","SOP5","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1a825f85-585a-4086-8118-ce912d4c1469-2018-05-31T040000.000Z","2018-05-31T04:00:00.000Z","Epilepsy"
"KCNB1","HGNC:6231","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_986348ad-e8bb-4391-9478-7834a19415cb-2019-04-16T160000.000Z","2019-04-16T16:00:00.000Z","Epilepsy"
"KCND3","HGNC:6239","Brugada syndrome 1","MONDO:0011001","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10151","2017-11-21T00:00:00","Brugada Syndrome"
"KCNE1","HGNC:6240","long QT syndrome 5","MONDO:0013372","AD","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_957550ae-d91c-49e7-be7c-ff5a13faa3ff-2020-12-15T002142.973Z","2020-12-15T00:21:42.973Z","Long QT Syndrome"
"KCNE1","HGNC:6240","Jervell and Lange-Nielsen syndrome 2","MONDO:0012871","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1d7672c-743f-4b93-b620-e20db96e47bd-2018-06-22T040000.000Z","2018-06-22T04:00:00.000Z","Hearing Loss"
"KCNE2","HGNC:6242","long QT syndrome","MONDO:0002442","AD","SOP8","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9912be79-b172-46ca-a67c-99698de5590b-2020-12-15T002341.412Z","2020-12-15T00:23:41.412Z","Long QT Syndrome"
"KCNE3","HGNC:6243","Brugada syndrome","MONDO:0015263","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10152","2017-11-21T00:00:00","Brugada Syndrome"
"KCNE5","HGNC:6241","Brugada syndrome","MONDO:0015263","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10153","2017-11-21T00:00:00","Brugada Syndrome"
"KCNH2","HGNC:6251","Brugada syndrome","MONDO:0015263","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10154","2017-11-21T17:00:00","Brugada Syndrome"
"KCNH2","HGNC:6251","long QT syndrome","MONDO:0002442","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_462eeb4e-357d-4c3d-89f0-e386ac0d011b-2018-09-25T040000.000Z","2018-09-25T04:00:00.000Z","Long QT Syndrome"
"KCNH2","HGNC:6251","short QT syndrome","MONDO:0000453","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6b033c3f-04de-4806-a9f3-0b318082b32e-2020-08-03T160000.000Z","2020-08-03T16:00:00.000Z","Short QT Syndrome"
"KCNJ10","HGNC:6256","enlarged vestibular aqueduct syndrome","MONDO:0023069","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_09f81c95-1213-4029-a6bd-279e52f240c7-2018-09-18T181546.700Z","2018-09-18T18:15:46.700Z","Hearing Loss"
"KCNJ11","HGNC:6257","monogenic diabetes","MONDO:0015967","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9353379e-564a-43bc-a859-7d27ab640e9e-2020-08-21T160000.000Z","2020-08-21T16:00:00.000Z","Monogenic Diabetes"
"KCNJ2","HGNC:6263","long QT syndrome","MONDO:0002442","AD","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5dc2acbc-8dbe-4142-8f71-89f1576dde08-2020-12-15T002535.799Z","2020-12-15T00:25:35.799Z","Long QT Syndrome"
"KCNJ2","HGNC:6263","short QT syndrome","MONDO:0000453","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9111653a-7d9c-4d0e-94d9-daaa208a0b05-2020-10-27T160000.000Z","2020-10-27T16:00:00.000Z","Short QT Syndrome"
"KCNJ2","HGNC:6263","catecholaminergic polymorphic ventricular tachycardia","MONDO:0017990","AD","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b5f2490f-215e-427e-be7b-6a68e3f89e32-2021-01-20T170000.000Z","2021-01-20T17:00:00.000Z","Catecholaminergic Polymorphic Ventricular Tachycardia"
"KCNJ5","HGNC:6266","long QT syndrome","MONDO:0002442","AD","SOP8","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6fa6a520-ae6b-4638-a092-a61831d481bf-2020-12-15T002641.568Z","2020-12-15T00:26:41.568Z","Long QT Syndrome"
"KCNJ8","HGNC:6269","Brugada syndrome 1","MONDO:0011001","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10155","2017-11-21T00:00:00","Brugada Syndrome"
"KCNK3","HGNC:6278","pulmonary arterial hypertension","MONDO:0015924","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e20d0ee0-4a14-4569-a451-729348ce8d23-2021-05-08T152719.928Z","2021-05-08T15:27:19.928Z","Pulmonary Hypertension"
"KCNQ1","HGNC:6294","obsolete Jervell and Lange-Nielsen syndrome","MONDO:0009078","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2cb5cd32-6663-48bc-b8b0-3b9ca34e2cb7-2017-12-19T050000.000Z","2017-12-19T05:00:00.000Z","Hearing Loss"
"KCNQ1","HGNC:6294","short QT syndrome","MONDO:0000453","AD","SOP7","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5000dde0-156c-45b0-87db-35a935c69cb7-2020-10-27T160000.000Z","2020-10-27T16:00:00.000Z","Short QT Syndrome"
"KCNQ1","HGNC:6294","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP7","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5b44eee3-56ea-4596-8d3e-e4d5c0ad8d60-2020-04-07T022907.489Z","2020-04-07T02:29:07.489Z","Hypertrophic Cardiomyopathy"
"KCNQ1","HGNC:6294","long QT syndrome","MONDO:0002442","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dff8874e-98a1-472b-9cc2-3f441b1c1064-2018-09-25T040000.000Z","2018-09-25T04:00:00.000Z","Long QT Syndrome"
"KCNQ4","HGNC:6298","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_88196c6d-4bd7-4aff-ba98-c7b4411c562d-2017-11-21T170000.000Z","2017-11-21T17:00:00.000Z","Hearing Loss"
"KCNT1","HGNC:18865","childhood-onset epilepsy syndrome","MONDO:0020072","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f1fe70b9-1f8b-4fbf-b79f-9f05dfbcf01c-2017-10-20T160000.000Z","2017-10-20T16:00:00.000Z","Epilepsy"
"KCTD7","HGNC:21957","progressive myoclonus epilepsy","MONDO:0020074","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e6068b08-413e-4105-b8dc-97426d64c6c4-2020-09-02T121001.258Z","2020-09-02T12:10:01.258Z","Epilepsy"
"KDM5C","HGNC:11114","X-linked syndromic intellectual disability","MONDO:0020119","XL","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_36896d71-1c04-4176-8cd9-16f5b283ef9c-2018-09-19T160000.000Z","2018-09-19T16:00:00.000Z","Intellectual Disability and Autism"
"KDM6A","HGNC:12637","Kabuki syndrome 2","MONDO:0010465","XL","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fb0b5b0f-d4c9-4c46-b4cc-2e516be7908d-2021-07-26T202903.760Z","2021-07-26T20:29:03.760Z","SCID-CID"
"KDR","HGNC:6307","pulmonary arterial hypertension","MONDO:0015924","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_07a11f06-0904-4a38-9fd3-0aec2bece699-2021-05-12T165601.478Z","2021-05-12T16:56:01.478Z","Pulmonary Hypertension"
"KDSR","HGNC:4021","erythrokeratodermia variabilis et progressiva 4","MONDO:0033014","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0a5d1542-feb7-4aaf-9079-55da7fb99a4a-2020-07-22T160000.000Z","2020-07-22T16:00:00.000Z","Hemostasis Thrombosis"
"KIF11","HGNC:6388","microcephaly with or without chorioretinopathy, lymphedema, or intellectual disability","MONDO:0007918","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aabff7c5-06ad-4602-a6f7-fef1bca0d1df-2021-07-01T160000.000Z","2021-07-01T16:00:00.000Z","Retina"
"KIF1A","HGNC:888","syndromic intellectual disability","MONDO:0000508","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1d586d93-7066-4db0-b623-8b7e3eafdc06-2020-09-24T134254.893Z","2020-09-24T13:42:54.893Z","Intellectual Disability and Autism"
"KIF1B","HGNC:16636","Charcot-Marie-Tooth disease type 2A1","MONDO:0007308","AD","SOP7","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ae6ffeae-9609-47bf-89a9-4863cf6ef05c-2020-10-05T161930.420Z","2020-10-05T16:19:30.420Z","Charcot-Marie-Tooth"
"KIF21A","HGNC:19349","congenital fibrosis of extraocular muscles","MONDO:0007614","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cc32bbc2-de76-42d0-8a6b-b3c3393ddd30-2021-10-26T144854.679Z","2021-10-26T14:48:54.679Z","Brain Malformations"
"KIT","HGNC:6342","gastrointestinal stromal tumor","MONDO:0011719","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fa076c63-8ffe-46ff-ba44-255a6fca07e5-2020-01-14T184619.396Z","2020-01-14T18:46:19.396Z","Hereditary Cancer"
"KITLG","HGNC:6343","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d2934de4-e4d7-41b7-8d12-83372e3b1b28-2018-01-16T170000.000Z","2018-01-16T17:00:00.000Z","Hearing Loss"
"KLF10","HGNC:11810","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_524bb91c-07d4-4f65-bdc0-fc568a5930c8-2017-08-01T160000.000Z","2017-08-01T16:00:00.000Z","Hypertrophic Cardiomyopathy"
"KLF11","HGNC:11811","monogenic diabetes","MONDO:0015967","AD","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b1e38a49-7c12-4514-a2a1-109e04da146f-2020-02-12T170000.000Z","2020-02-12T17:00:00.000Z","Monogenic Diabetes"
"KLHL40","HGNC:30372","nemaline myopathy 8","MONDO:0014138","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dd1008a8-dd54-43d0-962c-82453975dc3a-2019-11-05T134603.480Z","2019-11-05T13:46:03.480Z","Congenital Myopathies"
"KLHL41","HGNC:16905","nemaline myopathy 9","MONDO:0014326","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b6bd51c2-e7b8-4938-a700-fd0e393143a7-2019-11-05T134928.155Z","2019-11-05T13:49:28.155Z","Congenital Myopathies"
"KMT2D","HGNC:7133","Kabuki syndrome 1","MONDO:0007843","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_15029985-0c1a-4835-95fe-eb05dedaf85c-2021-10-21T145501.022Z","2021-10-21T14:55:01.022Z","SCID-CID"
"KNG1","HGNC:6383","congenital high-molecular-weight kininogen deficiency","MONDO:0009234","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6dbf4bc1-b04f-4f1d-8c11-2b7998370293-2021-06-23T160000.000Z","2021-06-23T16:00:00.000Z","Hemostasis Thrombosis"
"KRAS","HGNC:6407","cardiofaciocutaneous syndrome","MONDO:0015280","AD","SOP5","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_248e0d6b-9300-4d17-a350-f742fa92c82c-2018-07-24T160000.000Z","2018-07-24T16:00:00.000Z","RASopathy"
"KRAS","HGNC:6407","Noonan syndrome","MONDO:0018997","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6476a5fd-8f66-462b-b17a-43540dad3c1f-2018-07-24T160000.000Z","2018-07-24T16:00:00.000Z","RASopathy"
"KRAS","HGNC:6407","Costello syndrome","MONDO:0009026","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bc9a82d0-8447-454c-8d54-def792d20e1d-2018-07-24T160000.000Z","2018-07-24T16:00:00.000Z","RASopathy"
"KYNU","HGNC:6469","vertebral, cardiac, renal, and limb defects syndrome 2","MONDO:0060555","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_70d2f25f-b3f0-4f1b-b7bf-ad8d3562c959-2020-07-10T160000.000Z","2020-07-10T16:00:00.000Z","Aminoacidopathy"
"L1CAM","HGNC:6470","L1 syndrome","MONDO:0017140","XL","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e8541f5b-a166-44cd-a7f3-fce263ef8fde-2019-10-02T160000.000Z","2019-10-02T16:00:00.000Z","Intellectual Disability and Autism"
"LAMA2","HGNC:6482","LAMA2-related muscular dystrophy","MONDO:0100228","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_53f18520-6a7c-4781-ad0e-09250570f10e-2021-01-27T170000.000Z","2021-01-27T17:00:00.000Z","Congenital Myopathies"
"LAMA4","HGNC:6484","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e937f98e-7577-48bd-a24a-361634ba0a8d-2020-08-12T160000.000Z","2020-08-12T16:00:00.000Z","Dilated Cardiomyopathy"
"LAMB1","HGNC:6486","cobblestone lissencephaly without muscular or ocular involvement","MONDO:0014077","AR","SOP4","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5461","2016-11-15T00:00:00","General Gene Curation"
"LAMC3","HGNC:6494","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0ff89702-c97e-4ef9-91ce-2e37b66efd84-2020-09-01T160000.000Z","2020-09-01T16:00:00.000Z","Intellectual Disability and Autism"
"LAMP2","HGNC:6501","Danon disease","MONDO:0010281","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1f0d4050-f510-438d-a477-0a12669945d8-2017-10-11T040000.000Z","2017-10-11T04:00:00.000Z","Hypertrophic Cardiomyopathy"
"LARS2","HGNC:17095","Perrault syndrome","MONDO:0017312","AR","SOP5","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8afe11e7-7c53-46e2-b48e-37ee2bc144ce-2018-06-27T202427.557Z","2018-06-27T20:24:27.557Z","Hearing Loss"
"LAS1L","HGNC:25726","X-linked syndromic intellectual disability","MONDO:0020119","XL","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c5b85dbb-3d49-4924-8294-e518ff56f048-2021-09-21T160000.000Z","2021-09-21T16:00:00.000Z","Intellectual Disability and Autism"
"LBR","HGNC:6518","regressive spondylometaphyseal dysplasia","MONDO:0018663","AR","SOP4","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5462","2016-12-01T00:00:00","General Gene Curation"
"LCA5","HGNC:31923","inherited retinal dystrophy","MONDO:0019118","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ece57d88-4307-420a-aedb-4b5900248ea1-2021-10-07T160000.000Z","2021-10-07T16:00:00.000Z","Retina"
"LDB3","HGNC:15710","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7756e3c0-5a16-49b8-ac0f-220e79a4fa99-2020-09-25T160000.000Z","2020-09-25T16:00:00.000Z","Dilated Cardiomyopathy"
"LDB3","HGNC:15710","arrhythmogenic right ventricular cardiomyopathy","MONDO:0016587","AD","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8ebdc3e8-2e0a-4a5e-8906-8e616d14008b-2019-09-12T160000.000Z","2019-09-12T16:00:00.000Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"LDLR","HGNC:6547","hypercholesterolemia, familial, 1","MONDO:0007750","SD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_81788cfe-7520-4821-b80b-3ee0b2018909-2021-02-24T170000.000Z","2021-02-24T17:00:00.000Z","General Gene Curation"
"LGI1","HGNC:6572","Autosomal dominant epilepsy with auditory features","MONDO:0010898","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_662936d4-11a7-43f3-9daf-4ba1a7c92ffe-2020-07-07T183907.849Z","2020-07-07T18:39:07.849Z","Epilepsy"
"LHFPL5","HGNC:21253","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8a029f02-3524-4932-9293-9c02304fdd2b-2018-04-24T160000.000Z","2018-04-24T16:00:00.000Z","Hearing Loss"
"LIAS","HGNC:16429","Leigh syndrome","MONDO:0009723","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec6f6c96-262d-4ab8-ab7a-b09d585689ca-2021-03-11T171936.261Z","2021-03-11T17:19:36.261Z","Mitochondrial Diseases"
"LIFR","HGNC:6597","Stve-Wiedemann syndrome","MONDO:0011108","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9e336431-a56a-4144-8554-6fe62e4cb298-2021-07-27T145127.876Z","2021-07-27T14:51:27.876Z","Syndromic Disorders"
"LIG4","HGNC:6601","DNA ligase IV deficiency","MONDO:0011686","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ec863c8-d668-4ebf-806e-e01f5a6407fe-2021-04-16T230148.883Z","2021-04-16T23:01:48.883Z","SCID-CID"
"LIPT1","HGNC:29569","Leigh syndrome","MONDO:0009723","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_55d66b81-fe31-4965-b5fc-483393af820d-2021-04-09T142912.496Z","2021-04-09T14:29:12.496Z","Mitochondrial Diseases"
"LITAF","HGNC:16841","Charcot-Marie-Tooth disease","MONDO:0015626","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e7106097-314c-487a-9770-b7dea3f25f37-2020-04-07T160000.000Z","2020-04-07T16:00:00.000Z","Charcot-Marie-Tooth"
"LMAN1","HGNC:6631","factor V and factor VIII, combined deficiency of, type 1","MONDO:0009206","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_31792b8d-aca4-4832-b7f7-1993611777d7-2019-11-27T170000.000Z","2019-11-27T17:00:00.000Z","Hemostasis Thrombosis"
"LMBRD1","HGNC:23038","methylmalonic aciduria and homocystinuria type cblF","MONDO:0010183","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_14c077fe-c0ff-43d5-8436-041db18b20b1-2021-03-26T160000.000Z","2021-03-26T16:00:00.000Z","Aminoacidopathy"
"LMNA","HGNC:6636","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_132ea1ec-caa9-409a-8670-3edb2ec9c889-2020-11-06T175304.195Z","2020-11-06T17:53:04.195Z","Dilated Cardiomyopathy"
"LMNA","HGNC:6636","arrhythmogenic right ventricular cardiomyopathy","MONDO:0016587","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ef503af9-9d10-4714-848b-34cfa0049c23-2019-09-06T160000.000Z","2019-09-06T16:00:00.000Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"LMOD3","HGNC:6649","nemaline myopathy 10","MONDO:0014513","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_af248a78-5ef6-4c0b-b174-f43cc4688ec9-2019-09-09T160000.000Z","2019-09-09T16:00:00.000Z","Congenital Myopathies"
"LMX1B","HGNC:6654","nail-patella syndrome","MONDO:0008061","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c89e1a52-3ef8-4a61-bf56-1e43cf88fc6e-2021-07-27T144211.405Z","2021-07-27T14:42:11.405Z","Syndromic Disorders"
"LONP1","HGNC:9479","Leigh syndrome","MONDO:0009723","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3da0a308-3a7e-4101-b40b-1f23db106aea-2021-04-09T140215.539Z","2021-04-09T14:02:15.539Z","Mitochondrial Diseases"
"LOX","HGNC:6664","familial thoracic aortic aneurysm and aortic dissection","MONDO:0019625","AD","SOP4","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8258","2016-07-25T00:00:00","Heritable Thoracic Aortic Aneurysm and Dissection"
"LOXHD1","HGNC:26521","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a35c0909-7546-465c-a069-47e901fce483-2018-05-08T040000.000Z","2018-05-08T04:00:00.000Z","Hearing Loss"
"LPIN1","HGNC:13345","myoglobinuria, acute recurrent, autosomal recessive","MONDO:0009992","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_642c8d4a-d498-4739-957d-a4e0d457362a-2018-09-25T160000.000Z","2018-09-25T16:00:00.000Z","Fatty Acid Oxidation Disorders"
"LRPPRC","HGNC:15714","Leigh syndrome","MONDO:0009723","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_79691365-1911-423c-ab14-73a1f509ed22-2019-12-19T190157.942Z","2019-12-19T19:01:57.942Z","Mitochondrial Diseases"
"LRRC10","HGNC:20264","dilated cardiomyopathy","MONDO:0005021","AR","SOP7","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7403d325-ff12-4c92-a308-b2054e9861c5-2020-09-04T160000.000Z","2020-09-04T16:00:00.000Z","Dilated Cardiomyopathy"
"LRRK2","HGNC:18618","Parkinson disease","MONDO:0005180","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2728e13a-b95a-4c55-8cba-082260094ecd-2021-05-03T160000.000Z","2021-05-03T16:00:00.000Z","Parkinson's disease"
"LRTOMT","HGNC:25033","autosomal recessive nonsyndromic hearing loss 63","MONDO:0012670","AR","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5662","2017-02-15T00:00:00","Hearing Loss"
"LYST","HGNC:1968","Chediak-Higashi syndrome","MONDO:0008963","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5d752f7c-43d2-4ba9-910f-f286f5443012-2020-05-27T160000.000Z","2020-05-27T16:00:00.000Z","Hemostasis Thrombosis"
"LZTR1","HGNC:6742","Noonan syndrome","MONDO:0018997","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6f21db9c-87ea-4095-96ca-4277eaa21232-2020-04-23T170000.000Z","2020-04-23T17:00:00.000Z","RASopathy"
"LZTR1","HGNC:6742","Noonan syndrome","MONDO:0018997","AR","SOP7","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7aa1e103-4f77-4c50-99c5-621a6a837b95-2020-09-11T170000.000Z","2020-09-11T17:00:00.000Z","RASopathy"
"MAGEL2","HGNC:6814","Schaaf-Yang syndrome","MONDO:0014243","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aa89f10b-6ccf-4c69-aef3-fc2f6c8e6ea9-2021-06-01T160000.000Z","2021-06-01T16:00:00.000Z","Intellectual Disability and Autism"
"MAGI2","HGNC:18957","epilepsy","MONDO:0005027","XL","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7d622b88-9c77-47f8-93b1-808517da0cff-2018-06-19T160000.000Z","2018-06-19T16:00:00.000Z","Epilepsy"
"MAN1B1","HGNC:6823","MAN1B1-CDG","MONDO:0018349","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e0f50bc5-f7ac-4e0a-9762-d6cad9cc4585-2020-08-04T114702.993Z","2020-08-04T11:47:02.993Z","Intellectual Disability and Autism"
"MAOA","HGNC:6833","Brunner syndrome","MONDO:0010379","XL","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_20ffc014-ef31-4693-91c4-424bbe1e48dd-2020-04-14T203950.820Z","2020-04-14T20:39:50.820Z","Intellectual Disability and Autism"
"MAP2K1","HGNC:6840","Noonan syndrome","MONDO:0018997","AD","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1eafd4b1-29b1-4a17-a7ac-2c555f2e2648-2018-07-24T160000.000Z","2018-07-24T16:00:00.000Z","RASopathy"
"MAP2K1","HGNC:6840","Costello syndrome","MONDO:0009026","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8d28301c-df25-4c10-9edb-34be26f2838d-2018-07-24T160000.000Z","2018-07-24T16:00:00.000Z","RASopathy"
"MAP2K1","HGNC:6840","Noonan syndrome with multiple lentigines","MONDO:0007893","AD","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ee3071d5-ea0d-4804-ad61-3c6471f6a47e-2018-05-29T160000.000Z","2018-05-29T16:00:00.000Z","RASopathy"
"MAP2K1","HGNC:6840","cardiofaciocutaneous syndrome","MONDO:0015280","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f8c7a090-0a97-4653-bd51-702a9f9144b9-2018-05-29T160000.000Z","2018-05-29T16:00:00.000Z","RASopathy"
"MAP2K2","HGNC:6842","Noonan syndrome","MONDO:0018997","AD","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6a0eeefd-9105-435d-9daf-c748e52b0941-2018-06-01T160000.000Z","2018-06-01T16:00:00.000Z","RASopathy"
"MAP2K2","HGNC:6842","cardiofaciocutaneous syndrome","MONDO:0015280","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7765e2a4-19e4-4b15-9233-4847606fc501-2018-07-24T160000.000Z","2018-07-24T16:00:00.000Z","RASopathy"
"MAP3K20","HGNC:17797","myopathy, centronuclear, 6, with fiber-type disproportion","MONDO:0054695","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_03628749-51d6-437e-9816-1e32852645cf-2020-06-08T141802.817Z","2020-06-08T14:18:02.817Z","Congenital Myopathies"
"MAPKBP1","HGNC:29536","nephronophthisis 20","MONDO:0014997","AR","SOP8","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b8542450-d48b-45ba-bd5f-4e55d210aa6b-2021-05-26T160000.000Z","2021-05-26T16:00:00.000Z","Kidney Cystic and Ciliopathy Disorders"
"MARS1","HGNC:6898","Charcot-Marie-Tooth disease","MONDO:0015626","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8f042c42-893b-4c98-a719-0f778a54be43-2020-10-05T160651.479Z","2020-10-05T16:06:51.479Z","Charcot-Marie-Tooth"
"MARVELD2","HGNC:26401","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ba6df3f7-a000-401c-94d9-0dc5cb901f32-2018-08-29T191631.669Z","2018-08-29T19:16:31.669Z","Hearing Loss"
"MAT1A","HGNC:6903","methionine adenosyltransferase deficiency","MONDO:0009607","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_35cff382-98fe-4103-8edc-101f0c565a9e-2019-09-13T160000.000Z","2019-09-13T16:00:00.000Z","Aminoacidopathy"
"MAT2A","HGNC:6904","familial thoracic aortic aneurysm and aortic dissection","MONDO:0019625","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8263","2016-07-03T00:00:00","Heritable Thoracic Aortic Aneurysm and Dissection"
"MATR3","HGNC:6912","amyotrophic lateral sclerosis type 21","MONDO:0011632","AD","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_97ed1e35-c1b2-40c7-a60e-54b3c24004c4-2021-09-23T160000.000Z","2021-09-23T16:00:00.000Z","Amyotrophic Lateral Sclerosis Spectrum Disorders"
"MAX","HGNC:6913","hereditary pheochromocytoma-paraganglioma","MONDO:0017366","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f3ae9a06-6429-4b4b-b008-e1454511d5be-2021-06-16T144632.357Z","2021-06-16T14:46:32.357Z","Hereditary Cancer"
"MBD5","HGNC:20444","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_952cb4f8-e59b-4edb-a393-0266e0008963-2018-11-21T170000.000Z","2018-11-21T17:00:00.000Z","Intellectual Disability and Autism"
"MBTPS2","HGNC:15455","IFAP syndrome with or without BRESHECK syndrome","MONDO:0100213","XL","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_13a8a124-1071-4150-b6ea-0165cbf41c2d-2021-05-17T145233.620Z","2021-05-17T14:52:33.620Z","Intellectual Disability and Autism"
"MCCC1","HGNC:6936","3-methylcrotonyl-CoA carboxylase deficiency","MONDO:0018950","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6bd0c545-9ef8-4005-a124-a73be6178745-2019-10-25T160000.000Z","2019-10-25T16:00:00.000Z","Aminoacidopathy"
"MCCC2","HGNC:6937","3-methylcrotonyl-CoA carboxylase deficiency","MONDO:0018950","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3653ea30-b630-499a-a6f0-65152106ad8c-2019-10-25T160000.000Z","2019-10-25T16:00:00.000Z","Aminoacidopathy"
"MCEE","HGNC:16732","methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency","MONDO:0009615","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b8546531-fe3d-48fd-8103-f5f84fd04514-2020-07-09T160000.000Z","2020-07-09T16:00:00.000Z","Aminoacidopathy"
"MCFD2","HGNC:18451","factor 5 and Factor VIII, combined deficiency of, 2","MONDO:0013331","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_afa4ae2a-c40d-4f25-affe-852a67144cdd-2020-06-24T160000.000Z","2020-06-24T16:00:00.000Z","Hemostasis Thrombosis"
"MCM2","HGNC:6944","autosomal dominant nonsyndromic hearing loss 70","MONDO:0014853","AD","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9593","2018-01-04T00:00:00","Hearing Loss"
"MCM2","HGNC:6944","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_29172723-c896-4cbf-a20b-9921fc72547f-2020-04-21T190000.000Z","2020-04-21T19:00:00.000Z","Hearing Loss"
"MCPH1","HGNC:6954","hereditary breast carcinoma","MONDO:0016419","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8524","2017-01-11T00:00:00","Breast/Ovarian Cancer"
"MCPH1","HGNC:6954","familial ovarian cancer","MONDO:0016248","AD","SOP4","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8525","2017-01-11T00:00:00","Breast/Ovarian Cancer"
"MECP2","HGNC:6990","Rett syndrome","MONDO:0010726","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2df006ff-5ab4-4926-9b72-48909b09e608-2018-05-02T132629.570Z","2018-05-02T13:26:29.570Z","Rett and Angelman-like Disorders"
"MECR","HGNC:19691","Leigh syndrome","MONDO:0009723","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_75fcef99-f3fe-43b3-a544-a91f04ed1285-2021-06-14T142534.349Z","2021-06-14T14:25:34.349Z","Mitochondrial Diseases"
"MED12","HGNC:11957","MED12-related intellectual disability syndrome","MONDO:0100000","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_afba0573-9f47-4814-bf3a-ef41f5512dee-2018-04-27T193808.041Z","2018-04-27T19:38:08.041Z","Intellectual Disability and Autism"
"MED13L","HGNC:22962","syndromic intellectual disability","MONDO:0000508","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_41758f8d-1f99-47fa-beb6-c327fa6cb940-2021-04-21T040000.000Z","2021-04-21T04:00:00.000Z","Intellectual Disability and Autism"
"MED23","HGNC:2372","syndromic intellectual disability","MONDO:0000508","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6e8c75f0-39ae-4967-b95d-a92c55739876-2020-04-01T160000.000Z","2020-04-01T16:00:00.000Z","Intellectual Disability and Autism"
"MED25","HGNC:28845","Charcot-Marie-Tooth disease type 2B2","MONDO:0011570","AR","SOP8","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c0e0d66f-c68d-4df3-bab2-71afc448e4b0-2021-03-22T201527.084Z","2021-03-22T20:15:27.084Z","Charcot-Marie-Tooth"
"MEF2C","HGNC:6996","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_34354e8f-4343-4fba-82ba-e49579e504bb-2019-02-06T170000.000Z","2019-02-06T17:00:00.000Z","Intellectual Disability and Autism"
"MEGF10","HGNC:29634","MEGF10-Related Myopathy","MONDO:0013731","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1d00193c-b0fd-40b4-b5d5-51eecece9669-2020-01-27T170000.000Z","2020-01-27T17:00:00.000Z","Congenital Myopathies"
"MEGF8","HGNC:3233","MEGF8-related Carpenter syndrome","MONDO:0013998","AR","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dd9400f1-2c0b-4ffd-989a-486b81779a53-2021-12-23T193047.075Z","2021-12-23T19:30:47.075Z","Craniofacial Malformations"
"MEN1","HGNC:7010","multiple endocrine neoplasia type 1","MONDO:0007540","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a40ef20e-115c-4667-b4a2-6c7c8fb07a49-2020-05-13T170000.000Z","2020-05-13T17:00:00.000Z","Hereditary Cancer"
"MET","HGNC:7029","papillary renal cell carcinoma","MONDO:0017884","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a71d9990-7202-487a-b7a3-4e659e0be73c-2018-10-11T184745.818Z","2018-10-11T18:47:45.818Z","Hereditary Cancer"
"MET","HGNC:7029","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP8","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d55c61af-ef8e-475d-9ff7-454496cb6462-2021-01-19T170000.000Z","2021-01-19T17:00:00.000Z","Intellectual Disability and Autism"
"MET","HGNC:7029","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f0e6f9ac-f807-48fd-a5b6-bf67c4607e14-2021-03-26T160000.000Z","2021-03-26T16:00:00.000Z","Hearing Loss"
"MFAP5","HGNC:29673","familial thoracic aortic aneurysm and aortic dissection","MONDO:0019625","AD","SOP4","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8264","2016-12-22T00:00:00","Heritable Thoracic Aortic Aneurysm and Dissection"
"MFF","HGNC:24858","encephalopathy due to defective mitochondrial and peroxisomal fission 2","MONDO:0014905","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_021d15d7-dbf0-4b71-bbb5-48dc4a4b5ee6-2020-03-06T170000.000Z","2020-03-06T17:00:00.000Z","Peroxisomal Disorders"
"MFF","HGNC:24858","Leigh syndrome","MONDO:0009723","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4484881f-277f-47a2-b1dd-70072ec941e0-2021-04-09T141836.756Z","2021-04-09T14:18:36.756Z","Mitochondrial Diseases"
"MFSD8","HGNC:28486","neuronal ceroid lipofuscinosis","MONDO:0016295","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0f42cb66-5f28-4674-8f5a-76e15880bbfc-2020-12-15T170000.000Z","2020-12-15T17:00:00.000Z","Epilepsy"
"MIB1","HGNC:21086","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d97cecce-b9a7-42fb-bc2d-034468094949-2020-09-04T160000.000Z","2020-09-04T16:00:00.000Z","Dilated Cardiomyopathy"
"MID1","HGNC:7095","X-linked Opitz G/BBB syndrome","MONDO:0010222","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b2471967-d6b3-4ffb-a9fd-e3dbd089cb20-2018-03-21T160000.000Z","2018-03-21T16:00:00.000Z","Intellectual Disability and Autism"
"MIR96","HGNC:31648","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_01d1a7f4-8421-4be3-8fe7-2c2025f03ac9-2018-12-04T170000.000Z","2018-12-04T17:00:00.000Z","Hearing Loss"
"MITF","HGNC:7105","Waardenburg syndrome type 2","MONDO:0019517","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bc5d40d2-44b5-49b6-97a9-7bdfc39bee49-2018-07-26T161525.390Z","2018-07-26T16:15:25.390Z","Hearing Loss"
"MLH1","HGNC:7127","hereditary breast carcinoma","MONDO:0016419","AD","SOP4","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8526","2017-06-14T00:00:00","Breast/Ovarian Cancer"
"MLH1","HGNC:7127","colorectal cancer, hereditary nonpolyposis, type 2","MONDO:0012249","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9848","2017-07-10T00:00:00","Colon Cancer"
"MLH1","HGNC:7127","mismatch repair cancer syndrome 1","MONDO:0010159","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a313ad2e-5c2a-4bb4-bed4-3b4f9b5095df-2018-10-09T150623.105Z","2018-10-09T15:06:23.105Z","Hereditary Cancer"
"MLH3","HGNC:7128","hereditary nonpolyposis colon cancer","MONDO:0018630","AD","SOP4","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9860","2017-02-14T00:00:00","Colon Cancer"
"MLYCD","HGNC:7150","malonic aciduria","MONDO:0009556","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_70af8ffa-430b-4c69-bfa9-d6ba2f7b4f32-2018-06-26T160000.000Z","2018-06-26T16:00:00.000Z","Fatty Acid Oxidation Disorders"
"MMAA","HGNC:18871","vitamin B12-responsive methylmalonic acidemia type cblA","MONDO:0009613","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5b81bb9e-5f71-47bf-b187-5eef83d91d57-2021-02-12T142402.133Z","2021-02-12T14:24:02.133Z","Aminoacidopathy"
"MMAB","HGNC:19331","methylmalonic acidemia without homocystinuria","MONDO:0017390","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a238556a-5b89-413d-83d9-2d443b172c08-2021-02-17T192634.189Z","2021-02-17T19:26:34.189Z","Aminoacidopathy"
"MMACHC","HGNC:24525","methylmalonic aciduria and homocystinuria type cblC","MONDO:0010184","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6feb4bda-539f-4592-acaf-26dc186e953a-2020-06-29T174303.503Z","2020-06-29T17:43:03.503Z","Aminoacidopathy"
"MMADHC","HGNC:25221","inborn disorder of cobalamin metabolism and transport","MONDO:0019220","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_40ec59af-a143-4424-9218-7fd75deb6a61-2021-05-12T182739.747Z","2021-05-12T18:27:39.747Z","Aminoacidopathy"
"MMUT","HGNC:7526","methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency","MONDO:0009612","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3c5301da-0dad-417a-8257-5b1c6155e8fa-2019-05-09T160000.000Z","2019-05-09T16:00:00.000Z","Aminoacidopathy"
"MOGS","HGNC:24862","MOGS-CDG","MONDO:0011629","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5a628248-c2f9-4d31-b614-e082e3f83416-2021-07-20T130742.194Z","2021-07-20T13:07:42.194Z","General Inborn Errors of Metabolism"
"MORC2","HGNC:23573","Leigh syndrome","MONDO:0009723","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_23358115-fe60-41c7-b01e-44d1cb8329b1-2021-06-14T142952.247Z","2021-06-14T14:29:52.247Z","Mitochondrial Diseases"
"MPIG6B","HGNC:13937","thrombocytopenia, anemia, and myelofibrosis","MONDO:0044316","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_03b93956-5abe-41f2-ba14-1e57952606b3-2020-10-28T160000.000Z","2020-10-28T16:00:00.000Z","Hemostasis Thrombosis"
"MPL","HGNC:7217","thrombocythemia 2","MONDO:0011173","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_23b39955-2760-46aa-978b-d27d4a212567-2020-07-22T160000.000Z","2020-07-22T16:00:00.000Z","Hemostasis Thrombosis"
"MPL","HGNC:7217","congenital amegakaryocytic thrombocytopenia","MONDO:0011469","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d97f51ea-0148-483b-a18e-e61ee2e30690-2020-07-22T160000.000Z","2020-07-22T16:00:00.000Z","Hemostasis Thrombosis"
"MPZ","HGNC:7225","Charcot-Marie-Tooth disease","MONDO:0015626","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_11f638d2-d8d2-4fe4-ab79-acff5cf32a18-2020-08-25T160000.000Z","2020-08-25T16:00:00.000Z","Charcot-Marie-Tooth"
"MPZL2","HGNC:3496","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP8","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_046d28d7-60d8-4c7e-a901-37c86fa6a77e-2021-03-26T160000.000Z","2021-03-26T16:00:00.000Z","Hearing Loss"
"MRAS","HGNC:7227","Noonan syndrome","MONDO:0018997","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_04ca29c1-6b44-474c-b54b-1c8be52de172-2020-08-27T160000.000Z","2020-08-27T16:00:00.000Z","RASopathy"
"MRE11","HGNC:7230","hereditary breast carcinoma","MONDO:0016419","AD","SOP4","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9900","2017-10-25T00:00:00","Breast/Ovarian Cancer"
"MRE11","HGNC:7230","familial ovarian cancer","MONDO:0016248","AD","SOP4","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9901","2017-10-25T00:00:00","Breast/Ovarian Cancer"
"MRPS34","HGNC:16618","Leigh syndrome","MONDO:0009723","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_41d20487-f150-41b6-947c-ce77e405e8de-2020-08-27T162259.700Z","2020-08-27T16:22:59.700Z","Mitochondrial Diseases"
"MSH2","HGNC:7325","hereditary breast carcinoma","MONDO:0016419","AD","SOP4","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10084","2017-10-11T00:00:00","Breast/Ovarian Cancer"
"MSH2","HGNC:7325","Lynch syndrome","MONDO:0005835","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9849","2017-09-11T00:00:00","Colon Cancer"
"MSH2","HGNC:7325","mismatch repair cancer syndrome 1","MONDO:0010159","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7ce2b2b9-9b04-4a47-b6fa-b85c60ba1c08-2018-10-09T144400.302Z","2018-10-09T14:44:00.302Z","Hereditary Cancer"
"MSH3","HGNC:7326","MSH3-related attenuated familial adenomatous polyposis","MONDO:0018812","AR","SOP4","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9896","2016-12-13T00:00:00","Colon Cancer"
"MSH3","HGNC:7326","hereditary nonpolyposis colon cancer","MONDO:0018630","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9897","2017-11-13T00:00:00","Colon Cancer"
"MSH6","HGNC:7329","hereditary breast carcinoma","MONDO:0016419","AD","SOP4","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8531","2017-07-26T00:00:00","Breast/Ovarian Cancer"
"MSH6","HGNC:7329","Lynch syndrome","MONDO:0005835","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9850","2017-09-25T00:00:00","Colon Cancer"
"MSH6","HGNC:7329","mismatch repair cancer syndrome 1","MONDO:0010159","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b7d02927-ac93-4a43-a86d-01cd381f4e9f-2018-10-09T145726.378Z","2018-10-09T14:57:26.378Z","Hereditary Cancer"
"MSRB3","HGNC:27375","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ea7c7e0-dc56-4484-b2b6-5e3899d04013-2021-11-30T170000.000Z","2021-11-30T17:00:00.000Z","Hearing Loss"
"MSX2","HGNC:7392","parietal foramina","MONDO:0018953","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2bb862dd-e6d2-4dc8-a7f3-3a03d58f9ade-2020-07-08T170000.000Z","2020-07-08T17:00:00.000Z","Craniofacial Malformations"
"MSX2","HGNC:7392","craniosynostosis 2","MONDO:0011481","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ac8a9313-9ef2-4556-9a25-db7fa2ed99ed-2020-09-28T170000.000Z","2020-09-28T17:00:00.000Z","Craniofacial Malformations"
"MT-ATP6","HGNC:7414","Leigh syndrome","MONDO:0009723","MT","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e492464b-cb98-4bf4-a12e-169b59576b04-2021-06-28T145350.161Z","2021-06-28T14:53:50.161Z","Mitochondrial Diseases"
"MT-CO1","HGNC:7419","Leigh syndrome","MONDO:0009723","MT","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_227922e2-1f4e-4bd5-9fc2-d48bac5d394f-2021-06-28T143540.269Z","2021-06-28T14:35:40.269Z","Mitochondrial Diseases"
"MT-CO2","HGNC:7421","Leigh syndrome","MONDO:0009723","MT","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_41d6a25c-4300-4e43-b0f8-1923ff3ddad8-2021-06-28T144136.451Z","2021-06-28T14:41:36.451Z","Mitochondrial Diseases"
"MT-CO3","HGNC:7422","Leigh syndrome","MONDO:0009723","MT","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_996428ee-5af2-458b-afb7-6e29348c585a-2021-06-28T144716.059Z","2021-06-28T14:47:16.059Z","Mitochondrial Diseases"
"MT-ND5","HGNC:7461","Leigh syndrome","MONDO:0009723","MT","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e941d385-716f-4264-8f24-ffe3022579e2-2021-06-14T155537.548Z","2021-06-14T15:55:37.548Z","Mitochondrial Diseases"
"MT-TK","HGNC:7489","Leigh syndrome","MONDO:0009723","MT","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3f237644-83f5-412e-9bfa-01fbd280c15a-2021-06-28T155537.306Z","2021-06-28T15:55:37.306Z","Mitochondrial Diseases"
"MT-TL1","HGNC:7490","Leigh syndrome","MONDO:0009723","MT","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_efef782a-88db-470d-9687-23629c75e05a-2021-06-28T154710.419Z","2021-06-28T15:47:10.419Z","Mitochondrial Diseases"
"MT-TW","HGNC:7501","Leigh syndrome","MONDO:0009723","MT","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3dc54202-27f3-4bf4-883f-5273a49dcb70-2021-06-28T150550.120Z","2021-06-28T15:05:50.120Z","Mitochondrial Diseases"
"MTAP","HGNC:7413","diaphyseal medullary stenosis-bone malignancy syndrome","MONDO:0007205","AD","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3c2243ec-a10f-4aab-aaf9-99153d805455-2021-06-15T232951.915Z","2021-06-15T23:29:51.915Z","Hereditary Cancer"
"MTFMT","HGNC:29666","Leigh syndrome","MONDO:0009723","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0e7a00ee-ef09-443f-9d66-03128e1fb225-2020-03-19T194517.723Z","2020-03-19T19:45:17.723Z","Mitochondrial Diseases"
"MTHFR","HGNC:7436","homocystinuria due to methylene tetrahydrofolate reductase deficiency","MONDO:0009353","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cbfc5297-ed0d-4d7c-bca6-747114ed2b17-2019-06-18T160000.000Z","2019-06-18T16:00:00.000Z","Aminoacidopathy"
"MTM1","HGNC:7448","X-linked centronuclear myopathy","MONDO:0010683","XL","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2b60f008-871f-4c5f-aa46-099d09fb66df-2019-11-22T170000.000Z","2019-11-22T17:00:00.000Z","Congenital Myopathies"
"MTMR2","HGNC:7450","demyelinating hereditary motor and sensory neuropathy","MONDO:0018776","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_44a837e2-ae06-4e4d-b7cf-ae2a3009b47d-2020-02-11T170000.000Z","2020-02-11T17:00:00.000Z","Charcot-Marie-Tooth"
"MTOR","HGNC:3942","overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes","MONDO:0100283","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_92ce0145-031d-41c4-8b74-0f9411629b64-2021-07-29T213256.506Z","2021-07-29T21:32:56.506Z","Brain Malformations"
"MTR","HGNC:7468","methylcobalamin deficiency type cblG","MONDO:0009609","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1572b7da-1736-4a44-9420-d9734d53f950-2021-07-02T160000.000Z","2021-07-02T16:00:00.000Z","Aminoacidopathy"
"MTRFR","HGNC:26784","Leigh syndrome","MONDO:0009723","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_78f97463-d8b2-411a-9292-1908646dac77-2021-04-01T174500.572Z","2021-04-01T17:45:00.572Z","Mitochondrial Diseases"
"MTRR","HGNC:7473","methylcobalamin deficiency type cblE","MONDO:0009354","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_905575cf-cb80-4038-b82b-1de3ae1c469d-2021-07-02T160000.000Z","2021-07-02T16:00:00.000Z","Aminoacidopathy"
"MUTYH","HGNC:7527","MUTYH-related attenuated familial adenomatous polyposis","MONDO:0012041","AD","SOP4","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10072","2017-10-09T00:00:00","Colon Cancer"
"MUTYH","HGNC:7527","MUTYH-related attenuated familial adenomatous polyposis","MONDO:0012041","AR","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9855","2017-06-12T00:00:00","Colon Cancer"
"MUTYH","HGNC:7527","hereditary breast carcinoma","MONDO:0016419","AD","SOP4","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9902","2017-05-25T00:00:00","Breast/Ovarian Cancer"
"MUTYH","HGNC:7527","familial ovarian cancer","MONDO:0016248","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9903","2017-11-29T00:00:00","Breast/Ovarian Cancer"
"MUTYH","HGNC:7527","hereditary breast carcinoma","MONDO:0016419","AR","SOP4","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9904","2017-05-24T00:00:00","Breast/Ovarian Cancer"
"MUTYH","HGNC:7527","familial ovarian cancer","MONDO:0016248","AR","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9905","2017-11-29T00:00:00","Breast/Ovarian Cancer"
"MYBPC3","HGNC:7551","hypertrophic cardiomyopathy 4","MONDO:0007268","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10061","2017-09-05T13:00:00","Hypertrophic Cardiomyopathy"
"MYBPC3","HGNC:7551","arrhythmogenic right ventricular cardiomyopathy","MONDO:0016587","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0639d989-8415-425c-ab89-e8a3a0b6ea49-2019-08-06T160000.000Z","2019-08-06T16:00:00.000Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"MYBPC3","HGNC:7551","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_652d0370-9574-450c-b7c4-eec86ade9046-2020-09-04T160000.000Z","2020-09-04T16:00:00.000Z","Dilated Cardiomyopathy"
"MYH11","HGNC:7569","familial thoracic aortic aneurysm and aortic dissection","MONDO:0019625","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8252","2016-07-03T00:00:00","Heritable Thoracic Aortic Aneurysm and Dissection"
"MYH14","HGNC:23212","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_007697a5-2f83-40d0-b2ea-914e458a1452-2020-08-31T170000.000Z","2020-08-31T17:00:00.000Z","Hearing Loss"
"MYH2","HGNC:7572","myopathy, proximal, and ophthalmoplegia","MONDO:0011577","SD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_72e37c65-570c-4d1c-b749-61d8981a6f21-2020-03-09T160000.000Z","2020-03-09T16:00:00.000Z","Congenital Myopathies"
"MYH6","HGNC:7576","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10074","2017-11-01T00:00:00","Hypertrophic Cardiomyopathy"
"MYH6","HGNC:7576","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6d55ac7b-e9d8-4a97-bb20-92beeffaed96-2020-09-04T160000.000Z","2020-09-04T16:00:00.000Z","Dilated Cardiomyopathy"
"MYH7","HGNC:7577","arrhythmogenic right ventricular cardiomyopathy","MONDO:0016587","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0265f091-a67d-4521-b6bd-5a110bd5356f-2019-08-06T160000.000Z","2019-08-06T16:00:00.000Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"MYH7","HGNC:7577","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_31325c90-05cb-4db0-9372-e4f705cd5c82-2021-03-16T004905.482Z","2021-03-16T00:49:05.482Z","Hypertrophic Cardiomyopathy"
"MYH7","HGNC:7577","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4ec27d4f-70ea-4c6a-ad67-d6260ecadcde-2020-11-13T170000.000Z","2020-11-13T17:00:00.000Z","Dilated Cardiomyopathy"
"MYH7","HGNC:7577","MYH7-related skeletal myopathy","MONDO:0008050","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8974721a-f333-4fb7-b8b7-043233d3d100-2021-05-13T160000.000Z","2021-05-13T16:00:00.000Z","Congenital Myopathies"
"MYH9","HGNC:7579","macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss","MONDO:0015912","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d6801442-c490-44a0-9a60-84ab5b20f7ac-2018-07-17T191819.148Z","2018-07-17T19:18:19.148Z","Hearing Loss"
"MYL1","HGNC:7582","congenital myopathy","MONDO:0019952","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1c69fb71-4553-473e-94b7-a8c34af84739-2020-04-13T190000.000Z","2020-04-13T19:00:00.000Z","Congenital Myopathies"
"MYL2","HGNC:7583","hypertrophic cardiomyopathy 10","MONDO:0012112","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8768","2017-02-07T16:00:00","Hypertrophic Cardiomyopathy"
"MYL2","HGNC:7583","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7b25ff6c-3ede-46a3-a637-3eab7aa18569-2021-07-13T154913.625Z","2021-07-13T15:49:13.625Z","Hypertrophic Cardiomyopathy"
"MYL2","HGNC:7583","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8405609b-1664-4849-848e-bec138350c92-2020-10-09T160000.000Z","2020-10-09T16:00:00.000Z","Dilated Cardiomyopathy"
"MYL2","HGNC:7583","arrhythmogenic right ventricular cardiomyopathy","MONDO:0016587","AD","SOP7","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b1db17cf-199d-4bd7-9673-e8f06219fc26-2019-05-24T160000.000Z","2019-05-24T16:00:00.000Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"MYL3","HGNC:7584","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6fdf5074-f853-473c-bd04-2c95c172b98a-2020-10-09T160000.000Z","2020-10-09T16:00:00.000Z","Dilated Cardiomyopathy"
"MYL3","HGNC:7584","arrhythmogenic right ventricular cardiomyopathy","MONDO:0016587","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b1d5e9bf-ca57-445a-a432-27fe221484bf-2019-09-13T160000.000Z","2019-09-13T16:00:00.000Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"MYL3","HGNC:7584","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d74b9d56-4f2a-4479-8913-1d96ddc28592-2021-06-07T145050.605Z","2021-06-07T14:50:50.605Z","Hypertrophic Cardiomyopathy"
"MYLK","HGNC:7590","familial thoracic aortic aneurysm and aortic dissection","MONDO:0019625","AD","SOP4","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8257","2016-12-18T00:00:00","Heritable Thoracic Aortic Aneurysm and Dissection"
"MYLK2","HGNC:16243","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6f0f41e3-7b5b-477c-b45d-598b5f8f3df0-2017-04-17T160000.000Z","2017-04-17T16:00:00.000Z","Hypertrophic Cardiomyopathy"
"MYO15A","HGNC:7594","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2cf0898e-5e63-4327-9341-fdf26490beee-2017-11-21T170000.000Z","2017-11-21T17:00:00.000Z","Hearing Loss"
"MYO18B","HGNC:18150","Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome","MONDO:0014689","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_00998e50-dd3f-4bfa-8500-34d34980d5c8-2021-06-28T160000.000Z","2021-06-28T16:00:00.000Z","Congenital Myopathies"
"MYO1A","HGNC:7595","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP6","Refuted","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3dcc24f7-4cf7-413b-a956-16ad58bcbd36-2018-01-16T170000.000Z","2018-01-16T17:00:00.000Z","Hearing Loss"
"MYO1C","HGNC:7597","autosomal dominant nonsyndromic hearing loss","MONDO:0019587","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f27e3d88-0a3d-44f8-bbbc-1f668e596541-2018-06-28T175437.828Z","2018-06-28T17:54:37.828Z","Hearing Loss"
"MYO1F","HGNC:7600","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c422abbd-4f16-4da0-8569-d5d7138be488-2018-08-22T191519.097Z","2018-08-22T19:15:19.097Z","Hearing Loss"
"MYO3A","HGNC:7601","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a8fa3d7b-73a2-43a3-8f13-7dac3fd27737-2017-11-15T170000.000Z","2017-11-15T17:00:00.000Z","Hearing Loss"
"MYO5A","HGNC:7602","Griscelli syndrome type 1","MONDO:0008962","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_792cf7b2-5ca7-4d85-95a5-a43eaa52b180-2021-07-27T144901.941Z","2021-07-27T14:49:01.941Z","Syndromic Disorders"
"MYO6","HGNC:7605","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_50d408fe-e298-4683-985c-57a37b30e273-2018-02-20T170000.000Z","2018-02-20T17:00:00.000Z","Hearing Loss"
"MYO7A","HGNC:7606","Usher syndrome type 1","MONDO:0010168","AR","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1e897a2f-d4cf-4e13-85d8-f37405a09b18-2018-06-29T153730.271Z","2018-06-29T15:37:30.271Z","Hearing Loss"
"MYO7A","HGNC:7606","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_598b33f0-cdad-4290-b6eb-f9c2304c7bb6-2018-03-19T160000.000Z","2018-03-19T16:00:00.000Z","Hearing Loss"
"MYO9A","HGNC:7608","arthrogryposis syndrome","MONDO:0015225","AR","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5465","2016-11-24T00:00:00","General Gene Curation"
"MYOM1","HGNC:7613","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8ff00fbf-6b20-49cd-8af8-0f6404240db5-2018-08-01T185128.725Z","2018-08-01T18:51:28.725Z","Hypertrophic Cardiomyopathy"
"MYOZ2","HGNC:1330","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d74395ba-66ee-43c6-8d3c-c353bd8e5e82-2018-08-01T154603.482Z","2018-08-01T15:46:03.482Z","Hypertrophic Cardiomyopathy"
"MYPN","HGNC:23246","MYPN-related myopathy","MONDO:0015023","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6aeb67cc-c960-4511-a708-b0acadb34588-2020-06-17T194636.472Z","2020-06-17T19:46:36.472Z","Congenital Myopathies"
"MYPN","HGNC:23246","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d992d892-856b-4f25-bab1-997f6493018c-2020-05-01T133957.037Z","2020-05-01T13:39:57.037Z","Hypertrophic Cardiomyopathy"
"MYPN","HGNC:23246","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ffd924ad-55ce-4b05-8a91-584ef49b4e80-2020-10-09T160000.000Z","2020-10-09T16:00:00.000Z","Dilated Cardiomyopathy"
"MYT1L","HGNC:7623","syndromic intellectual disability","MONDO:0000508","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_32897f25-e36a-4ec8-9401-0374a95e06a5-2020-08-18T160000.000Z","2020-08-18T16:00:00.000Z","Intellectual Disability and Autism"
"NAA10","HGNC:18704","NAA10-related syndrome","MONDO:0100124","XL","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fcdd3d02-82f3-4ea3-a2b0-8ac2d4c40b1b-2020-09-02T005020.640Z","2020-09-02T00:50:20.640Z","Intellectual Disability and Autism"
"NADK2","HGNC:26404","progressive encephalopathy with leukodystrophy due to DECR deficiency","MONDO:0014464","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_285bdfcd-10c2-48f9-9be9-d77894b26f19-2020-12-01T170000.000Z","2020-12-01T17:00:00.000Z","Fatty Acid Oxidation Disorders"
"NAGS","HGNC:17996","hyperammonemia due to N-acetylglutamate synthase deficiency","MONDO:0009377","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_33dcead1-e3d9-4427-98fd-05a655c8c213-2019-07-26T160000.000Z","2019-07-26T16:00:00.000Z","Aminoacidopathy"
"NARS2","HGNC:26274","Leigh syndrome","MONDO:0009723","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8874861d-9d28-440d-a751-54c22df0d4ad-2019-12-19T190722.572Z","2019-12-19T19:07:22.572Z","Mitochondrial Diseases"
"NARS2","HGNC:26274","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9db16e79-4c14-437f-9723-749f99053d5c-2021-11-17T170000.000Z","2021-11-17T17:00:00.000Z","Hearing Loss"
"NAT8L","HGNC:26742","N-acetylaspartate deficiency","MONDO:0013549","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_854ce0ef-7744-483d-87c7-b2dc436f9f0f-2020-10-23T171820.214Z","2020-10-23T17:18:20.214Z","Aminoacidopathy"
"NAXE","HGNC:18453","Leigh syndrome","MONDO:0009723","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a062b287-a561-4c3e-942a-3379dee307c8-2021-04-09T142130.880Z","2021-04-09T14:21:30.880Z","Mitochondrial Diseases"
"NBEA","HGNC:7648","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f40357db-6cc2-4240-8771-1206cd27298a-2020-12-02T170000.000Z","2020-12-02T17:00:00.000Z","Intellectual Disability and Autism"
"NBEAL2","HGNC:31928","gray platelet syndrome","MONDO:0007686","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ae8bd4d6-8810-423b-83e0-98667f06426d-2019-06-26T160000.000Z","2019-06-26T16:00:00.000Z","Hemostasis Thrombosis"
"NBN","HGNC:7652","hereditary breast carcinoma","MONDO:0016419","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9906","2017-09-27T00:00:00","Breast/Ovarian Cancer"
"NBN","HGNC:7652","Nijmegen breakage syndrome","MONDO:0009623","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_de6fa1fe-a86e-4f0d-8da8-7690debe9aec-2019-08-14T193132.776Z","2019-08-14T19:31:32.776Z","Hereditary Cancer"
"NDP","HGNC:7678","Norrie disease","MONDO:0010691","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_335ce5aa-7f87-4b91-a447-928399f40f11-2018-03-21T160000.000Z","2018-03-21T16:00:00.000Z","Intellectual Disability and Autism"
"NDUFA1","HGNC:7683","Leigh syndrome","MONDO:0009723","XL","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_497170a6-a042-46cb-9809-3c3094fcd05e-2019-05-20T184847.372Z","2019-05-20T18:48:47.372Z","Mitochondrial Diseases"
"NDUFA10","HGNC:7684","Leigh syndrome","MONDO:0009723","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e40eec3c-0ce0-442e-9058-6bf4d90d6dc3-2019-11-25T162049.949Z","2019-11-25T16:20:49.949Z","Mitochondrial Diseases"
"NDUFA12","HGNC:23987","Leigh syndrome","MONDO:0009723","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_81f38f43-5e0c-4cb8-9be8-091f2c8a2c71-2019-11-25T160815.348Z","2019-11-25T16:08:15.348Z","Mitochondrial Diseases"
"NDUFA13","HGNC:17194","Leigh syndrome","MONDO:0009723","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0bc56951-c454-4e79-95f3-7ffda20482b7-2021-01-21T005411.435Z","2021-01-21T00:54:11.435Z","Mitochondrial Diseases"
"NDUFA2","HGNC:7685","Leigh syndrome","MONDO:0009723","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3f40eb04-1cc3-477c-ab0a-c8162958fd4f-2019-05-20T190623.871Z","2019-05-20T19:06:23.871Z","Mitochondrial Diseases"
"NDUFA4","HGNC:7687","Leigh syndrome","MONDO:0009723","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2854d105-0d20-4a19-9dee-d7aa6a60ed99-2021-01-14T214439.481Z","2021-01-14T21:44:39.481Z","Mitochondrial Diseases"
"NDUFA9","HGNC:7693","Leigh syndrome","MONDO:0009723","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_87c6c5c5-7bf7-4bd2-94f0-2d529a512e74-2019-11-25T162851.567Z","2019-11-25T16:28:51.567Z","Mitochondrial Diseases"
"NDUFAF2","HGNC:28086","Leigh syndrome","MONDO:0009723","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7c26c06d-17dc-4783-8145-5de35c9a73f5-2020-11-23T193634.959Z","2020-11-23T19:36:34.959Z","Mitochondrial Diseases"
"NDUFAF4","HGNC:21034","Leigh syndrome","MONDO:0009723","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2df4e73b-a8a5-4ce2-bab6-2be732d3c542-2020-02-12T194734.160Z","2020-02-12T19:47:34.160Z","Mitochondrial Diseases"
"NDUFAF5","HGNC:15899","Leigh syndrome","MONDO:0009723","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_55a2c102-f05d-4ff1-9527-3a55fb3f00c3-2021-04-09T135236.631Z","2021-04-09T13:52:36.631Z","Mitochondrial Diseases"
"NDUFAF6","HGNC:28625","Leigh syndrome","MONDO:0009723","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f7b6ace1-5b89-41c7-83a6-d6f37826d8c5-2020-11-23T194212.660Z","2020-11-23T19:42:12.660Z","Mitochondrial Diseases"
"NDUFAF8","HGNC:33551","Leigh syndrome","MONDO:0009723","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3459bec0-88a8-463b-a135-54670357137a-2021-04-01T195856.777Z","2021-04-01T19:58:56.777Z","Mitochondrial Diseases"
"NDUFB8","HGNC:7703","Leigh syndrome","MONDO:0009723","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bef2c930-4b79-4938-8325-94a0f58cdfd9-2021-01-21T004458.566Z","2021-01-21T00:44:58.566Z","Mitochondrial Diseases"
"NDUFC2","HGNC:7706","Leigh syndrome","MONDO:0009723","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3d819bce-43ed-45a3-a16b-74033d432272-2021-01-21T004055.963Z","2021-01-21T00:40:55.963Z","Mitochondrial Diseases"
"NDUFS1","HGNC:7707","Leigh syndrome","MONDO:0009723","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b6995e66-f840-485a-a635-b64cb9f45cd9-2019-06-20T161718.750Z","2019-06-20T16:17:18.750Z","Mitochondrial Diseases"
"NDUFS2","HGNC:7708","Leigh syndrome","MONDO:0009723","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6df726c1-2897-46f8-aed1-f9939b9acf0c-2021-04-09T143144.546Z","2021-04-09T14:31:44.546Z","Mitochondrial Diseases"
"NDUFS3","HGNC:7710","Leigh syndrome","MONDO:0009723","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4ae2af25-4fc1-48c3-a289-fae04977b192-2019-06-20T162502.779Z","2019-06-20T16:25:02.779Z","Mitochondrial Diseases"
"NDUFS4","HGNC:7711","Leigh syndrome","MONDO:0009723","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1ed6ae7f-8c64-4ca3-a71b-6e97ae21d71d-2019-04-08T162953.550Z","2019-04-08T16:29:53.550Z","Mitochondrial Diseases"
"NDUFS7","HGNC:7714","Leigh syndrome","MONDO:0009723","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b702a150-de60-429e-bb12-ba8cde1483e7-2019-11-25T160008.570Z","2019-11-25T16:00:08.570Z","Mitochondrial Diseases"
"NDUFS8","HGNC:7715","Leigh syndrome","MONDO:0009723","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_01a27520-f92a-4b81-b63b-c15132c873be-2019-11-25T152406.734Z","2019-11-25T15:24:06.734Z","Mitochondrial Diseases"
"NDUFV1","HGNC:7716","Leigh syndrome","MONDO:0009723","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1b96e332-59c4-4636-8bdf-bf893ea059f1-2019-11-26T163430.120Z","2019-11-26T16:34:30.120Z","Mitochondrial Diseases"
"NDUFV2","HGNC:7717","Leigh syndrome","MONDO:0009723","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1266aed1-8c25-4b28-bf8a-a0e16d9b3da9-2019-11-25T145748.766Z","2019-11-25T14:57:48.766Z","Mitochondrial Diseases"
"NEB","HGNC:7720","nemaline myopathy 2","MONDO:0009725","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_796dd762-f35c-425a-be3f-05424324ade0-2019-10-21T160000.000Z","2019-10-21T16:00:00.000Z","Congenital Myopathies"
"NEBL","HGNC:16932","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_29bc6c4f-3f2d-45e2-b796-a79616857094-2020-09-25T160000.000Z","2020-09-25T16:00:00.000Z","Dilated Cardiomyopathy"
"NEDD4L","HGNC:7728","periventricular nodular heterotopia 7","MONDO:0014966","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b131d46a-069b-4c2e-a290-e7df2519a2df-2021-11-30T170000.000Z","2021-11-30T17:00:00.000Z","Brain Malformations"
"NEFH","HGNC:7737","Charcot-Marie-Tooth disease axonal type 2CC","MONDO:0014836","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8e1390ea-fd6c-4fa4-9b43-0eccff9e2829-2020-10-05T161645.817Z","2020-10-05T16:16:45.817Z","Charcot-Marie-Tooth"
"NEK8","HGNC:13387","renal-hepatic-pancreatic dysplasia 2","MONDO:0014174","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6888a91a-6589-42a9-9622-553b4918bed6-2021-10-05T220942.997Z","2021-10-05T22:09:42.997Z","Kidney Cystic and Ciliopathy Disorders"
"NEUROD1","HGNC:7762","monogenic diabetes","MONDO:0015967","AD","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8f4e7f54-becc-432e-9827-514c783e6bc1-2021-10-13T170637.558Z","2021-10-13T17:06:37.558Z","Monogenic Diabetes"
"NEUROD1","HGNC:7762","monogenic diabetes","MONDO:0015967","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9ace1b58-44d4-4479-9328-0871a8fb0e9f-2021-03-10T172754.003Z","2021-03-10T17:27:54.003Z","Monogenic Diabetes"
"NEXMIF","HGNC:29433","X-linked complex neurodevelopmental disorder","MONDO:0100148","XL","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_191437ab-2e73-4a0b-a660-ab5eab4c1066-2020-02-05T170000.000Z","2020-02-05T17:00:00.000Z","Intellectual Disability and Autism"
"NEXN","HGNC:29557","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9456bdef-7708-45b2-a698-c897167d7f5b-2016-10-28T160000.000Z","2016-10-28T16:00:00.000Z","Hypertrophic Cardiomyopathy"
"NEXN","HGNC:29557","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ffe00b43-a449-4476-b7e0-f24cf6613766-2020-08-12T160000.000Z","2020-08-12T16:00:00.000Z","Dilated Cardiomyopathy"
"NF1","HGNC:7765","familial ovarian cancer","MONDO:0016248","AD","SOP4","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10082","2017-02-22T00:00:00","Breast/Ovarian Cancer"
"NF1","HGNC:7765","neurofibromatosis type 1","MONDO:0018975","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_367a3958-ce81-47fa-a505-a451ca67aab5-2019-03-05T170000.000Z","2019-03-05T17:00:00.000Z","General Gene Curation"
"NF2","HGNC:7773","neurofibromatosis type 2","MONDO:0007039","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a185a859-a499-4c4a-bebe-996b16fb3cf3-2019-02-27T170000.000Z","2019-02-27T17:00:00.000Z","General Gene Curation"
"NFKB1","HGNC:7794","immunodeficiency, common variable, 12","MONDO:0014697","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e922c85d-f51a-4394-8906-cf01978d8154-2021-05-14T152859.709Z","2021-05-14T15:28:59.709Z","Antibody Deficiencies GCEP"
"NFKB2","HGNC:7795","immunodeficiency, common variable, 10","MONDO:0014260","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_61b546f1-5683-4588-a5bc-030ebbd5b401-2021-10-13T132601.192Z","2021-10-13T13:26:01.192Z","Antibody Deficiencies GCEP"
"NFKBIZ","HGNC:29805","hereditary nonpolyposis colon cancer","MONDO:0018630","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9867","2017-07-10T00:00:00","Colon Cancer"
"NGLY1","HGNC:17646","NGLY1-deficiency","MONDO:0014109","AR","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5619","2016-12-01T00:00:00","General Gene Curation"
"NHEJ1","HGNC:25737","Cernunnos-XLF deficiency","MONDO:0012650","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_765b118e-c60a-4696-b401-f63b3349d6d2-2021-05-20T151233.276Z","2021-05-20T15:12:33.276Z","SCID-CID"
"NHLRC1","HGNC:21576","Lafora disease","MONDO:0009697","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c4dbe715-b897-482d-afeb-b05c0653a79a-2020-03-03T170000.000Z","2020-03-03T17:00:00.000Z","Epilepsy"
"NHP2","HGNC:14377","dyskeratosis congenita","MONDO:0015780","AR","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3201","2017-01-25T00:00:00","General Gene Curation"
"NHS","HGNC:7820","Nance-Horan syndrome","MONDO:0010545","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9520","2017-10-20T00:00:00","Intellectual Disability and Autism"
"NIPBL","HGNC:28862","Cornelia de Lange syndrome","MONDO:0016033","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d4ecc430-6562-4d58-9118-c5253dc95ae9-2018-06-20T144433.262Z","2018-06-20T14:44:33.262Z","Intellectual Disability and Autism"
"NKX2-5","HGNC:2488","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6335de7f-71db-4768-8fa0-6faebd0ea0e8-2020-11-06T170000.000Z","2020-11-06T17:00:00.000Z","Dilated Cardiomyopathy"
"NLGN3","HGNC:14289","X-linked complex neurodevelopmental disorder","MONDO:0100148","XL","SOP5","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b6e7e531-093b-4216-8c56-0c94e63c2811-2018-08-15T040000.000Z","2018-08-15T04:00:00.000Z","Intellectual Disability and Autism"
"NLGN4X","HGNC:14287","X-linked complex neurodevelopmental disorder","MONDO:0100148","XL","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bed32aec-b1a6-41ff-9607-b4172888c46a-2018-08-01T160000.000Z","2018-08-01T16:00:00.000Z","Intellectual Disability and Autism"
"NOD2","HGNC:5331","Blau syndrome","MONDO:0008523","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1fd650d7-6a84-4b33-b86e-d34cab5b7d57-2020-10-07T171807.983Z","2020-10-07T17:18:07.983Z","Syndromic Disorders"
"NOTCH1","HGNC:7881","familial thoracic aortic aneurysm and aortic dissection","MONDO:0019625","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8269","2016-04-06T00:00:00","Heritable Thoracic Aortic Aneurysm and Dissection"
"NPHP1","HGNC:7905","nephronophthisis 1","MONDO:0009728","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_abc69434-e9e6-4a2b-96b6-b7186f40021f-2021-01-27T170000.000Z","2021-01-27T17:00:00.000Z","Kidney Cystic and Ciliopathy Disorders"
"NPHP4","HGNC:19104","nephronophthisis 4","MONDO:0011752","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cafd0d51-dd5d-4691-8725-86518345b097-2021-02-10T170000.000Z","2021-02-10T17:00:00.000Z","Kidney Cystic and Ciliopathy Disorders"
"NPPA","HGNC:7939","dilated cardiomyopathy","MONDO:0005021","AR","SOP7","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d85124b6-b754-4a0f-bbe4-3bbf1ca95283-2020-09-04T160000.000Z","2020-09-04T16:00:00.000Z","Dilated Cardiomyopathy"
"NR4A2","HGNC:7981","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c8923fda-35f3-47e3-a987-8ca2b86e4b92-2021-05-05T160000.000Z","2021-05-05T16:00:00.000Z","Intellectual Disability and Autism"
"NRAS","HGNC:7989","Costello syndrome","MONDO:0009026","AD","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_28526e91-0db9-4724-94f3-e4222ace602c-2018-07-24T160000.000Z","2018-07-24T16:00:00.000Z","RASopathy"
"NRAS","HGNC:7989","Noonan syndrome","MONDO:0018997","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_34419b69-59c3-458b-a2a5-38a401679deb-2018-05-30T160000.000Z","2018-05-30T16:00:00.000Z","RASopathy"
"NRAS","HGNC:7989","cardiofaciocutaneous syndrome","MONDO:0015280","AD","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d466df2a-8e3d-4d4a-bb96-8e483d4c56e7-2018-07-24T160000.000Z","2018-07-24T16:00:00.000Z","RASopathy"
"NRAS","HGNC:7989","Noonan syndrome with multiple lentigines","MONDO:0007893","AD","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e5622684-4367-4d90-b769-f7205ee1cac8-2018-05-30T160000.000Z","2018-05-30T16:00:00.000Z","RASopathy"
"NRXN1","HGNC:8008","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_14bb833a-eefd-4f02-b112-c74b6866d5be-2019-07-10T160000.000Z","2019-07-10T16:00:00.000Z","Intellectual Disability and Autism"
"NSD1","HGNC:14234","Sotos syndrome","MONDO:0019349","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aa1a412a-ee7d-4517-81ba-0ceead9668d1-2018-10-26T160000.000Z","2018-10-26T16:00:00.000Z","Intellectual Disability and Autism"
"NSD2","HGNC:12766","syndromic intellectual disability","MONDO:0000508","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_de3c113b-0a7d-454d-88e3-faf4f1fdb9ac-2021-06-02T160000.000Z","2021-06-02T16:00:00.000Z","Intellectual Disability and Autism"
"NSDHL","HGNC:13398","CK syndrome","MONDO:0010441","XL","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d94406f0-a459-47ed-aabc-80c7b6be9293-2021-01-20T170000.000Z","2021-01-20T17:00:00.000Z","Intellectual Disability and Autism"
"NSUN2","HGNC:25994","RASopathy","MONDO:0021060","AR","SOP6","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6442d764-3ff8-41f4-984d-776254226b05-2019-02-04T170000.000Z","2019-02-04T17:00:00.000Z","RASopathy"
"NSUN2","HGNC:25994","intellectual disability","MONDO:0001071","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c6878f90-f485-4c44-95d3-a33b0ec9f66f-2019-02-06T170000.000Z","2019-02-06T17:00:00.000Z","Intellectual Disability and Autism"
"NTNG1","HGNC:23319","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2c648acf-5801-481b-a1c4-f950e99d4d96-2021-02-02T170000.000Z","2021-02-02T17:00:00.000Z","Intellectual Disability and Autism"
"NTRK1","HGNC:8031","hereditary sensory and autonomic neuropathy type 4","MONDO:0009746","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e716345f-08da-4a06-b3e1-d07974a4305d-2021-11-17T030955.951Z","2021-11-17T03:09:55.951Z","Charcot-Marie-Tooth"
"NUBPL","HGNC:20278","Leigh syndrome","MONDO:0009723","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4365ffcd-637c-4862-9fa0-fb8a780a6d25-2020-03-19T195115.036Z","2020-03-19T19:51:15.036Z","Mitochondrial Diseases"
"NUP62","HGNC:8066","Leigh syndrome","MONDO:0009723","AR","SOP7","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8441b4db-da7d-49a2-816c-9f868a96ffab-2021-06-14T152710.966Z","2021-06-14T15:27:10.966Z","Mitochondrial Diseases"
"OAT","HGNC:8091","ornithine aminotransferase deficiency","MONDO:0009796","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_edbab666-9ae6-46db-b818-809a4bf8333e-2019-07-10T160000.000Z","2019-07-10T16:00:00.000Z","Aminoacidopathy"
"OBSCN","HGNC:15719","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e1b69281-f3d0-4efe-998d-db080868b57e-2020-11-06T180624.436Z","2020-11-06T18:06:24.436Z","Dilated Cardiomyopathy"
"OCA2","HGNC:8101","oculocutaneous albinism type 2","MONDO:0008746","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7433c1e2-a3a6-4351-88e0-cb3edcf39910-2021-08-25T160000.000Z","2021-08-25T16:00:00.000Z","General Gene Curation"
"OCRL","HGNC:8108","oculocerebrorenal syndrome","MONDO:0010645","XL","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5140c756-fac0-435b-8f59-a5d4a0b0adb3-2020-07-10T160000.000Z","2020-07-10T16:00:00.000Z","Intellectual Disability and Autism"
"OFD1","HGNC:2567","ciliopathy","MONDO:0005308","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_15e32789-4f24-4870-94d3-b5618e67509f-2018-04-27T165136.294Z","2018-04-27T16:51:36.294Z","Intellectual Disability and Autism"
"OGT","HGNC:8127","intellectual disability, X-linked 106","MONDO:0030907","XL","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_07776d36-7494-4ee4-992e-c6fb82c36749-2021-07-27T145857.330Z","2021-07-27T14:58:57.330Z","Syndromic Disorders"
"OPA1","HGNC:8140","Leigh syndrome","MONDO:0009723","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7e72abd1-4b0a-4f66-b681-7a51d4467026-2021-06-14T152117.821Z","2021-06-14T15:21:17.821Z","Mitochondrial Diseases"
"ORAI1","HGNC:25896","tubular aggregate myopathy","MONDO:0008051","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bb8d614e-e8ff-4f16-bba3-6fc35ea56e8a-2020-07-13T164919.164Z","2020-07-13T16:49:19.164Z","Congenital Myopathies"
"OSBPL2","HGNC:15761","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a493a4c4-3a9f-431a-a68e-d90d9a11b6f0-2020-02-06T172031.658Z","2020-02-06T17:20:31.658Z","Hearing Loss"
"OTC","HGNC:8512","ornithine carbamoyltransferase deficiency","MONDO:0010703","XL","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_132fafbf-bb34-447c-9f6a-65803679eeb8-2019-10-29T181325.783Z","2019-10-29T18:13:25.783Z","Aminoacidopathy"
"OTOA","HGNC:16378","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_87661be2-f024-49bb-a60e-a906f7f113b7-2018-05-01T040000.000Z","2018-05-01T04:00:00.000Z","Hearing Loss"
"OTOF","HGNC:8515","autosomal recessive nonsyndromic hearing loss 9","MONDO:0010986","AR","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5613","2017-01-30T00:00:00","Hearing Loss"
"OTOG","HGNC:8516","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0fac4fd4-d674-4017-a9a6-1d6793162c6b-2018-06-28T160000.000Z","2018-06-28T16:00:00.000Z","Hearing Loss"
"OTOGL","HGNC:26901","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_28b962a1-8394-4366-8746-4b71a59cd60b-2018-01-05T170000.000Z","2018-01-05T17:00:00.000Z","Hearing Loss"
"P2RX2","HGNC:15459","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c1dae6b6-4ed7-4c5a-ba4e-bcfaba026be8-2018-02-20T170000.000Z","2018-02-20T17:00:00.000Z","Hearing Loss"
"P2RY12","HGNC:18124","platelet-type bleeding disorder 8","MONDO:0012354","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_81c56aba-1414-4365-a8de-847c080251f3-2020-08-26T160000.000Z","2020-08-26T16:00:00.000Z","Hemostasis Thrombosis"
"PACS1","HGNC:30032","Schuurs-Hoeijmakers syndrome","MONDO:0014006","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f5fb6cba-cff6-4498-a725-3f863a910cf1-2020-06-26T182716.855Z","2020-06-26T18:27:16.855Z","Intellectual Disability and Autism"
"PAH","HGNC:8582","phenylketonuria","MONDO:0009861","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5a617cb4-94ec-4f34-b97e-10d9808a1581-2020-04-24T160000.000Z","2020-04-24T16:00:00.000Z","Aminoacidopathy"
"PAK3","HGNC:8592","X-linked syndromic intellectual disability","MONDO:0020119","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c2f13863-a52d-49bd-b7f6-294edd73717a-2018-08-13T185556.727Z","2018-08-13T18:55:56.727Z","Intellectual Disability and Autism"
"PALB2","HGNC:26144","hereditary nonpolyposis colon cancer","MONDO:0018630","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10073","2018-03-12T00:00:00","Colon Cancer"
"PALB2","HGNC:26144","hereditary breast carcinoma","MONDO:0016419","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3213","2016-12-01T00:00:00","Breast/Ovarian Cancer"
"PALB2","HGNC:26144","familial ovarian cancer","MONDO:0016248","AD","SOP4","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9940","2017-11-08T00:00:00","Breast/Ovarian Cancer"
"PALB2","HGNC:26144","Fanconi anemia complementation group N","MONDO:0012565","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ebabbf1-1a43-4a57-b0b8-2b29bb57ade1-2019-08-18T160312.829Z","2019-08-18T16:03:12.829Z","Hereditary Cancer"
"PAX3","HGNC:8617","Waardenburg syndrome","MONDO:0018094","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_594ef026-3730-43bc-b721-d15cf0bbbf26-2017-11-15T050000.000Z","2017-11-15T05:00:00.000Z","Hearing Loss"
"PAX4","HGNC:8618","monogenic diabetes","MONDO:0015967","AD","SOP7","Refuted","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e2e54103-c1c4-4095-8a12-d602e5326d90-2021-01-13T170000.000Z","2021-01-13T17:00:00.000Z","Monogenic Diabetes"
"PAX7","HGNC:8621","congenital myopathy with myasthenic-like onset","MONDO:0018528","AR","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_684596b8-b8c4-40e5-8ab6-8b23cac49be5-2021-07-27T145321.701Z","2021-07-27T14:53:21.701Z","Syndromic Disorders"
"PCBD1","HGNC:8646","pterin-4 alpha-carbinolamine dehydratase 1 deficiency","MONDO:0009908","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d305c30f-50c1-491a-846f-4af6a2ad8aff-2021-07-27T160000.000Z","2021-07-27T16:00:00.000Z","Aminoacidopathy"
"PCCA","HGNC:8653","propionic acidemia","MONDO:0011628","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_32a55e25-8632-4f31-84af-3eaf8098ca18-2018-12-13T170000.000Z","2018-12-13T17:00:00.000Z","Aminoacidopathy"
"PCCB","HGNC:8654","propionic acidemia","MONDO:0011628","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1cd49a9b-08c2-49db-8e97-e334f171e34d-2018-12-13T170000.000Z","2018-12-13T17:00:00.000Z","Aminoacidopathy"
"PCDH15","HGNC:14674","Usher syndrome type 1","MONDO:0010168","AR","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5657","2017-02-15T00:00:00","Hearing Loss"
"PCDH15","HGNC:14674","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_48910592-40d6-4eb7-a53c-4b0883070287-2018-06-19T040000.000Z","2018-06-19T04:00:00.000Z","Hearing Loss"
"PCDH19","HGNC:14270","X-linked complex neurodevelopmental disorder","MONDO:0100148","XL","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c00aad39-c6c4-4a46-af84-613592b166a3-2018-09-04T160000.000Z","2018-09-04T16:00:00.000Z","Epilepsy"
"PCSK9","HGNC:20001","hypercholesterolemia, autosomal dominant, 3","MONDO:0011369","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bf710ddc-c189-419f-ab70-25300b067db2-2018-11-14T170000.000Z","2018-11-14T17:00:00.000Z","General Gene Curation"
"PCYT1A","HGNC:8754","spondylometaphyseal dysplasia-cone-rod dystrophy syndrome","MONDO:0012160","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_eff306ea-95ff-4b4e-8597-f50849b1b4c2-2021-07-26T183711.748Z","2021-07-26T18:37:11.748Z","Retina"
"PDGFRA","HGNC:8803","gastrointestinal stromal tumor","MONDO:0011719","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_08bbf13f-bc04-47a7-a3c5-1ec6abfc9190-2020-01-13T195509.878Z","2020-01-13T19:55:09.878Z","Hereditary Cancer"
"PDHA1","HGNC:8806","Leigh syndrome","MONDO:0009723","XL","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a579324c-3586-4636-9192-c2ea29391a4e-2019-04-08T161203.224Z","2019-04-08T16:12:03.224Z","Mitochondrial Diseases"
"PDHB","HGNC:8808","Leigh syndrome","MONDO:0009723","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_133f688f-b498-4f5e-bd9b-b3406880ddd4-2021-03-11T172853.362Z","2021-03-11T17:28:53.362Z","Mitochondrial Diseases"
"PDHX","HGNC:21350","Leigh syndrome","MONDO:0009723","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3608ac5e-4b1f-4bb5-aa0c-cc42a2262304-2021-03-11T174226.092Z","2021-03-11T17:42:26.092Z","Mitochondrial Diseases"
"PDLIM3","HGNC:20767","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_76cba060-8080-42b1-b9ea-2193fea658b0-2018-08-06T132124.189Z","2018-08-06T13:21:24.189Z","Hypertrophic Cardiomyopathy"
"PDLIM3","HGNC:20767","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_78f8d362-f690-4319-912f-1bdceceacccd-2020-09-16T160000.000Z","2020-09-16T16:00:00.000Z","Dilated Cardiomyopathy"
"PDSS2","HGNC:23041","Leigh syndrome","MONDO:0009723","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5e0928f3-2b7d-4622-bc96-68a4d0078826-2021-03-11T172336.036Z","2021-03-11T17:23:36.036Z","Mitochondrial Diseases"
"PDZD7","HGNC:26257","hearing loss, autosomal recessive","MONDO:0019588","AR","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8406","2017-04-26T00:00:00","Hearing Loss"
"PET100","HGNC:40038","Leigh syndrome","MONDO:0009723","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_33c546f5-a285-424b-9ae2-9ca4fc718c67-2019-05-20T191347.510Z","2019-05-20T19:13:47.510Z","Mitochondrial Diseases"
"PET117","HGNC:40045","Leigh syndrome","MONDO:0009723","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_69d9bbe0-ba3f-44f0-b340-d6d824cb969f-2019-05-20T191805.361Z","2019-05-20T19:18:05.361Z","Mitochondrial Diseases"
"PEX1","HGNC:8850","peroxisome biogenesis disorder","MONDO:0019234","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a345ba65-9dcd-43dd-a1c2-1778c1a921ea-2019-05-17T160000.000Z","2019-05-17T16:00:00.000Z","Peroxisomal Disorders"
"PEX10","HGNC:8851","peroxisome biogenesis disorder","MONDO:0019234","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c0f7f094-ac3b-4309-ad8f-8e604f006485-2019-12-06T050000.000Z","2019-12-06T05:00:00.000Z","Peroxisomal Disorders"
"PEX11A","HGNC:8852","peroxisome biogenesis disorder","MONDO:0019234","AR","SOP8","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9f83cdb0-7fca-4bc5-b896-3201000364f9-2020-07-17T160000.000Z","2020-07-17T16:00:00.000Z","Peroxisomal Disorders"
"PEX11B","HGNC:8853","peroxisome biogenesis disorder","MONDO:0019234","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_93eacb33-b099-485d-bf8a-782479dc0a3b-2020-01-17T170000.000Z","2020-01-17T17:00:00.000Z","Peroxisomal Disorders"
"PEX11G","HGNC:20208","peroxisome biogenesis disorder","MONDO:0019234","AR","SOP8","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_932d75de-89f1-4ba6-8a2a-05f53ecdf097-2020-09-04T160000.000Z","2020-09-04T16:00:00.000Z","Peroxisomal Disorders"
"PEX12","HGNC:8854","peroxisome biogenesis disorder","MONDO:0019234","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_124c97b0-92ed-4921-a0b9-2ff33135139d-2019-12-06T170000.000Z","2019-12-06T17:00:00.000Z","Peroxisomal Disorders"
"PEX13","HGNC:8855","peroxisome biogenesis disorder","MONDO:0019234","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0c662669-4eb8-45e3-8540-c394ea40c1b2-2019-10-04T160000.000Z","2019-10-04T16:00:00.000Z","Peroxisomal Disorders"
"PEX14","HGNC:8856","peroxisome biogenesis disorder","MONDO:0019234","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_846efcc3-5456-4db3-9bc2-e441acb768cd-2019-09-20T160000.000Z","2019-09-20T16:00:00.000Z","Peroxisomal Disorders"
"PEX16","HGNC:8857","peroxisome biogenesis disorder","MONDO:0019234","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7506d938-efb4-416c-aafd-221251d00e6e-2020-01-13T170000.000Z","2020-01-13T17:00:00.000Z","Peroxisomal Disorders"
"PEX19","HGNC:9713","peroxisome biogenesis disorder","MONDO:0019234","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fa073c77-0623-4e82-b5b2-9fcd0eb0dc6e-2020-01-17T170000.000Z","2020-01-17T17:00:00.000Z","Peroxisomal Disorders"
"PEX2","HGNC:9717","peroxisome biogenesis disorder","MONDO:0019234","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_17bf1c4a-1775-40c6-a499-774c93827343-2020-02-07T170000.000Z","2020-02-07T17:00:00.000Z","Peroxisomal Disorders"
"PEX26","HGNC:22965","peroxisome biogenesis disorder","MONDO:0019234","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bf6af95e-6696-420c-8731-d2e37ca6e692-2020-02-07T170000.000Z","2020-02-07T17:00:00.000Z","Peroxisomal Disorders"
"PEX3","HGNC:8858","peroxisome biogenesis disorder","MONDO:0019234","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d53df483-c31a-4672-8a11-04d33d6df336-2019-11-01T160000.000Z","2019-11-01T16:00:00.000Z","Peroxisomal Disorders"
"PEX5","HGNC:9719","peroxisome biogenesis disorder","MONDO:0019234","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b49d9cfd-0e51-4219-84bb-76b4c9b99fa9-2020-01-17T170000.000Z","2020-01-17T17:00:00.000Z","Peroxisomal Disorders"
"PEX6","HGNC:8859","peroxisome biogenesis disorder","MONDO:0019234","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_54df6fb2-b692-4ece-a525-ae0cfe243826-2019-09-06T160000.000Z","2019-09-06T16:00:00.000Z","Peroxisomal Disorders"
"PEX7","HGNC:8860","peroxisome biogenesis disorder","MONDO:0019234","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d0796d69-b304-4670-b4a2-8785ff6fd161-2020-02-14T170000.000Z","2020-02-14T17:00:00.000Z","Peroxisomal Disorders"
"PFN1","HGNC:8881","amyotrophic lateral sclerosis type 18","MONDO:0013891","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_948de40f-2cef-4235-ae87-491c01ffe803-2021-04-22T160000.000Z","2021-04-22T16:00:00.000Z","Amyotrophic Lateral Sclerosis Spectrum Disorders"
"PHF6","HGNC:18145","Borjeson-Forssman-Lehmann syndrome","MONDO:0010537","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9555","2018-02-21T00:00:00","Intellectual Disability and Autism"
"PHF8","HGNC:20672","syndromic X-linked intellectual disability Siderius type","MONDO:0010286","XL","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b9e94640-1950-4438-bcda-4859545d83d1-2018-11-07T170000.000Z","2018-11-07T17:00:00.000Z","Intellectual Disability and Autism"
"PHGDH","HGNC:8923","neurometabolic disorder due to serine deficiency","MONDO:0018162","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f1b4e8da-d6e7-4494-abb0-f2953548a722-2020-06-29T174326.589Z","2020-06-29T17:43:26.589Z","Aminoacidopathy"
"PHOX2B","HGNC:9143","Haddad syndrome","MONDO:0020493","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_07133a39-00fb-43c4-a7e2-a465c3c0c4ca-2021-06-15T152906.892Z","2021-06-15T15:29:06.892Z","Hereditary Cancer"
"PHOX2B","HGNC:9143","congenital central hypoventilation syndrome","MONDO:0008852","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5ed68efa-cafc-4e28-ab56-ab9b65666c15-2021-06-15T151832.283Z","2021-06-15T15:18:32.283Z","Hereditary Cancer"
"PHYKPL","HGNC:28249","phosphohydroxylysinuria","MONDO:0014008","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_82ba1358-e58c-4187-bbe7-0f1bf41267d0-2020-09-25T165428.427Z","2020-09-25T16:54:28.427Z","Aminoacidopathy"
"PIGA","HGNC:8957","developmental and epileptic encephalopathy","MONDO:0100062","XL","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1fbb591b-eb34-4b73-a741-2f101886c896-2019-04-26T160000.000Z","2019-04-26T16:00:00.000Z","Epilepsy"
"PIGO","HGNC:23215","complex neurodevelopmental disorder","MONDO:0100038","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_830b11ca-6ec1-4aa9-bb44-379f03f738c7-2021-10-21T004641.341Z","2021-10-21T00:46:41.341Z","Epilepsy"
"PIK3CA","HGNC:8975","hereditary breast carcinoma","MONDO:0016419","AD","SOP4","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8693","2017-02-08T00:00:00","Breast/Ovarian Cancer"
"PIK3CA","HGNC:8975","familial ovarian cancer","MONDO:0016248","AD","SOP4","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8694","2017-02-08T00:00:00","Breast/Ovarian Cancer"
"PIK3CA","HGNC:8975","overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes","MONDO:0100283","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c670e6ce-97b6-4383-bea6-5c216ab2a4a0-2021-07-29T213157.366Z","2021-07-29T21:31:57.366Z","Brain Malformations"
"PIK3R1","HGNC:8979","SHORT syndrome","MONDO:0010026","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_194f9130-2529-4016-a689-47ec259f941c-2018-07-03T165117.140Z","2018-07-03T16:51:17.140Z","UNC Biocuration Core"
"PIK3R1","HGNC:8979","immunodeficiency 36","MONDO:0014453","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_40c5f722-d25e-46b1-8a52-c407d1c64e63-2021-07-22T195122.034Z","2021-07-22T19:51:22.034Z","Antibody Deficiencies GCEP"
"PIK3R1","HGNC:8979","agammaglobulinemia 7, autosomal recessive","MONDO:0014083","AR","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e019aaad-09a8-44c4-9fc0-12a1d53e79db-2021-05-20T153438.351Z","2021-05-20T15:34:38.351Z","Antibody Deficiencies GCEP"
"PIK3R2","HGNC:8980","overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes","MONDO:0100283","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fc9a451e-0e75-47d2-a090-a2409732c465-2021-07-29T213616.452Z","2021-07-29T21:36:16.452Z","Brain Malformations"
"PJVK","HGNC:29502","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b3e304c3-33fd-41ec-81f9-1c0725a5549f-2017-12-19T050000.000Z","2017-12-19T05:00:00.000Z","Hearing Loss"
"PKD1","HGNC:9008","autosomal dominant polycystic kidney disease","MONDO:0004691","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_09d61dec-314b-4c5f-af2e-f22fc5992c12-2021-02-26T151356.823Z","2021-02-26T15:13:56.823Z","Kidney Cystic and Ciliopathy Disorders"
"PKD2","HGNC:9009","autosomal dominant polycystic kidney disease","MONDO:0004691","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ae0ae123-be04-4ba2-b685-594ca47a3467-2021-02-26T151635.009Z","2021-02-26T15:16:35.009Z","Kidney Cystic and Ciliopathy Disorders"
"PKP2","HGNC:9024","Brugada syndrome 1","MONDO:0011001","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10156","2017-11-21T00:00:00","Brugada Syndrome"
"PKP2","HGNC:9024","catecholaminergic polymorphic ventricular tachycardia","MONDO:0017990","AD","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1231ec3b-3570-48dd-bea4-f7cd7fc54811-2021-01-20T170000.000Z","2021-01-20T17:00:00.000Z","Catecholaminergic Polymorphic Ventricular Tachycardia"
"PKP2","HGNC:9024","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2a8e26ad-c4ce-48d7-acab-1198d3b12ce5-2020-10-09T160000.000Z","2020-10-09T16:00:00.000Z","Dilated Cardiomyopathy"
"PKP2","HGNC:9024","arrhythmogenic right ventricular cardiomyopathy","MONDO:0016587","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6f97b6cd-5225-4076-b67a-2f609908e6fe-2018-03-08T170000.000Z","2018-03-08T17:00:00.000Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"PLA2G4A","HGNC:9035","cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder","MONDO:0018794","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ff7f6f85-cca7-4eb2-9957-9023c94402f0-2020-03-25T160000.000Z","2020-03-25T16:00:00.000Z","Hemostasis Thrombosis"
"PLAU","HGNC:9052","Quebec platelet disorder","MONDO:0011136","AD","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6ffd0133-1004-4a53-b38d-940c257e56c1-2022-01-05T160123.087Z","2022-01-05T16:01:23.087Z","Hemostasis Thrombosis"
"PLCB1","HGNC:15917","developmental and epileptic encephalopathy","MONDO:0100062","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c7887c3b-332b-4586-93cf-4098796ab66f-2020-09-18T040000.000Z","2020-09-18T04:00:00.000Z","Epilepsy"
"PLEKHM2","HGNC:29131","dilated cardiomyopathy","MONDO:0005021","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_44c534b9-16d1-435b-9eca-fb7d1de6ea26-2020-10-09T160000.000Z","2020-10-09T16:00:00.000Z","Dilated Cardiomyopathy"
"PLG","HGNC:9071","hypoplasminogenemia","MONDO:0009009","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2c9320e7-9f02-4b54-beba-0ca781a442eb-2019-10-23T160000.000Z","2019-10-23T16:00:00.000Z","Hemostasis Thrombosis"
"PLN","HGNC:9080","arrhythmogenic right ventricular cardiomyopathy","MONDO:0016587","AD","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_13027de9-c84a-4968-936b-6356265193a6-2020-12-17T213224.631Z","2020-12-17T21:32:24.631Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"PLN","HGNC:9080","intrinsic cardiomyopathy","MONDO:0000591","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f49f65fb-a2df-4e86-9a89-da2325b207c8-2021-02-12T170000.000Z","2021-02-12T17:00:00.000Z","Hypertrophic Cardiomyopathy"
"PLP1","HGNC:9086","Pelizaeus-Merzbacher disease","MONDO:0010714","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c1a44c5f-744e-4d02-a08f-e7c687531b21-2018-03-07T170000.000Z","2018-03-07T17:00:00.000Z","Intellectual Disability and Autism"
"PMP2","HGNC:9117","Charcot-Marie-Tooth disease","MONDO:0015626","AD","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aa4c5730-f807-45d7-afe7-573a3960916f-2021-03-22T201734.319Z","2021-03-22T20:17:34.319Z","Charcot-Marie-Tooth"
"PMS1","HGNC:9121","Lynch syndrome","MONDO:0005835","AD","SOP4","Refuted","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9853","2017-05-22T00:00:00","Colon Cancer"
"PMS2","HGNC:9122","hereditary breast carcinoma","MONDO:0016419","AD","SOP4","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10085","2017-11-08T00:00:00","Breast/Ovarian Cancer"
"PMS2","HGNC:9122","Lynch syndrome","MONDO:0005835","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9851","2017-06-26T00:00:00","Colon Cancer"
"PMS2","HGNC:9122","mismatch repair cancer syndrome 1","MONDO:0010159","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_38bc9d1d-a436-4f21-9952-bd5e7790a797-2018-10-09T150318.285Z","2018-10-09T15:03:18.285Z","Hereditary Cancer"
"PNKP","HGNC:9154","microcephaly, seizures, and developmental delay","MONDO:0013254","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_901a984a-c678-4f35-81c2-9436785d3698-2020-04-17T165304.309Z","2020-04-17T16:53:04.309Z","Epilepsy"
"PNPO","HGNC:30260","pyridoxal phosphate-responsive seizures","MONDO:0012407","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f3ff7b38-dd26-458a-afbb-4870785c42ec-2020-12-15T170000.000Z","2020-12-15T17:00:00.000Z","Epilepsy"
"PNPT1","HGNC:23166","Leigh syndrome","MONDO:0009723","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6ed99943-2ab9-417d-b0ec-ddbfa11c8645-2020-03-19T191429.965Z","2020-03-19T19:14:29.965Z","Mitochondrial Diseases"
"POGZ","HGNC:18801","intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome","MONDO:0014606","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c5742d94-0642-4598-9fbd-fd43a2c21559-2020-03-09T160000.000Z","2020-03-09T16:00:00.000Z","Intellectual Disability and Autism"
"POLD1","HGNC:9175","Polymerase proofreading-related adenomatous polyposis","MONDO:0018653","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8441","2017-04-10T00:00:00","Colon Cancer"
"POLE","HGNC:9177","Polymerase proofreading-related adenomatous polyposis","MONDO:0018653","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8442","2017-12-11T00:00:00","Colon Cancer"
"POLG","HGNC:9179","Leigh syndrome","MONDO:0009723","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1212393e-b517-4430-a8d7-df7e32295aff-2021-06-30T144955.983Z","2021-06-30T14:49:55.983Z","Mitochondrial Diseases"
"POLH","HGNC:9181","xeroderma pigmentosum variant type","MONDO:0010214","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bdb29404-0c05-4519-b6ee-8591368ad1ff-2018-11-02T215846.146Z","2018-11-02T21:58:46.146Z","Hereditary Cancer"
"POLR2A","HGNC:9187","neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities","MONDO:0032829","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_45cab675-1ca5-4c25-97a9-bfeeeb1e112a-2020-08-25T131429.407Z","2020-08-25T13:14:29.407Z","Syndromic Disorders"
"POMGNT1","HGNC:19139","muscular dystrophy-dystroglycanopathy","MONDO:0018276","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_03bb8479-2ed3-4b15-9e54-378ea0729ab2-2020-09-09T120352.877Z","2020-09-09T12:03:52.877Z","Limb Girdle Muscular Dystrophy"
"POMGNT2","HGNC:25902","muscular dystrophy-dystroglycanopathy","MONDO:0018276","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_522f3d3f-8026-439f-9318-2e4df6097a2e-2020-09-10T122353.145Z","2020-09-10T12:23:53.145Z","Limb Girdle Muscular Dystrophy"
"POMT1","HGNC:9202","muscular dystrophy-dystroglycanopathy","MONDO:0018276","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_146ee85f-a6c2-468f-aacb-a320767de36e-2021-07-27T163845.521Z","2021-07-27T16:38:45.521Z","Limb Girdle Muscular Dystrophy"
"POPDC3","HGNC:17649","autosomal recessive limb-girdle muscular dystrophy","MONDO:0015152","AR","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bb7755df-a1e3-4398-a771-cd6c2d112b68-2021-01-13T194210.166Z","2021-01-13T19:42:10.166Z","Limb Girdle Muscular Dystrophy"
"PORCN","HGNC:17652","focal dermal hypoplasia","MONDO:0010592","XL","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_20fc3afa-d10d-4239-885f-24e91cbb31a8-2020-08-05T124432.168Z","2020-08-05T12:44:32.168Z","Intellectual Disability and Autism"
"POU3F4","HGNC:9217","nonsyndromic genetic hearing loss","MONDO:0019497","XL","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4ab4f4a3-757d-4de3-90e7-42a229c360a0-2018-01-05T170000.000Z","2018-01-05T17:00:00.000Z","Hearing Loss"
"POU4F3","HGNC:9220","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1476f1d9-7538-40bd-b602-b76781630cee-2017-11-21T170000.000Z","2017-11-21T17:00:00.000Z","Hearing Loss"
"PPM1K","HGNC:25415","maple syrup urine disease, mild variant","MONDO:0014057","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d2b1c4d4-ca12-4456-afe0-f727106afeaf-2020-09-25T165546.698Z","2020-09-25T16:55:46.698Z","Aminoacidopathy"
"PPP1CB","HGNC:9282","Noonan syndrome-like disorder with loose anagen hair","MONDO:0011899","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_16bcb316-090f-420d-9c89-b7642d3dc725-2020-04-23T160000.000Z","2020-04-23T16:00:00.000Z","RASopathy"
"PPP1R12A","HGNC:7618","genitourinary and/or brain malformation syndrome","MONDO:0032934","AD","SOP8","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_93fa5165-a907-4ca8-b0d3-bb174bf3fca9-2021-07-27T145458.008Z","2021-07-27T14:54:58.008Z","Syndromic Disorders"
"PPP2R5D","HGNC:9312","syndromic intellectual disability","MONDO:0000508","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4b43ff91-1ea4-475b-97d9-6fbda924ea16-2022-01-12T055053.721Z","2022-01-12T05:50:53.721Z","Intellectual Disability and Autism"
"PPT1","HGNC:9325","neuronal ceroid lipofuscinosis 1","MONDO:0009744","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8f72e2d3-f951-44da-a052-555d4f680114-2021-09-02T160000.000Z","2021-09-02T16:00:00.000Z","Retina"
"PQBP1","HGNC:9330","Renpenning syndrome","MONDO:0010653","XL","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8128f36b-f273-49ee-bfd8-bee64b4df921-2018-11-09T170000.000Z","2018-11-09T17:00:00.000Z","Intellectual Disability and Autism"
"PRDM16","HGNC:14000","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c0a3445a-5bb0-4d77-a4f0-5b7cfceb837f-2020-08-12T160000.000Z","2020-08-12T16:00:00.000Z","Dilated Cardiomyopathy"
"PRG4","HGNC:9364","camptodactyly-arthropathy-coxa vara-pericarditis syndrome","MONDO:0008828","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3b4be938-664c-421e-922b-dc6ac83e5dec-2021-07-30T130737.801Z","2021-07-30T13:07:37.801Z","Syndromic Disorders"
"PRICKLE1","HGNC:17019","epilepsy","MONDO:0005027","AD","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_71a3c632-fd63-4103-a069-5e9e413043e7-2020-09-01T160000.000Z","2020-09-01T16:00:00.000Z","Epilepsy"
"PRICKLE1","HGNC:17019","progressive myoclonus epilepsy","MONDO:0020074","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d4e1195f-21ea-4721-b94b-99604e7c6554-2020-08-18T170000.000Z","2020-08-18T17:00:00.000Z","Epilepsy"
"PRKAG2","HGNC:9386","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10051","2017-01-30T00:00:00","Hypertrophic Cardiomyopathy"
"PRKAR1A","HGNC:9388","Carney complex, type 1","MONDO:0008057","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fc16b2a9-c8dc-4a04-a029-2f6af049404d-2018-12-21T154044.801Z","2018-12-21T15:40:44.801Z","Hereditary Cancer"
"PRKCSH","HGNC:9411","polycystic liver disease 1","MONDO:0008265","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_83607ef3-6ec2-4d63-991a-4aeb3f7c2a25-2020-07-08T040000.000Z","2020-07-08T04:00:00.000Z","Kidney Cystic and Ciliopathy Disorders"
"PRKG1","HGNC:9414","familial thoracic aortic aneurysm and aortic dissection","MONDO:0019625","AD","SOP4","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8259","2016-12-22T00:00:00","Heritable Thoracic Aortic Aneurysm and Dissection"
"PROC","HGNC:9451","hereditary thrombophilia due to congenital protein C deficiency","MONDO:0019145","SD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c6fe2f63-36ad-40c2-beb6-8804de17409d-2020-01-22T170000.000Z","2020-01-22T17:00:00.000Z","Hemostasis Thrombosis"
"PRODH","HGNC:9453","hyperprolinemia type 1","MONDO:0009400","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5f28c677-a9b4-4bb3-9aed-14af97ad9896-2021-04-27T160000.000Z","2021-04-27T16:00:00.000Z","Aminoacidopathy"
"PRODH2","HGNC:17325","hydroxyprolinemia","MONDO:0009374","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d9101c67-2635-4595-b9a8-8e749bba58d1-2019-09-13T173000.499Z","2019-09-13T17:30:00.499Z","Aminoacidopathy"
"PROS1","HGNC:9456","hereditary thrombophilia due to congenital protein S deficiency","MONDO:0019144","SD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_10e3af9d-80aa-4934-b592-594b1bd1cd92-2020-01-22T170000.000Z","2020-01-22T17:00:00.000Z","Hemostasis Thrombosis"
"PRPS1","HGNC:9462","phosphoribosylpyrophosphate synthetase superactivity","MONDO:0010395","XL","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_76dc3f8d-e1c9-4506-9381-d2b5ab3df300-2020-02-14T170000.000Z","2020-02-14T17:00:00.000Z","Hearing Loss"
"PRPS1","HGNC:9462","PRPS1 deficiency disorder","MONDO:0100061","XL","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9416f6e2-8de3-48b0-9a1c-9bd11a59315c-2020-02-14T170000.000Z","2020-02-14T17:00:00.000Z","Hearing Loss"
"PRRT2","HGNC:30500","infantile convulsions and choreoathetosis","MONDO:0011178","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_62af25b8-b9a4-421f-b897-4fc222569618-2020-01-21T213814.191Z","2020-01-21T21:38:14.191Z","Epilepsy"
"PRSS1","HGNC:9475","hereditary chronic pancreatitis","MONDO:0008185","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d271c52b-b0bb-4e9b-a745-ea03dc716fa0-2020-07-30T205014.833Z","2020-07-30T20:50:14.833Z","Hereditary Cancer"
"PRSS12","HGNC:9477","non-syndromic intellectual disability","MONDO:0000509","AR","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d98f99d6-b1df-4cad-a53b-c94cfb532167-2021-08-04T160000.000Z","2021-08-04T16:00:00.000Z","Intellectual Disability and Autism"
"PSAT1","HGNC:19129","neurometabolic disorder due to serine deficiency","MONDO:0018162","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ca702099-7dc9-4434-b661-a6f9b8c72d5c-2020-06-29T165656.452Z","2020-06-29T16:56:56.452Z","Aminoacidopathy"
"PSD3","HGNC:19093","antecubital pterygium syndrome","MONDO:0008339","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_4845","2016-11-24T00:00:00","General Gene Curation"
"PSEN1","HGNC:9508","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d71e8591-dece-4855-ae6c-d43e20cbf836-2020-11-06T170000.000Z","2020-11-06T17:00:00.000Z","Dilated Cardiomyopathy"
"PSEN2","HGNC:9509","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9e20579f-efc7-4ccd-8653-85c0aafe788f-2020-09-04T160000.000Z","2020-09-04T16:00:00.000Z","Dilated Cardiomyopathy"
"PSPH","HGNC:9577","neurometabolic disorder due to serine deficiency","MONDO:0018162","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fa832956-c4e9-4620-a2e7-3d6d6e9eea8c-2020-09-29T134342.753Z","2020-09-29T13:43:42.753Z","Aminoacidopathy"
"PTCD3","HGNC:24717","Leigh syndrome","MONDO:0009723","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ac3d1e08-56f0-43b6-a2fa-0d06571ba121-2019-06-20T164419.242Z","2019-06-20T16:44:19.242Z","Mitochondrial Diseases"
"PTCH1","HGNC:9585","nevoid basal cell carcinoma syndrome","MONDO:0007187","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2a3f55f5-e39b-4571-a41f-e46ddb8e298d-2018-06-04T195607.312Z","2018-06-04T19:56:07.312Z","Hereditary Cancer"
"PTCH2","HGNC:9586","nevoid basal cell carcinoma syndrome","MONDO:0007187","AD","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d189ca00-ba80-49af-9b2e-8523c8d29a44-2018-10-12T213908.660Z","2018-10-12T21:39:08.660Z","Hereditary Cancer"
"PTCHD1","HGNC:26392","non-syndromic X-linked intellectual disability","MONDO:0019181","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_05d36fe2-0026-4bbc-af4b-6d952490969b-2018-09-19T131340.824Z","2018-09-19T13:13:40.824Z","Intellectual Disability and Autism"
"PTEN","HGNC:9588","PTEN hamartoma tumor syndrome","MONDO:0017623","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9990","2017-10-09T00:00:00","PTEN"
"PTPN11","HGNC:9644","Noonan syndrome","MONDO:0018997","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2bb08565-4669-4633-b6ed-c04e2a431cf9-2018-07-24T160000.000Z","2018-07-24T16:00:00.000Z","RASopathy"
"PTPN11","HGNC:9644","Costello syndrome","MONDO:0009026","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_72fca24b-243b-49de-9ceb-ae76e12f60a8-2018-05-31T160000.000Z","2018-05-31T16:00:00.000Z","RASopathy"
"PTPN11","HGNC:9644","cardiofaciocutaneous syndrome","MONDO:0015280","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1a2133e-4ce8-45b7-87da-1c52990d3890-2018-05-30T160000.000Z","2018-05-30T16:00:00.000Z","RASopathy"
"PTPN11","HGNC:9644","Noonan syndrome with multiple lentigines","MONDO:0007893","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e6c41f3b-c2d1-4d66-a1a3-a5beaa304578-2018-07-25T160000.000Z","2018-07-25T16:00:00.000Z","RASopathy"
"PTPRC","HGNC:9666","severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive","MONDO:0012163","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f4b09bbc-c749-45be-9f2a-1a54813b2906-2021-12-22T205504.201Z","2021-12-22T20:55:04.201Z","SCID-CID"
"PTPRJ","HGNC:9673","hereditary nonpolyposis colon cancer","MONDO:0018630","AD","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_051bd795-fea1-4d6d-8947-348b7f0be80a-2018-10-12T210742.630Z","2018-10-12T21:07:42.630Z","Hereditary Cancer"
"PTPRQ","HGNC:9679","hearing loss, autosomal recessive","MONDO:0019588","AR","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8404","2017-02-23T00:00:00","Hearing Loss"
"PTS","HGNC:9689","BH4-deficient hyperphenylalaninemia A","MONDO:0009863","AR","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f3f9b683-bd6b-4566-9341-ddd7195b5108-2017-12-22T170000.000Z","2017-12-22T17:00:00.000Z","Aminoacidopathy"
"PUF60","HGNC:17042","syndromic intellectual disability","MONDO:0000508","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_661c140f-11a3-46f8-b001-14a2314582e4-2021-12-15T170000.000Z","2021-12-15T17:00:00.000Z","Intellectual Disability and Autism"
"PURA","HGNC:9701","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6819633c-e488-4856-8dec-3981cd14db9b-2018-12-18T170000.000Z","2018-12-18T17:00:00.000Z","Epilepsy"
"PYCR1","HGNC:9721","autosomal recessive cutis laxa type 2B","MONDO:0013051","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ca242cd8-1f57-4c7b-ba97-5ec0c97b425b-2020-05-21T191607.864Z","2020-05-21T19:16:07.864Z","Aminoacidopathy"
"PYROXD1","HGNC:26162","myofibrillar myopathy 8","MONDO:0014993","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_44f4197c-2004-4d10-81dc-e61190eba909-2019-11-05T134731.947Z","2019-11-05T13:47:31.947Z","Congenital Myopathies"
"QARS1","HGNC:9751","diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome","MONDO:0014335","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6b0cbc0e-c97c-4f6d-a351-0ac23a4ba8a5-2020-05-26T150033.131Z","2020-05-26T15:00:33.131Z","Brain Malformations"
"QDPR","HGNC:9752","dihydropteridine reductase deficiency","MONDO:0009862","AR","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3cd45f13-9412-4439-9b68-cf2e3d02a646-2018-06-18T160000.000Z","2018-06-18T16:00:00.000Z","Aminoacidopathy"
"RAB23","HGNC:14263","RAB23-related Carpenter syndrome","MONDO:0008710","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_46756b21-4bb5-4384-a42c-cf10c76e98c8-2021-04-22T160000.000Z","2021-04-22T16:00:00.000Z","Craniofacial Malformations"
"RAB27A","HGNC:9766","Griscelli syndrome type 2","MONDO:0011872","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_85b7d8d2-1d22-44f3-9b24-580b42d69300-2020-12-17T171600.737Z","2020-12-17T17:16:00.737Z","Syndromic Disorders"
"RAB39B","HGNC:16499","early-onset parkinsonism-intellectual disability syndrome","MONDO:0010709","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_01dc73a8-fbd2-4081-95cd-ab7cb59236d7-2018-06-04T121339.240Z","2018-06-04T12:13:39.240Z","Intellectual Disability and Autism"
"RAB3GAP1","HGNC:17063","Warburg micro syndrome 1","MONDO:0010822","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1e4a47e-757a-442f-b82f-2ddfd69d0854-2020-05-26T135951.050Z","2020-05-26T13:59:51.050Z","Brain Malformations"
"RAC2","HGNC:9802","immunodeficiency 73c with defective neutrophil chemotaxis and hypogammaglobulinemia","MONDO:0033555","AR","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8191c879-cc6a-4c5e-9ceb-7101aa7cbc15-2021-10-19T154613.500Z","2021-10-19T15:46:13.500Z","Antibody Deficiencies GCEP"
"RAC2","HGNC:9802","immunodeficiency 73b with defective neutrophil chemotaxis and lymphopenia","MONDO:0033554","AD","SOP8","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a6c1e0b1-de02-4899-9825-acc950bedcc3-2021-10-19T155522.241Z","2021-10-19T15:55:22.241Z","Antibody Deficiencies GCEP"
"RAC2","HGNC:9802","neutrophil immunodeficiency syndrome","MONDO:0011988","AD","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f415e195-889f-4812-becd-5b3e7fe6b84f-2021-12-21T135017.284Z","2021-12-21T13:50:17.284Z","Antibody Deficiencies GCEP"
"RAD21","HGNC:9811","Cornelia de Lange syndrome","MONDO:0016033","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_30ad5023-6c68-42ab-b8ea-a601a134eaf6-2020-01-08T170000.000Z","2020-01-08T17:00:00.000Z","Intellectual Disability and Autism"
"RAD50","HGNC:9816","hereditary breast carcinoma","MONDO:0016419","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8695","2016-12-14T00:00:00","Breast/Ovarian Cancer"
"RAD50","HGNC:9816","familial ovarian cancer","MONDO:0016248","AD","SOP4","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8696","2016-10-26T00:00:00","Breast/Ovarian Cancer"
"RAD51C","HGNC:9820","Fanconi anemia","MONDO:0019391","AR","SOP4","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3202","2017-01-05T00:00:00","General Gene Curation"
"RAD51C","HGNC:9820","hereditary breast carcinoma","MONDO:0016419","AD","SOP4","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8697","2017-05-10T00:00:00","Breast/Ovarian Cancer"
"RAD51C","HGNC:9820","familial ovarian cancer","MONDO:0016248","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8699","2017-04-12T00:00:00","Breast/Ovarian Cancer"
"RAD51D","HGNC:9823","hereditary breast carcinoma","MONDO:0016419","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3215","2017-11-08T00:00:00","Breast/Ovarian Cancer"
"RAD51D","HGNC:9823","familial ovarian cancer","MONDO:0016248","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9957","2017-10-11T00:00:00","Breast/Ovarian Cancer"
"RAF1","HGNC:9829","Costello syndrome","MONDO:0009026","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_67081421-a4a3-4b62-88e0-4a78d19859ba-2018-07-24T160000.000Z","2018-07-24T16:00:00.000Z","RASopathy"
"RAF1","HGNC:9829","Noonan syndrome","MONDO:0018997","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_85645d27-2056-4ad3-9593-8d7739aa4121-2018-07-24T160000.000Z","2018-07-24T16:00:00.000Z","RASopathy"
"RAF1","HGNC:9829","cardiofaciocutaneous syndrome","MONDO:0015280","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b1e7c802-14d7-435c-b396-637b728a3ae2-2018-05-31T160000.000Z","2018-05-31T16:00:00.000Z","RASopathy"
"RAF1","HGNC:9829","Noonan syndrome with multiple lentigines","MONDO:0007893","AD","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cda0bf05-836b-40bb-99f5-e1dbfd0f6741-2018-07-25T160000.000Z","2018-07-25T16:00:00.000Z","RASopathy"
"RAG1","HGNC:9831","recombinase activating gene 1 deficiency","MONDO:0000572","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f08ada81-650b-4764-99e4-f3156f67cbc9-2021-06-17T160000.000Z","2021-06-17T16:00:00.000Z","SCID-CID"
"RAG2","HGNC:9832","recombinase activating gene 2 deficiency","MONDO:0000573","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4e9918ba-b94a-4526-bd99-09abef894225-2021-08-19T140520.555Z","2021-08-19T14:05:20.555Z","SCID-CID"
"RAI1","HGNC:9834","Smith-Magenis syndrome","MONDO:0008434","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1e576e58-debf-49c6-a86d-c599806180ff-2018-09-27T130055.105Z","2018-09-27T13:00:55.105Z","Intellectual Disability and Autism"
"RANBP2","HGNC:9848","Leigh syndrome","MONDO:0009723","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_183be314-face-471f-9643-9cc1a302636f-2021-06-30T145342.020Z","2021-06-30T14:53:42.020Z","Mitochondrial Diseases"
"RANGRF","HGNC:17679","Brugada syndrome","MONDO:0015263","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10157","2017-11-21T00:00:00","Brugada Syndrome"
"RASA1","HGNC:9871","Noonan syndrome","MONDO:0018997","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a957c2df-eeec-4bdf-b423-6f1667f66abd-2018-06-07T160000.000Z","2018-06-07T16:00:00.000Z","RASopathy"
"RASA2","HGNC:9872","Noonan syndrome","MONDO:0018997","AD","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9635e391-79b6-4054-824e-1c607a02cd07-2018-07-24T160000.000Z","2018-07-24T16:00:00.000Z","RASopathy"
"RASGRP2","HGNC:9879","platelet-type bleeding disorder 18","MONDO:0014386","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f4401e99-145a-4b93-aa73-6854b8037895-2019-09-27T135300.165Z","2019-09-27T13:53:00.165Z","Hemostasis Thrombosis"
"RB1","HGNC:9884","retinoblastoma","MONDO:0008380","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f8c79621-7ace-4c0c-874e-a315a2e6c872-2020-07-30T213929.219Z","2020-07-30T21:39:29.219Z","Hereditary Cancer"
"RBM20","HGNC:27424","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3e123751-078a-4d30-9f83-847119982342-2020-08-20T160000.000Z","2020-08-20T16:00:00.000Z","Dilated Cardiomyopathy"
"RBM8A","HGNC:9905","thrombocytopenia-absent radius syndrome","MONDO:0010121","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_56c276a7-3068-48db-9baa-6f178eb9c3a7-2020-05-15T160000.000Z","2020-05-15T16:00:00.000Z","Hemostasis Thrombosis"
"RDH5","HGNC:9940","inherited retinal dystrophy","MONDO:0019118","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5399fd62-ca69-4665-b3ba-c15ceefbf6d9-2021-09-03T164559.434Z","2021-09-03T16:45:59.434Z","Retina"
"RDX","HGNC:9944","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2cf494e5-7335-4e2a-8b50-75cf8412a9d0-2018-01-02T170000.000Z","2018-01-02T17:00:00.000Z","Hearing Loss"
"RECQL","HGNC:9948","hereditary breast carcinoma","MONDO:0016419","AD","SOP4","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8700","2016-09-28T00:00:00","Breast/Ovarian Cancer"
"RECQL","HGNC:9948","familial ovarian cancer","MONDO:0016248","AD","SOP4","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8701","2016-09-14T00:00:00","Breast/Ovarian Cancer"
"RECQL4","HGNC:9949","Rothmund-Thomson syndrome","MONDO:0010002","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dbf00cfa-ac36-4eb0-94c4-69b05014e0f6-2018-10-11T170000.000Z","2018-10-11T17:00:00.000Z","Hereditary Cancer"
"RELN","HGNC:9957","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP8","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c654081c-5abd-4f86-a3f7-90d7f117b93d-2021-03-17T160000.000Z","2021-03-17T16:00:00.000Z","Intellectual Disability and Autism"
"REN","HGNC:9958","renal tubular dysgenesis of genetic origin","MONDO:0009970","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9a9a43c4-771a-4a73-b66f-dd99ab76aeec-2020-10-28T160000.000Z","2020-10-28T16:00:00.000Z","Kidney Cystic and Ciliopathy Disorders"
"REN","HGNC:9958","familial juvenile hyperuricemic nephropathy type 2","MONDO:0013128","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cae92b57-f5b9-4000-9a42-72161f2d7dd3-2020-10-28T160000.000Z","2020-10-28T16:00:00.000Z","Kidney Cystic and Ciliopathy Disorders"
"RET","HGNC:9967","multiple endocrine neoplasia type 2B","MONDO:0008082","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5e4425f0-0900-43c3-aac4-5b37554be386-2020-05-14T010345.543Z","2020-05-14T01:03:45.543Z","Hereditary Cancer"
"RET","HGNC:9967","multiple endocrine neoplasia type 2A","MONDO:0008234","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c5f3c875-2438-4bfe-b785-b86d7d3e6507-2020-05-14T005952.060Z","2020-05-14T00:59:52.060Z","Hereditary Cancer"
"RGS9","HGNC:10004","bradyopsia","MONDO:0012033","AR","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f90aa6cd-9e08-4fab-b6c3-570beb8232dd-2021-09-08T160000.000Z","2021-09-08T16:00:00.000Z","Retina"
"RHBDF2","HGNC:20788","palmoplantar keratoderma-esophageal carcinoma syndrome","MONDO:0007856","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b7e72765-1a53-44fb-bfee-9e5923507bbe-2020-07-30T212232.808Z","2020-07-30T21:22:32.808Z","Hereditary Cancer"
"RINT1","HGNC:21876","hereditary breast carcinoma","MONDO:0016419","AD","SOP4","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8702","2016-09-26T00:00:00","Breast/Ovarian Cancer"
"RINT1","HGNC:21876","familial ovarian cancer","MONDO:0016248","AD","SOP4","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8703","2016-09-14T00:00:00","Breast/Ovarian Cancer"
"RIPOR2","HGNC:13872","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ed7e0813-4e94-40a9-b3ef-ef90d5c4dce4-2018-09-18T160000.000Z","2018-09-18T16:00:00.000Z","Hearing Loss"
"RIT1","HGNC:10023","Noonan syndrome","MONDO:0018997","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_240565fc-61b9-4ff8-9f5a-85938f17cdd9-2018-07-24T160000.000Z","2018-07-24T16:00:00.000Z","RASopathy"
"RLBP1","HGNC:10024","inherited retinal dystrophy","MONDO:0019118","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d8c69db5-8d29-40af-85f0-59471ce0c62c-2021-06-03T170000.000Z","2021-06-03T17:00:00.000Z","Retina"
"RMRP","HGNC:10031","cartilage-hair hypoplasia","MONDO:0009595","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c7328b31-364b-4a7c-aaed-731b582cb716-2021-07-27T155213.681Z","2021-07-27T15:52:13.681Z","SCID-CID"
"RNASEH1","HGNC:18466","Leigh syndrome","MONDO:0009723","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fcf8b7a4-7bd5-45fe-824c-6a90825620f7-2021-01-14T213824.328Z","2021-01-14T21:38:24.328Z","Mitochondrial Diseases"
"RNF43","HGNC:18505","sessile serrated polyposis cancer syndrome","MONDO:0014919","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9857","2017-10-23T00:00:00","Colon Cancer"
"ROR1","HGNC:10256","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fdee1ffc-d8bd-4188-acb6-5fad8f5902a6-2018-03-20T160000.000Z","2018-03-20T16:00:00.000Z","Hearing Loss"
"RPE65","HGNC:10294","inherited retinal dystrophy","MONDO:0019118","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_375ffa04-a8d9-427e-8948-f913bc8ff68d-2021-10-26T142732.609Z","2021-10-26T14:27:32.609Z","Retina"
"RPL10","HGNC:10298","X-linked syndromic intellectual disability","MONDO:0020119","XL","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_974ac8bb-f7b1-4480-869a-e9ef4b8b3fa3-2021-01-20T170000.000Z","2021-01-20T17:00:00.000Z","Intellectual Disability and Autism"
"RPS10","HGNC:10383","Diamond-Blackfan anemia","MONDO:0015253","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3205","2017-01-19T00:00:00","General Gene Curation"
"RPS20","HGNC:10405","hereditary nonpolyposis colon cancer","MONDO:0018630","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8436","2017-06-08T00:00:00","Colon Cancer"
"RPS24","HGNC:10411","Diamond-Blackfan anemia","MONDO:0015253","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3206","2017-01-19T00:00:00","General Gene Curation"
"RPS6KA3","HGNC:10432","Coffin-Lowry syndrome","MONDO:0010561","XL","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_af32a931-1d55-432f-82cf-ce87f6c26580-2019-05-28T040000.000Z","2019-05-28T04:00:00.000Z","Intellectual Disability and Autism"
"RRAS","HGNC:10447","Noonan syndrome","MONDO:0018997","AD","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_96280a14-d8cd-4c9b-b3e0-d5fcd8bf9ef6-2018-07-24T160000.000Z","2018-07-24T16:00:00.000Z","RASopathy"
"RRAS2","HGNC:17271","Noonan syndrome","MONDO:0018997","AD","SOP6","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c5742615-3820-41dd-a523-e660a498f9e8-2019-06-27T160000.000Z","2019-06-27T16:00:00.000Z","RASopathy"
"RS1","HGNC:10457","X-linked retinoschisis","MONDO:0010725","XL","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_061adaaf-8b09-42e4-ae31-9b9c03d6e944-2020-12-18T165803.135Z","2020-12-18T16:58:03.135Z","Retina"
"RUNX1","HGNC:10471","hereditary thrombocytopenia and hematologic cancer predisposition syndrome","MONDO:0011071","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_06aed341-58db-459b-a750-7142e29b420b-2018-06-04T194655.831Z","2018-06-04T19:46:55.831Z","Hereditary Cancer"
"RYR1","HGNC:10483","malignant hyperthermia, susceptibility to, 1","MONDO:0007783","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bcd5e6ba-ef77-434c-9ec6-47f72f597bfe-2020-11-25T170000.000Z","2020-11-25T17:00:00.000Z","General Gene Curation"
"RYR1","HGNC:10483","RYR1-related myopathy","MONDO:0100150","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d5e4ff9a-94ad-453f-b2de-76deb98fe4ca-2020-07-27T160000.000Z","2020-07-27T16:00:00.000Z","Congenital Myopathies"
"RYR1","HGNC:10483","RYR1-related myopathy","MONDO:0100150","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fbd82373-705c-4b60-8b73-147ed461d357-2020-10-26T160000.000Z","2020-10-26T16:00:00.000Z","Congenital Myopathies"
"RYR2","HGNC:10484","catecholaminergic polymorphic ventricular tachycardia","MONDO:0017990","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1da07a67-9d04-448b-843b-39dac372cb59-2021-01-20T170000.000Z","2021-01-20T17:00:00.000Z","Catecholaminergic Polymorphic Ventricular Tachycardia"
"RYR2","HGNC:10484","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ac9dd09-674f-4d67-94da-234ffb4e5070-2019-07-19T160000.000Z","2019-07-19T16:00:00.000Z","Hypertrophic Cardiomyopathy"
"RYR2","HGNC:10484","arrhythmogenic right ventricular cardiomyopathy","MONDO:0016587","AD","SOP7","Refuted","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_52fa7dee-4daa-4685-9461-f39c57a22f05-2019-07-19T160000.000Z","2019-07-19T16:00:00.000Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"RYR3","HGNC:10485","developmental and epileptic encephalopathy","MONDO:0100062","AD","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a277276e-7efa-45c9-ad01-74e9aa2dea63-2018-06-19T160000.000Z","2018-06-19T16:00:00.000Z","Epilepsy"
"RYR3","HGNC:10485","congenital myopathy","MONDO:0019952","AR","SOP7","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f234219f-23fd-449f-9d7e-4c1731af3309-2020-01-27T170000.000Z","2020-01-27T17:00:00.000Z","Congenital Myopathies"
"S1PR2","HGNC:3169","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP4","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8405","2017-03-02T00:00:00","Hearing Loss"
"SARDH","HGNC:10536","sarcosinemia","MONDO:0010008","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2b994b6f-f296-45af-9d52-c1d0b211ef74-2019-06-28T160000.000Z","2019-06-28T16:00:00.000Z","Aminoacidopathy"
"SATB2","HGNC:21637","SATB2 associated disorder","MONDO:0100147","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_44d14081-fa32-4159-9049-35f510d2351a-2020-09-15T160000.000Z","2020-09-15T16:00:00.000Z","Intellectual Disability and Autism"
"SBDS","HGNC:19440","Shwachman-Diamond syndrome","MONDO:0009833","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7c2a84f0-e42d-487f-a2af-5b536a30d30c-2020-07-30T210401.699Z","2020-07-30T21:04:01.699Z","Hereditary Cancer"
"SBF1","HGNC:10542","Charcot-Marie-Tooth disease type 4B3","MONDO:0014117","AR","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c0f814d9-02db-4c0c-8e1c-20a7759d993f-2021-11-20T022238.296Z","2021-11-20T02:22:38.296Z","Charcot-Marie-Tooth"
"SBF2","HGNC:2135","Charcot-Marie-Tooth disease type 4B2","MONDO:0011475","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_01893bf4-e95d-4206-9d2e-e3822f778b7a-2021-03-22T201309.257Z","2021-03-22T20:13:09.257Z","Charcot-Marie-Tooth"
"SCARB2","HGNC:1665","progressive myoclonus epilepsy","MONDO:0020074","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dc556613-cf24-44ee-8354-98ce91f78d7d-2020-08-23T190000.000Z","2020-08-23T19:00:00.000Z","Epilepsy"
"SCN10A","HGNC:10582","Brugada syndrome 1","MONDO:0011001","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10161","2017-11-21T00:00:00","Brugada Syndrome"
"SCN1A","HGNC:10585","developmental and epileptic encephalopathy","MONDO:0100062","AD","SOP7","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_529f9cae-ac00-47d1-94d5-52c98bf6e2a2-2019-10-25T040000.000Z","2019-10-25T04:00:00.000Z","Epilepsy"
"SCN1A","HGNC:10585","generalized epilepsy with febrile seizures plus","MONDO:0018214","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5ac39f7a-0743-47b1-8efd-21e0ca836840-2019-09-06T194357.485Z","2019-09-06T19:43:57.485Z","Epilepsy"
"SCN1A","HGNC:10585","Dravet syndrome","MONDO:0100135","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_60334a15-c73e-42ce-b7d2-4796c2affde4-2019-08-20T160000.000Z","2019-08-20T16:00:00.000Z","Epilepsy"
"SCN1A","HGNC:10585","familial hemiplegic migraine","MONDO:0000700","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c8c1e158-983d-4547-a739-7781961e5bb8-2021-09-14T163408.306Z","2021-09-14T16:34:08.306Z","Epilepsy"
"SCN1B","HGNC:10586","Brugada syndrome 1","MONDO:0011001","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10158","2017-11-21T00:00:00","Brugada Syndrome"
"SCN1B","HGNC:10586","generalized epilepsy with febrile seizures plus","MONDO:0018214","AD","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_91fb4b50-478b-4e3a-ac8a-a5cb7634a492-2022-01-04T211619.605Z","2022-01-04T21:16:19.605Z","Epilepsy"
"SCN1B","HGNC:10586","developmental and epileptic encephalopathy","MONDO:0100062","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d4c35c20-6e59-46cf-9347-852b80af8dcc-2022-01-04T211051.949Z","2022-01-04T21:10:51.949Z","Epilepsy"
"SCN2A","HGNC:10588","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2a1b7361-5c9e-4803-844d-ad6606a0acdb-2019-05-07T160000.000Z","2019-05-07T16:00:00.000Z","Epilepsy"
"SCN2B","HGNC:10589","Brugada syndrome 1","MONDO:0011001","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10159","2017-11-21T00:00:00","Brugada Syndrome"
"SCN3B","HGNC:20665","Brugada syndrome 1","MONDO:0011001","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10160","2017-11-21T00:00:00","Brugada Syndrome"
"SCN4A","HGNC:10591","SCN4A-related myopathy, autosomal recessive","MONDO:0100121","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f71b22d2-1ee8-46f6-9488-a86588edd7d3-2021-05-13T160000.000Z","2021-05-13T16:00:00.000Z","Congenital Myopathies"
"SCN4B","HGNC:10592","long QT syndrome","MONDO:0002442","AD","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0e276096-21ab-42bc-866a-b1b4dcb01753-2018-09-25T160000.000Z","2018-09-25T16:00:00.000Z","Long QT Syndrome"
"SCN5A","HGNC:10593","Brugada syndrome","MONDO:0015263","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10165","2017-11-21T00:00:00","Brugada Syndrome"
"SCN5A","HGNC:10593","arrhythmogenic right ventricular cardiomyopathy","MONDO:0016587","AD","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3c1cdce2-c8de-442d-b0c4-5936919b310f-2019-06-06T160000.000Z","2019-06-06T16:00:00.000Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"SCN5A","HGNC:10593","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_53c90d2e-4d40-48ab-8761-b0158102c977-2020-11-06T181622.881Z","2020-11-06T18:16:22.881Z","Dilated Cardiomyopathy"
"SCN5A","HGNC:10593","familial long QT syndrome","MONDO:0019171","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ab19e69c-50fb-41e3-8adf-4d27617f3d55-2018-09-25T160000.000Z","2018-09-25T16:00:00.000Z","Long QT Syndrome"
"SCN5A","HGNC:10593","short QT syndrome","MONDO:0000453","AD","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c89660b5-d048-48fb-9d35-6f78f8c2ff01-2020-10-27T160000.000Z","2020-10-27T16:00:00.000Z","Short QT Syndrome"
"SCN5A","HGNC:10593","catecholaminergic polymorphic ventricular tachycardia","MONDO:0017990","AD","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_caef7504-ac08-43d4-8512-86f344a888a6-2021-01-20T170000.000Z","2021-01-20T17:00:00.000Z","Catecholaminergic Polymorphic Ventricular Tachycardia"
"SCN8A","HGNC:10596","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f52993aa-ddee-483d-b15e-dbf21608d5a9-2018-07-18T125000.560Z","2018-07-18T12:50:00.560Z","Epilepsy"
"SCN9A","HGNC:10597","epilepsy","MONDO:0005027","AD","SOP8","Refuted","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_72a91ef6-e052-44a4-b14e-6a5ba93393ff-2021-03-09T163649.218Z","2021-03-09T16:36:49.218Z","Epilepsy"
"SCO2","HGNC:10604","Leigh syndrome","MONDO:0009723","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_011dd1c7-94bb-4a70-8b95-cc25432a5ea2-2019-03-28T154245.471Z","2019-03-28T15:42:45.471Z","Mitochondrial Diseases"
"SDHA","HGNC:10680","hereditary pheochromocytoma-paraganglioma","MONDO:0017366","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4833b4b4-071c-4062-9007-8b0f6896a54e-2021-06-17T011716.456Z","2021-06-17T01:17:16.456Z","Hereditary Cancer"
"SDHA","HGNC:10680","Leigh syndrome","MONDO:0009723","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4c5801d0-5839-47d9-81cc-a53cea959b57-2019-05-20T190935.665Z","2019-05-20T19:09:35.665Z","Mitochondrial Diseases"
"SDHAF1","HGNC:33867","Leigh syndrome","MONDO:0009723","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0baf56d2-40f8-465a-9b50-22f57481a5cb-2020-02-12T201133.569Z","2020-02-12T20:11:33.569Z","Mitochondrial Diseases"
"SDHAF2","HGNC:26034","hereditary pheochromocytoma-paraganglioma","MONDO:0017366","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f70f16ee-a8b5-4f81-bd98-270fda25ffa4-2021-06-17T020032.120Z","2021-06-17T02:00:32.120Z","Hereditary Cancer"
"SDHB","HGNC:10681","hereditary pheochromocytoma-paraganglioma","MONDO:0017366","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b5b8852d-1641-4c45-8aa2-57c2dfbac4ea-2021-06-17T012105.373Z","2021-06-17T01:21:05.373Z","Hereditary Cancer"
"SDHC","HGNC:10682","hereditary pheochromocytoma-paraganglioma","MONDO:0017366","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8c6e49d4-8117-4fc2-88cd-aad0017ce2c4-2021-06-17T013125.314Z","2021-06-17T01:31:25.314Z","Hereditary Cancer"
"SDHD","HGNC:10683","hereditary pheochromocytoma-paraganglioma","MONDO:0017366","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9d0b732e-81e4-4834-8fe6-fe71f694399e-2021-06-17T015316.638Z","2021-06-17T01:53:16.638Z","Hereditary Cancer"
"SEC61A1","HGNC:18276","SEC61A1 deficiency","MONDO:0100337","AD","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1ff61d15-19f9-42a2-8dc4-0a4071b562eb-2021-07-27T154837.287Z","2021-07-27T15:48:37.287Z","Antibody Deficiencies GCEP"
"SEC61B","HGNC:16993","SEC61B-related polycystic liver disease","MONDO:0550003","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0fc2c7f6-caef-4f23-82ba-2360a5eb0990-2020-07-08T160000.000Z","2020-07-08T16:00:00.000Z","Kidney Cystic and Ciliopathy Disorders"
"SEC63","HGNC:21082","polycystic liver disease 2","MONDO:0014860","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_76312e16-e3b1-400a-8a22-4c0cca5e6918-2020-09-23T040000.000Z","2020-09-23T04:00:00.000Z","Kidney Cystic and Ciliopathy Disorders"
"SELENON","HGNC:15999","SELENON-related myopathy","MONDO:0100100","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7485529e-a573-4a47-aa0f-7c0d7067ae49-2020-04-27T190000.000Z","2020-04-27T19:00:00.000Z","Congenital Myopathies"
"SEMA4A","HGNC:10729","hereditary nonpolyposis colon cancer","MONDO:0018630","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9864","2017-11-13T00:00:00","Colon Cancer"
"SERAC1","HGNC:21061","Leigh syndrome","MONDO:0009723","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bf6861ce-e13a-42c9-a4ff-942a83874bfd-2021-01-14T213356.750Z","2021-01-14T21:33:56.750Z","Mitochondrial Diseases"
"SERPINB6","HGNC:8950","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b84c49a8-3b02-4e07-a0c7-80394c0cf991-2018-04-24T040000.000Z","2018-04-24T04:00:00.000Z","Hearing Loss"
"SERPINB8","HGNC:8952","exfoliative ichthyosis","MONDO:0017339","AR","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2e02ec85-306f-4465-b8f9-a6eb7e4e8056-2018-07-03T150807.977Z","2018-07-03T15:08:07.977Z","UNC Biocuration Core"
"SERPINC1","HGNC:775","antithrombin III deficiency","MONDO:0013144","SD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dd6376b1-1593-461f-bfc8-cec5cfb1c3f8-2020-02-26T170000.000Z","2020-02-26T17:00:00.000Z","Hemostasis Thrombosis"
"SERPIND1","HGNC:4838","heparin cofactor 2 deficiency","MONDO:0012876","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0888745c-f1e6-4af7-bdcd-bd229f043f07-2020-11-18T170000.000Z","2020-11-18T17:00:00.000Z","Hemostasis Thrombosis"
"SERPINE1","HGNC:8583","congenital plasminogen activator inhibitor type 1 deficiency","MONDO:0013227","AR","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_33baf899-f63b-42ed-b2fd-689cca44a7b6-2021-01-05T170000.000Z","2021-01-05T17:00:00.000Z","Hemostasis Thrombosis"
"SERPINF2","HGNC:9075","alpha-2-plasmin inhibitor deficiency","MONDO:0009883","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a8fa2353-ff89-41f1-b030-bde64517edbb-2020-09-23T160000.000Z","2020-09-23T16:00:00.000Z","Hemostasis Thrombosis"
"SETBP1","HGNC:15573","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_70505ca8-8869-4fa9-9965-fc8e03a19b28-2020-10-20T160000.000Z","2020-10-20T16:00:00.000Z","Intellectual Disability and Autism"
"SETBP1","HGNC:15573","Schinzel-Giedion syndrome","MONDO:0010010","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_71885c03-b578-4baf-a17c-4817349eaf36-2021-02-16T170000.000Z","2021-02-16T17:00:00.000Z","Intellectual Disability and Autism"
"SGCA","HGNC:10805","autosomal recessive limb-girdle muscular dystrophy","MONDO:0015152","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e60e8b70-857e-4dae-bc45-da7db0dd5bf1-2020-04-14T184243.590Z","2020-04-14T18:42:43.590Z","Limb Girdle Muscular Dystrophy"
"SGCB","HGNC:10806","autosomal recessive limb-girdle muscular dystrophy","MONDO:0015152","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c90753f2-8252-400f-b7b3-9d0b04e1e12c-2020-02-11T170000.000Z","2020-02-11T17:00:00.000Z","Limb Girdle Muscular Dystrophy"
"SGCD","HGNC:10807","autosomal recessive limb-girdle muscular dystrophy","MONDO:0015152","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1ad12a23-af71-4b3b-8a79-831b4d338c97-2020-04-14T183000.400Z","2020-04-14T18:30:00.400Z","Limb Girdle Muscular Dystrophy"
"SGCD","HGNC:10807","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_59326e1b-5cc1-4dfe-8d67-3379aa305c40-2020-09-04T160000.000Z","2020-09-04T16:00:00.000Z","Dilated Cardiomyopathy"
"SGCG","HGNC:10809","autosomal recessive limb-girdle muscular dystrophy","MONDO:0015152","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dc0d70af-ecb5-4755-a840-9e8bb6f4e0a7-2020-04-14T185145.093Z","2020-04-14T18:51:45.093Z","Limb Girdle Muscular Dystrophy"
"SH3KBP1","HGNC:13867","immunodeficiency 61","MONDO:0010296","XL","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3cc42cdd-5484-467b-9e35-7529716114dd-2021-11-16T170000.000Z","2021-11-16T17:00:00.000Z","Antibody Deficiencies GCEP"
"SHANK2","HGNC:14295","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_911cb9ff-e68e-4b47-8639-f6a63ab11b3e-2019-07-17T160000.000Z","2019-07-17T16:00:00.000Z","Intellectual Disability and Autism"
"SHANK3","HGNC:14294","Phelan-McDermid syndrome","MONDO:0011652","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e941703a-0f30-4f4c-a997-bc3b4295f289-2018-12-12T170000.000Z","2018-12-12T17:00:00.000Z","Intellectual Disability and Autism"
"SHOC2","HGNC:15454","Noonan syndrome-like disorder with loose anagen hair","MONDO:0011899","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0ecc1335-fb21-4d65-8df2-19558e8f5c07-2018-07-25T160000.000Z","2018-07-25T16:00:00.000Z","RASopathy"
"SHOC2","HGNC:15454","Noonan syndrome","MONDO:0018997","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_185c93c8-e875-46a2-83af-a8575b19a228-2018-05-31T160000.000Z","2018-05-31T16:00:00.000Z","RASopathy"
"SHOC2","HGNC:15454","Costello syndrome","MONDO:0009026","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7035ea3-d556-4aa4-b525-5ed6c02866df-2018-07-24T160000.000Z","2018-07-24T16:00:00.000Z","RASopathy"
"SHOC2","HGNC:15454","cardiofaciocutaneous syndrome","MONDO:0015280","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fd8e5069-4023-4763-9b41-03350b03ee7f-2018-06-01T160000.000Z","2018-06-01T16:00:00.000Z","RASopathy"
"SHROOM4","HGNC:29215","X-linked complex neurodevelopmental disorder","MONDO:0100148","XL","SOP8","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a94d20f8-9909-48b2-9860-d17c6dc73ec3-2021-01-13T170000.000Z","2021-01-13T17:00:00.000Z","Intellectual Disability and Autism"
"SIK1","HGNC:11142","developmental and epileptic encephalopathy","MONDO:0100062","AD","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cd76888e-9502-48f3-af06-56f1ae5ed975-2018-10-02T160000.000Z","2018-10-02T16:00:00.000Z","Epilepsy"
"SIX1","HGNC:10887","branchio-oto-renal syndrome","MONDO:0007029","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e2587f3b-52e1-4765-a9ac-82d8cc5ae45b-2017-06-22T160000.000Z","2017-06-22T16:00:00.000Z","Hearing Loss"
"SIX5","HGNC:10891","branchio-oto-renal syndrome","MONDO:0007029","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0667561f-aa48-4ad5-b4ff-45aac933b255-2018-08-23T131052.066Z","2018-08-23T13:10:52.066Z","Hearing Loss"
"SKI","HGNC:10896","Shprintzen-Goldberg syndrome","MONDO:0008426","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_019ffb7a-be5f-482d-9adf-e28d5aadaede-2020-10-29T160000.000Z","2020-10-29T16:00:00.000Z","Craniofacial Malformations"
"SLC16A2","HGNC:10923","Allan-Herndon-Dudley syndrome","MONDO:0010354","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b9242e32-a339-4426-8ef5-39df0960d390-2018-08-09T140238.174Z","2018-08-09T14:02:38.174Z","Intellectual Disability and Autism"
"SLC17A8","HGNC:20151","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP6","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8c399400-090a-4b2e-93ff-0c4915ce81c7-2018-09-18T160000.000Z","2018-09-18T16:00:00.000Z","Hearing Loss"
"SLC19A3","HGNC:16266","Leigh syndrome","MONDO:0009723","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e3907183-4cb2-4df7-bace-ecc1821b3acc-2019-01-14T170000.000Z","2019-01-14T17:00:00.000Z","Mitochondrial Diseases"
"SLC1A1","HGNC:10939","dicarboxylic aminoaciduria","MONDO:0009110","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fd6cc720-f37b-4abf-a887-8701ac805343-2019-10-11T160000.000Z","2019-10-11T16:00:00.000Z","Aminoacidopathy"
"SLC1A2","HGNC:10940","developmental and epileptic encephalopathy, 41","MONDO:0014916","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ebb83674-206f-461b-b98e-e12420208deb-2020-10-29T160000.000Z","2020-10-29T16:00:00.000Z","Aminoacidopathy"
"SLC1A3","HGNC:10941","episodic ataxia type 6","MONDO:0012982","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3bcae41b-3438-4e82-8f29-83cca7f142f0-2020-10-09T160000.000Z","2020-10-09T16:00:00.000Z","Aminoacidopathy"
"SLC1A4","HGNC:10942","spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome","MONDO:0014725","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8cff4bb6-caab-4696-a061-1f9a40c56c80-2021-05-14T160000.000Z","2021-05-14T16:00:00.000Z","Aminoacidopathy"
"SLC22A5","HGNC:10969","systemic primary carnitine deficiency disease","MONDO:0008919","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2beee8a9-193c-41ca-92c4-484c8e034b02-2018-04-24T160000.000Z","2018-04-24T16:00:00.000Z","Fatty Acid Oxidation Disorders"
"SLC22A5","HGNC:10969","short QT syndrome","MONDO:0000453","AR","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b23b9707-bb3c-423d-b68e-54c57b991db6-2020-08-03T160000.000Z","2020-08-03T16:00:00.000Z","Short QT Syndrome"
"SLC25A13","HGNC:10983","citrin deficiency","MONDO:0016602","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bc373b9e-ec5e-4471-92a1-bbdd9aa3378c-2021-07-23T220742.579Z","2021-07-23T22:07:42.579Z","Aminoacidopathy"
"SLC25A15","HGNC:10985","ornithine translocase deficiency","MONDO:0009393","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e5cb32c9-d506-484f-b023-1c4f17ef0d93-2019-12-04T170000.000Z","2019-12-04T17:00:00.000Z","Aminoacidopathy"
"SLC25A19","HGNC:14409","Leigh syndrome","MONDO:0009723","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6ae17da7-86b0-4aba-a401-de1ccb6ecb83-2020-08-27T162850.918Z","2020-08-27T16:28:50.918Z","Mitochondrial Diseases"
"SLC25A20","HGNC:1421","carnitine-acylcarnitine translocase deficiency","MONDO:0008918","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_95c9aece-49b5-496f-9547-f6d03dd69b4f-2018-05-22T160000.000Z","2018-05-22T16:00:00.000Z","Fatty Acid Oxidation Disorders"
"SLC25A22","HGNC:19954","developmental and epileptic encephalopathy","MONDO:0100062","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e9a7ba06-6ddf-4a94-a0df-0b6c164f72b9-2020-05-19T160000.000Z","2020-05-19T16:00:00.000Z","Epilepsy"
"SLC25A4","HGNC:10990","mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive","MONDO:0014175","AR","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10062","2017-08-30T00:00:00","Hypertrophic Cardiomyopathy"
"SLC25A4","HGNC:10990","Leigh syndrome","MONDO:0009723","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0a6890a4-e2d5-4895-956d-3f3103ec6a2b-2021-06-14T151738.675Z","2021-06-14T15:17:38.675Z","Mitochondrial Diseases"
"SLC25A46","HGNC:25198","Leigh syndrome","MONDO:0009723","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6e456b6d-7a9b-42d2-ab51-0531f5184b41-2020-08-27T163757.565Z","2020-08-27T16:37:57.565Z","Mitochondrial Diseases"
"SLC25A46","HGNC:25198","neuropathy, hereditary motor and sensory, type 6B","MONDO:0014671","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9852fb40-0df1-4668-ba57-38a4971cb244-2020-05-26T160000.000Z","2020-05-26T16:00:00.000Z","Charcot-Marie-Tooth"
"SLC26A2","HGNC:10994","diastrophic dysplasia","MONDO:0009107","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_311c9799-169e-4409-98bd-74b6d414904c-2020-06-01T160000.000Z","2020-06-01T16:00:00.000Z","Skeletal Disorders"
"SLC26A2","HGNC:10994","achondrogenesis type IB","MONDO:0010966","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_392a7ac1-7ef5-45c7-97e0-2c1c1bd7884d-2020-08-03T160000.000Z","2020-08-03T16:00:00.000Z","Skeletal Disorders"
"SLC26A2","HGNC:10994","multiple epiphyseal dysplasia","MONDO:0016648","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b53d2317-709a-4b12-b846-fa51bfddf7e1-2020-04-06T160000.000Z","2020-04-06T16:00:00.000Z","Skeletal Disorders"
"SLC26A2","HGNC:10994","atelosteogenesis type II","MONDO:0009727","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_da79a651-9fc7-453e-a1c1-145771baa2f9-2020-07-14T160000.000Z","2020-07-14T16:00:00.000Z","Skeletal Disorders"
"SLC26A4","HGNC:8818","Pendred syndrome","MONDO:0010134","AR","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_49e794f4-8725-4499-a0a2-82591b42cab5-2018-08-02T132641.899Z","2018-08-02T13:26:41.899Z","Hearing Loss"
"SLC26A5","HGNC:9359","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2f835f34-fe68-49a8-9399-bccebba540d4-2017-12-19T170000.000Z","2017-12-19T17:00:00.000Z","Hearing Loss"
"SLC2A1","HGNC:11005","GLUT1 deficiency syndrome","MONDO:0000188","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a20a0bc0-49d5-41fc-9507-cec19a43bd81-2019-04-18T123454.696Z","2019-04-18T12:34:54.696Z","Intellectual Disability and Autism"
"SLC2A10","HGNC:13444","familial thoracic aortic aneurysm and aortic dissection","MONDO:0019625","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8270","2016-04-17T00:00:00","Heritable Thoracic Aortic Aneurysm and Dissection"
"SLC35A2","HGNC:11022","X-linked complex neurodevelopmental disorder","MONDO:0100148","XL","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e8173aea-692d-4f50-aca4-228e3df16e80-2021-04-23T160000.000Z","2021-04-23T16:00:00.000Z","Epilepsy"
"SLC36A2","HGNC:18762","iminoglycinuria","MONDO:0009448","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_38341e13-b026-4a61-a049-5f7ef9df1805-2020-03-13T160000.000Z","2020-03-13T16:00:00.000Z","Aminoacidopathy"
"SLC39A7","HGNC:4927","agammaglobulinemia","MONDO:0015977","AR","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_69ebdc60-2bdd-4020-9d20-7c0ea0fd3cdd-2021-09-21T130638.465Z","2021-09-21T13:06:38.465Z","Antibody Deficiencies GCEP"
"SLC39A8","HGNC:20862","Leigh syndrome","MONDO:0009723","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5fddaae4-d982-49e7-9e83-b84d15f3cf2c-2020-11-23T195104.867Z","2020-11-23T19:51:04.867Z","Mitochondrial Diseases"
"SLC3A1","HGNC:11025","cystinuria","MONDO:0009067","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fbde8280-d4bc-47e8-8f3d-aed8bb05e22e-2020-06-29T174347.853Z","2020-06-29T17:43:47.853Z","Aminoacidopathy"
"SLC44A4","HGNC:13941","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ddbe083-55c3-483b-8c32-fc9bdbef10c6-2018-04-24T040000.000Z","2018-04-24T04:00:00.000Z","Hearing Loss"
"SLC4A3","HGNC:11029","short QT syndrome","MONDO:0000453","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b5f6fcca-f8a9-47c2-bae9-a72df92f3bd1-2020-08-03T160000.000Z","2020-08-03T16:00:00.000Z","Short QT Syndrome"
"SLC52A1","HGNC:30225","maternal riboflavin deficiency","MONDO:0014013","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f44e2049-ade2-464c-a4e5-eaf851252082-2020-12-01T170000.000Z","2020-12-01T17:00:00.000Z","Fatty Acid Oxidation Disorders"
"SLC52A2","HGNC:30224","brown-Vialetto-van Laere syndrome 2","MONDO:0013867","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5a500078-4cd5-49db-b22e-c5628ee07304-2018-07-09T160000.000Z","2018-07-09T16:00:00.000Z","Hearing Loss"
"SLC52A3","HGNC:16187","Brown-Vialetto-van Laere syndrome 1","MONDO:0024537","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b0ae82e2-4c39-45b2-ba2d-6fe2570dbcfc-2018-12-06T050000.000Z","2018-12-06T05:00:00.000Z","Hearing Loss"
"SLC5A7","HGNC:14025","neuronopathy, distal hereditary motor, type 7A","MONDO:0008024","AD","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c6e46608-98f5-4e4d-9bcf-22e42997af6e-2021-11-20T022003.630Z","2021-11-20T02:20:03.630Z","Charcot-Marie-Tooth"
"SLC6A19","HGNC:27960","Hartnup disease","MONDO:0009324","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_44c34762-450b-4abd-8fe4-3f17ff700630-2020-05-07T160000.000Z","2020-05-07T16:00:00.000Z","Aminoacidopathy"
"SLC6A4","HGNC:11050","autism spectrum disorder","MONDO:0005258","AD","SOP8","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cc4b0612-0a53-4e36-b737-5c0f49a387a1-2021-01-06T170000.000Z","2021-01-06T17:00:00.000Z","Intellectual Disability and Autism"
"SLC6A8","HGNC:11055","creatine transporter deficiency","MONDO:0010305","XL","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3795f0ae-7668-47b8-b69e-9c686b82bd0a-2020-02-10T170000.000Z","2020-02-10T17:00:00.000Z","Aminoacidopathy"
"SLC7A7","HGNC:11065","lysinuric protein intolerance","MONDO:0009109","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_207778e3-aff9-427d-ae87-f68fd938af88-2019-11-08T170000.000Z","2019-11-08T17:00:00.000Z","Aminoacidopathy"
"SLC7A9","HGNC:11067","cystinuria","MONDO:0009067","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a8e706c5-4b10-4c8a-b5ab-dda8545f464a-2020-06-29T174426.491Z","2020-06-29T17:44:26.491Z","Aminoacidopathy"
"SLC9A6","HGNC:11079","Christianson syndrome","MONDO:0010278","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1d97fc8d-e744-449a-939c-386895c121cd-2018-05-02T130416.790Z","2018-05-02T13:04:16.790Z","Rett and Angelman-like Disorders"
"SLC9A9","HGNC:20653","autism spectrum disorder","MONDO:0005258","AD","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_463ee005-1264-45da-bd85-3776a6637c68-2020-10-08T160000.000Z","2020-10-08T16:00:00.000Z","Intellectual Disability and Autism"
"SLFN14","HGNC:32689","platelet-type bleeding disorder 20","MONDO:0014830","AD","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f31ec838-fc84-47a2-9341-1fe494788a09-2021-01-27T170000.000Z","2021-01-27T17:00:00.000Z","Hemostasis Thrombosis"
"SLITRK6","HGNC:23503","high myopia-sensorineural deafness syndrome","MONDO:0009082","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e9b9e41c-1b12-4159-9729-8de648e747b0-2020-04-21T211522.429Z","2020-04-21T21:15:22.429Z","Hearing Loss"
"SLMAP","HGNC:16643","Brugada syndrome","MONDO:0015263","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10163","2017-11-21T00:00:00","Brugada Syndrome"
"SLX4","HGNC:23845","hereditary breast carcinoma","MONDO:0016419","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8704","2017-03-08T00:00:00","Breast/Ovarian Cancer"
"SLX4","HGNC:23845","familial ovarian cancer","MONDO:0016248","AD","SOP4","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8705","2017-03-08T00:00:00","Breast/Ovarian Cancer"
"SMAD2","HGNC:6768","familial thoracic aortic aneurysm and aortic dissection","MONDO:0019625","AD","SOP4","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8265","2017-04-10T00:00:00","Heritable Thoracic Aortic Aneurysm and Dissection"
"SMAD3","HGNC:6769","aneurysm-osteoarthritis syndrome","MONDO:0013426","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3210","2016-12-01T00:00:00","General Gene Curation"
"SMAD3","HGNC:6769","familial thoracic aortic aneurysm and aortic dissection","MONDO:0019625","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8253","2016-12-22T00:00:00","Heritable Thoracic Aortic Aneurysm and Dissection"
"SMAD4","HGNC:6770","generalized juvenile polyposis/juvenile polyposis coli","MONDO:0008276","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9856","2017-06-26T00:00:00","Colon Cancer"
"SMAD4","HGNC:6770","Myhre syndrome","MONDO:0007688","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a5a082cc-c214-4bfa-8cb8-caead239d129-2021-12-30T170000.000Z","2021-12-30T17:00:00.000Z","Intellectual Disability and Autism"
"SMAD4","HGNC:6770","juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome","MONDO:0008278","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b9b79d0f-4259-49d7-882d-4ca23bb7e8cf-2020-12-16T170000.000Z","2020-12-16T17:00:00.000Z","Hemostasis Thrombosis"
"SMAD9","HGNC:6774","pulmonary arterial hypertension","MONDO:0015924","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_14f5a0c2-f82c-4571-a161-fb7ce61ae6d4-2021-05-14T192954.557Z","2021-05-14T19:29:54.557Z","Pulmonary Hypertension"
"SMARCA1","HGNC:11097","Coffin-Siris syndrome","MONDO:0015452","AD","SOP4","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5479","2016-11-15T00:00:00","General Gene Curation"
"SMARCA2","HGNC:11098","intellectual disability-sparse hair-brachydactyly syndrome","MONDO:0011053","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5cde86bc-f99f-40cf-8c32-eac9f8f8a67d-2020-08-18T160000.000Z","2020-08-18T16:00:00.000Z","Intellectual Disability and Autism"
"SMARCA4","HGNC:11100","hereditary nonpolyposis colon cancer","MONDO:0018630","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9866","2017-05-08T00:00:00","Colon Cancer"
"SMARCA4","HGNC:11100","Coffin-Siris syndrome","MONDO:0015452","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_61d29c73-9a30-4664-9df2-2f5831219221-2020-06-17T160000.000Z","2020-06-17T16:00:00.000Z","Intellectual Disability and Autism"
"SMARCA4","HGNC:11100","rhabdoid tumor predisposition syndrome 2","MONDO:0013224","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e5edb191-f515-47a3-b1d8-cc723eaef665-2018-06-29T055002.692Z","2018-06-29T05:50:02.692Z","Hereditary Cancer"
"SMARCAL1","HGNC:11102","Schimke immuno-osseous dysplasia","MONDO:0009458","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_58700233-acb6-4ea8-911b-b3f474906aaa-2021-07-30T130548.284Z","2021-07-30T13:05:48.284Z","Syndromic Disorders"
"SMARCB1","HGNC:11103","rhabdoid tumor predisposition syndrome 1","MONDO:0012252","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8d7390e7-0bb1-4ba1-b97e-7f666b52c86b-2018-10-12T205953.762Z","2018-10-12T20:59:53.762Z","Hereditary Cancer"
"SMARCE1","HGNC:11109","familial meningioma","MONDO:0011789","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_01e68b67-987e-48ec-a167-cb659cc245e9-2020-07-30T211630.144Z","2020-07-30T21:16:30.144Z","Hereditary Cancer"
"SMC1A","HGNC:11111","X-linked complex neurodevelopmental disorder","MONDO:0100148","XL","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c281f5fd-d868-4425-a7b4-8e39e3b2090e-2019-06-19T160000.000Z","2019-06-19T16:00:00.000Z","Intellectual Disability and Autism"
"SMC3","HGNC:2468","Cornelia de Lange syndrome","MONDO:0016033","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9467eaad-a86a-4b24-8cd4-98ebb57121c1-2020-04-07T160000.000Z","2020-04-07T16:00:00.000Z","Intellectual Disability and Autism"
"SMPX","HGNC:11122","nonsyndromic genetic hearing loss","MONDO:0019497","XL","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_29773bee-1f13-43f6-bda0-c5a646efccd7-2017-09-12T160000.000Z","2017-09-12T16:00:00.000Z","Hearing Loss"
"SMS","HGNC:11123","syndromic X-linked intellectual disability Snyder type","MONDO:0010664","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8f1ca85b-ad57-4c64-9abf-9ae5d915703f-2018-05-16T195543.428Z","2018-05-16T19:55:43.428Z","Intellectual Disability and Autism"
"SNAI2","HGNC:11094","Waardenburg syndrome","MONDO:0018094","AR","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9c01d8d8-40a4-4b11-ad9c-8283bb937c55-2018-08-23T143204.472Z","2018-08-23T14:32:04.472Z","Hearing Loss"
"SNTA1","HGNC:11167","long QT syndrome","MONDO:0002442","AD","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_03c758a6-9290-4e14-9501-0ffb0fbfe8ce-2020-04-24T160000.000Z","2020-04-24T16:00:00.000Z","Long QT Syndrome"
"SOD1","HGNC:11179","amyotrophic lateral sclerosis type 1","MONDO:0007103","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_97d17778-d21e-441f-b4b7-49eccaa8cbab-2021-07-13T192226.690Z","2021-07-13T19:22:26.690Z","Amyotrophic Lateral Sclerosis Spectrum Disorders"
"SOS1","HGNC:11187","Noonan syndrome","MONDO:0018997","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9781b6bf-9b1e-4a10-a0a9-7e56562a6e3a-2018-07-24T160000.000Z","2018-07-24T16:00:00.000Z","RASopathy"
"SOS1","HGNC:11187","Costello syndrome","MONDO:0009026","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cf0ea291-849a-4bd9-a12a-cd9daad7e214-2018-07-24T160000.000Z","2018-07-24T16:00:00.000Z","RASopathy"
"SOS1","HGNC:11187","cardiofaciocutaneous syndrome","MONDO:0015280","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ee5b916f-82ef-4738-82c8-46ee2fad131b-2018-06-01T160000.000Z","2018-06-01T16:00:00.000Z","RASopathy"
"SOS2","HGNC:11188","Noonan syndrome","MONDO:0018997","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f20a1034-e29d-49bb-aed9-b4ba63dc5968-2020-08-27T160000.000Z","2020-08-27T16:00:00.000Z","RASopathy"
"SOX10","HGNC:11190","Waardenburg syndrome type 4C","MONDO:0013202","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_00a5b707-a265-4af0-a7e1-f15734ea42b9-2018-06-19T160000.000Z","2018-06-19T16:00:00.000Z","Hearing Loss"
"SOX9","HGNC:11204","isolated Pierre-Robin syndrome","MONDO:0009869","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_951f7fcd-2b6a-46cd-be1d-7993ee5119c1-2020-09-16T170000.000Z","2020-09-16T17:00:00.000Z","Skeletal Disorders"
"SOX9","HGNC:11204","Cooks syndrome","MONDO:0007134","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1fdeca1-a725-4ccb-a7f6-e77c2d6158aa-2020-09-16T170000.000Z","2020-09-16T17:00:00.000Z","Skeletal Disorders"
"SOX9","HGNC:11204","campomelic dysplasia","MONDO:0007251","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ca6e2118-28d5-4a6f-8333-ee30994d41cd-2020-06-01T170000.000Z","2020-06-01T17:00:00.000Z","Skeletal Disorders"
"SPEG","HGNC:16901","myopathy, centronuclear, 5","MONDO:0014418","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3a8f91f1-da1e-489d-84e1-46aa543b3df9-2020-01-12T213416.305Z","2020-01-12T21:34:16.305Z","Congenital Myopathies"
"SPR","HGNC:11257","dopa-responsive dystonia due to sepiapterin reductase deficiency","MONDO:0012994","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1c9f2ff6-39f1-4abc-9fdf-de4c0e23120d-2021-06-04T221815.205Z","2021-06-04T22:18:15.205Z","Aminoacidopathy"
"SPRED1","HGNC:20249","Legius syndrome","MONDO:0012669","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ba44430-8f71-4b94-a6f1-7f66d3a27897-2019-01-24T050000.000Z","2019-01-24T05:00:00.000Z","RASopathy"
"SPTAN1","HGNC:11273","developmental and epileptic encephalopathy","MONDO:0100062","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6737ac52-8177-4be1-95fe-92ddecbf5636-2019-01-17T170000.000Z","2019-01-17T17:00:00.000Z","Epilepsy"
"SQOR","HGNC:20390","Leigh syndrome","MONDO:0009723","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_09ea3b0c-cc3a-44d1-a702-9f1674c33040-2021-01-21T005124.845Z","2021-01-21T00:51:24.845Z","Mitochondrial Diseases"
"SRC","HGNC:11283","thrombocytopenia 6","MONDO:0014837","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3420133d-7a37-4f76-a3e7-6b9a0bc3803e-2020-02-26T170000.000Z","2020-02-26T17:00:00.000Z","Hemostasis Thrombosis"
"SRPX2","HGNC:30668","epilepsy","MONDO:0005027","XL","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e9555886-a248-4bd4-b3dc-50ff503d6e7a-2018-07-19T160000.000Z","2018-07-19T16:00:00.000Z","Epilepsy"
"SSBP1","HGNC:11317","Leigh syndrome","MONDO:0009723","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6ef6f4e7-6e59-4eaf-b303-7f975542d1b9-2021-06-14T144803.625Z","2021-06-14T14:48:03.625Z","Mitochondrial Diseases"
"ST3GAL3","HGNC:10866","complex neurodevelopmental disorder","MONDO:0100038","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e151129d-46fc-4f7e-a434-e423a3fb644b-2020-06-03T160000.000Z","2020-06-03T16:00:00.000Z","Intellectual Disability and Autism"
"STAC3","HGNC:28423","Bailey-Bloch congenital myopathy","MONDO:0009722","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_940572b9-6a5a-4de1-8ee1-6394f589515f-2020-04-25T160000.000Z","2020-04-25T16:00:00.000Z","Congenital Myopathies"
"STAT3","HGNC:11364","Hyper-IgE recurrent infection syndrome 1","MONDO:0007818","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_beb3aa5b-240e-45d7-969a-9de3e5564457-2021-12-24T160548.234Z","2021-12-24T16:05:48.234Z","SCID-CID"
"STIM1","HGNC:11386","tubular aggregate myopathy","MONDO:0008051","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9419adda-b3fb-4c2d-8562-6a0318260bbd-2021-04-01T160000.000Z","2021-04-01T16:00:00.000Z","Congenital Myopathies"
"STK11","HGNC:11389","familial ovarian cancer","MONDO:0016248","AD","SOP4","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8708","2016-10-26T00:00:00","Breast/Ovarian Cancer"
"STK11","HGNC:11389","Peutz-Jeghers syndrome","MONDO:0008280","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9992","2017-02-22T00:00:00","Colon Cancer"
"STRC","HGNC:16035","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_977b98b7-00f4-4200-9b17-f37303889ab4-2017-12-19T050000.000Z","2017-12-19T05:00:00.000Z","Hearing Loss"
"STXBP1","HGNC:11444","developmental and epileptic encephalopathy","MONDO:0100062","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a8d21800-652f-431b-a5d8-4208d4e91d46-2017-10-20T160000.000Z","2017-10-20T16:00:00.000Z","Epilepsy"
"SUCLA2","HGNC:11448","Leigh syndrome","MONDO:0009723","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_eedc8c99-a02a-4a34-ba72-1b0fc975e63f-2019-04-18T180100.762Z","2019-04-18T18:01:00.762Z","Mitochondrial Diseases"
"SUCLG1","HGNC:11449","Leigh syndrome","MONDO:0009723","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fd0a5a96-69b8-47fb-9b7b-17de29439ecc-2019-04-18T181448.882Z","2019-04-18T18:14:48.882Z","Mitochondrial Diseases"
"SUFU","HGNC:16466","medulloblastoma","MONDO:0007959","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1408d8b1-015c-48b3-a28e-d99b5545fce8-2018-10-11T184215.077Z","2018-10-11T18:42:15.077Z","Hereditary Cancer"
"SUGCT","HGNC:16001","glutaric acidemia type 3","MONDO:0009283","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_10622f19-d307-4fa8-b3ff-a799922e7fea-2020-09-25T170244.514Z","2020-09-25T17:02:44.514Z","Aminoacidopathy"
"SUOX","HGNC:11460","isolated sulfite oxidase deficiency","MONDO:0010089","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_be1ff294-4444-4d39-a507-a2115bcdcd58-2019-03-22T160000.000Z","2019-03-22T16:00:00.000Z","Aminoacidopathy"
"SURF1","HGNC:11474","Leigh syndrome","MONDO:0009723","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2ed17d9b-e746-4f1f-9c39-26f46bb2eadc-2019-04-08T160338.698Z","2019-04-08T16:03:38.698Z","Mitochondrial Diseases"
"SYN1","HGNC:11494","X-linked complex neurodevelopmental disorder","MONDO:0100148","XL","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ca5a3e64-5daa-4a2f-876d-4e7648c53ff8-2018-12-05T170000.000Z","2018-12-05T17:00:00.000Z","Intellectual Disability and Autism"
"SYNE4","HGNC:26703","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7ba8e80d-ccfe-4c9d-a2a9-6abaa9dfacc6-2020-02-06T171016.249Z","2020-02-06T17:10:16.249Z","Hearing Loss"
"SYNGAP1","HGNC:11497","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b19f2a30-5538-4339-9018-150fd1bcd9c8-2019-04-02T160000.000Z","2019-04-02T16:00:00.000Z","Epilepsy"
"SYP","HGNC:11506","non-syndromic X-linked intellectual disability","MONDO:0019181","XL","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b0d770a5-873c-4a55-98da-fa8d235ff93b-2020-12-16T170000.000Z","2020-12-16T17:00:00.000Z","Intellectual Disability and Autism"
"TACO1","HGNC:24316","Leigh syndrome","MONDO:0009723","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ae2fd0e4-db4e-4e17-bfc8-c43719066f97-2019-10-16T150433.004Z","2019-10-16T15:04:33.004Z","Mitochondrial Diseases"
"TAF15","HGNC:11547","amyotrophic lateral sclerosis","MONDO:0004976","AD","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_605446ae-fd1f-4451-bd49-643c24cd652e-2021-11-03T020945.214Z","2021-11-03T02:09:45.214Z","Amyotrophic Lateral Sclerosis Spectrum Disorders"
"TAFAZZIN","HGNC:11577","Barth syndrome","MONDO:0010543","XL","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1629e6ab-9749-4949-bf54-fe1addf4dcfd-2021-02-12T170000.000Z","2021-02-12T17:00:00.000Z","General Inborn Errors of Metabolism"
"TAOK1","HGNC:29259","syndromic intellectual disability","MONDO:0000508","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_79c712d0-ac0e-4bf0-8e68-bd598b3bca42-2021-08-04T160000.000Z","2021-08-04T16:00:00.000Z","Intellectual Disability and Autism"
"TARDBP","HGNC:11571","amyotrophic lateral sclerosis type 10","MONDO:0012790","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bf8bf781-25c9-4f16-b8cc-b0533390e4e2-2021-07-27T160623.437Z","2021-07-27T16:06:23.437Z","Amyotrophic Lateral Sclerosis Spectrum Disorders"
"TARS2","HGNC:30740","Leigh syndrome","MONDO:0009723","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_475a994f-8420-45bb-8f14-9fe85cdcdbbc-2021-06-14T144425.888Z","2021-06-14T14:44:25.888Z","Mitochondrial Diseases"
"TAT","HGNC:11573","tyrosinemia type II","MONDO:0010160","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7a28aa11-78af-4c3b-900e-79c6a1e9339a-2020-06-29T174208.705Z","2020-06-29T17:42:08.705Z","Aminoacidopathy"
"TBC1D24","HGNC:29203","DOORS syndrome","MONDO:0009079","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0fcb9839-6798-4195-8959-08d45bc63339-2020-03-11T132031.642Z","2020-03-11T13:20:31.642Z","Hearing Loss"
"TBC1D24","HGNC:29203","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cd496a45-5ae0-4e56-8a3d-2c410a5bd0c8-2018-03-27T160000.000Z","2018-03-27T16:00:00.000Z","Hearing Loss"
"TBL1XR1","HGNC:29529","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8352a921-43c0-4097-9147-2618a4165b57-2020-07-07T170000.000Z","2020-07-07T17:00:00.000Z","Intellectual Disability and Autism"
"TBR1","HGNC:11590","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_853c90ef-34a8-4d7d-931d-5fb4add3e4d0-2020-03-25T160000.000Z","2020-03-25T16:00:00.000Z","Intellectual Disability and Autism"
"TBX20","HGNC:11598","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_58a014d9-2d97-4041-961d-cfd09fa11adf-2020-08-12T160000.000Z","2020-08-12T16:00:00.000Z","Dilated Cardiomyopathy"
"TBX4","HGNC:11603","pulmonary arterial hypertension","MONDO:0015924","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1b8cc228-67d2-4530-8129-ebafee7fafa1-2021-03-10T214611.990Z","2021-03-10T21:46:11.990Z","Pulmonary Hypertension"
"TBX5","HGNC:11604","Holt-Oram syndrome","MONDO:0007732","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_24e6c85a-33cf-4248-be1f-6431c7c6b1e5-2021-07-27T145706.838Z","2021-07-27T14:57:06.838Z","Syndromic Disorders"
"TBXA2R","HGNC:11608","qualitative platelet defect","MONDO:0001197","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ab65570e-c07b-402c-99c0-322df4a86ee4-2020-12-16T170000.000Z","2020-12-16T17:00:00.000Z","Hemostasis Thrombosis"
"TBXAS1","HGNC:11609","ghosal hematodiaphyseal dysplasia","MONDO:0009274","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_612c46e2-8b4f-4bff-9d8b-28769d8854e2-2020-10-28T160000.000Z","2020-10-28T16:00:00.000Z","Hemostasis Thrombosis"
"TCAP","HGNC:11610","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4c8ab9d8-919a-443f-b027-5aec92b273d1-2020-08-12T160000.000Z","2020-08-12T16:00:00.000Z","Dilated Cardiomyopathy"
"TCAP","HGNC:11610","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c35abc20-c04c-49ec-af02-1bd270b0b50b-2020-05-01T134853.347Z","2020-05-01T13:48:53.347Z","Hypertrophic Cardiomyopathy"
"TCAP","HGNC:11610","autosomal recessive limb-girdle muscular dystrophy type 2G","MONDO:0011170","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f3c6c72e-7c2b-42d4-963b-aeddbbe0e4fc-2021-10-12T160000.000Z","2021-10-12T16:00:00.000Z","Limb Girdle Muscular Dystrophy"
"TCF12","HGNC:11623","TCF12-related craniosynostosis","MONDO:0014128","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_11e46ed0-dbfb-4151-ba1c-cc56214d6ca6-2021-01-28T170000.000Z","2021-01-28T17:00:00.000Z","Craniofacial Malformations"
"TCF20","HGNC:11631","developmental delay with variable intellectual impairment and behavioral abnormalities","MONDO:0032745","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_619ae2be-5ab6-418d-8824-373369337faa-2020-10-07T172001.182Z","2020-10-07T17:20:01.182Z","Syndromic Disorders"
"TCF4","HGNC:11634","Pitt-Hopkins syndrome","MONDO:0012589","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_096f830c-0065-456a-9e26-db54fd157981-2018-05-02T170000.000Z","2018-05-02T17:00:00.000Z","Rett and Angelman-like Disorders"
"TCOF1","HGNC:11654","Treacher-Collins syndrome","MONDO:0002457","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3f91c5fe-8e58-4c98-9878-e428e2e41dd7-2019-09-17T160000.000Z","2019-09-17T16:00:00.000Z","Hearing Loss"
"TDO2","HGNC:11708","familial hypertryptophanemia","MONDO:0010907","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b20a4b6d-c43c-4397-bbd2-3d4c6ea6f0e0-2020-07-10T165838.141Z","2020-07-10T16:58:38.141Z","Aminoacidopathy"
"TECRL","HGNC:27365","catecholaminergic polymorphic ventricular tachycardia","MONDO:0017990","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6889dc44-eef0-4a4d-8fdb-aef2dc570f29-2021-01-20T170000.000Z","2021-01-20T17:00:00.000Z","Catecholaminergic Polymorphic Ventricular Tachycardia"
"TECTA","HGNC:11720","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0c7395aa-89bb-40e2-a226-0500fef478bb-2018-09-12T155622.335Z","2018-09-12T15:56:22.335Z","Hearing Loss"
"TECTA","HGNC:11720","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_95b38b73-f807-4401-9600-fe1f319b9dd9-2018-01-02T170000.000Z","2018-01-02T17:00:00.000Z","Hearing Loss"
"TERT","HGNC:11730","dyskeratosis congenita, autosomal dominant 2","MONDO:0013521","SD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_afb6ea76-e8ac-4a38-b42c-23fc18a9623b-2020-07-30T205843.081Z","2020-07-30T20:58:43.081Z","Hereditary Cancer"
"TGFB2","HGNC:11768","familial thoracic aortic aneurysm and aortic dissection","MONDO:0019625","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8254","2016-05-06T00:00:00","Heritable Thoracic Aortic Aneurysm and Dissection"
"TGFB3","HGNC:11769","familial thoracic aortic aneurysm and aortic dissection","MONDO:0019625","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8266","2016-12-22T00:00:00","Heritable Thoracic Aortic Aneurysm and Dissection"
"TGFB3","HGNC:11769","arrhythmogenic right ventricular cardiomyopathy","MONDO:0016587","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_36ed9be9-2854-49e5-801c-a8fd65fec98e-2019-08-16T160000.000Z","2019-08-16T16:00:00.000Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"TGFBR1","HGNC:11772","familial thoracic aortic aneurysm and aortic dissection","MONDO:0019625","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8255","2016-10-12T00:00:00","Heritable Thoracic Aortic Aneurysm and Dissection"
"TGFBR1","HGNC:11772","multiple self-healing squamous epithelioma","MONDO:0007566","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_570947a0-3e45-419c-bc22-0fdc60ca6009-2019-12-20T212550.834Z","2019-12-20T21:25:50.834Z","Hereditary Cancer"
"TGFBR1","HGNC:11772","Loeys-Dietz syndrome","MONDO:0018954","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8a546ce2-432c-4c8a-90e5-97293d7938be-2019-03-27T160000.000Z","2019-03-27T16:00:00.000Z","General Gene Curation"
"TGFBR2","HGNC:11773","familial thoracic aortic aneurysm and aortic dissection","MONDO:0019625","AD","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8256","2016-02-15T00:00:00","Heritable Thoracic Aortic Aneurysm and Dissection"
"TGFBR2","HGNC:11773","Loeys-Dietz syndrome 2","MONDO:0012427","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_73be8b4f-d823-44e5-ab76-faa3bc8eca84-2020-11-25T180000.000Z","2020-11-25T18:00:00.000Z","General Gene Curation"
"TH","HGNC:11782","tyrosine hydroxylase deficiency","MONDO:0100064","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c4bf9fbb-0046-4a90-9e74-0b3b79f28f59-2019-03-22T160000.000Z","2019-03-22T16:00:00.000Z","Aminoacidopathy"
"THBD","HGNC:11784","thrombomodulin-related bleeding disorder","MONDO:0013775","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_358cb384-4303-425d-9b92-509c600c2d03-2021-10-27T160000.000Z","2021-10-27T16:00:00.000Z","Hemostasis Thrombosis"
"THBD","HGNC:11784","thrombomodulin-related bleeding disorder","MONDO:0013775","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_65204ffc-d2bd-4334-bf9f-eaea618593dd-2021-10-27T160000.000Z","2021-10-27T16:00:00.000Z","Hemostasis Thrombosis"
"TIMM50","HGNC:23656","3-methylglutaconic aciduria type 9","MONDO:0044724","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_92bd34f9-b744-4246-b50f-cfa8ab95597b-2021-10-25T202158.414Z","2021-10-25T20:21:58.414Z","General Inborn Errors of Metabolism"
"TIMM8A","HGNC:11817","deafness dystonia syndrome","MONDO:0010578","XL","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a21d3842-b39e-4f98-860a-61a9aa4e2d2b-2017-12-19T050000.000Z","2017-12-19T05:00:00.000Z","Hearing Loss"
"TIMMDC1","HGNC:1321","Leigh syndrome","MONDO:0009723","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_83d26d62-2863-46d9-ad7d-96c086e65e8e-2021-06-30T220013.257Z","2021-06-30T22:00:13.257Z","Mitochondrial Diseases"
"TIMP3","HGNC:11822","Sorsby fundus dystrophy","MONDO:0007640","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8594a02c-c0f3-4542-b6d3-f089ba94417e-2021-07-02T174320.328Z","2021-07-02T17:43:20.328Z","Retina"
"TJP1","HGNC:11827","arrhythmogenic right ventricular cardiomyopathy","MONDO:0016587","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_435951df-5a0d-4596-b112-ccd6d6204409-2019-02-08T170000.000Z","2019-02-08T17:00:00.000Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"TJP2","HGNC:11828","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bb5c5be5-918d-4ba5-b4ad-e243119a7e6a-2022-01-19T170000.000Z","2022-01-19T17:00:00.000Z","Hearing Loss"
"TMC1","HGNC:16513","autosomal recessive nonsyndromic hearing loss 7","MONDO:0010967","AR","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5658","2017-02-15T00:00:00","Hearing Loss"
"TMC1","HGNC:16513","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_966d2fa1-5245-420d-9bf0-4a36aab29d74-2018-06-22T160000.000Z","2018-06-22T16:00:00.000Z","Hearing Loss"
"TMEM127","HGNC:26038","hereditary pheochromocytoma-paraganglioma","MONDO:0017366","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9b965b4e-c909-41da-995b-cdc2af9b3183-2021-06-16T143347.758Z","2021-06-16T14:33:47.758Z","Hereditary Cancer"
"TMEM132E","HGNC:26991","hearing loss, autosomal recessive","MONDO:0019588","AR","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9547","2017-11-21T00:00:00","Hearing Loss"
"TMEM132E","HGNC:26991","hearing loss, autosomal recessive 99","MONDO:0032776","AR","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_867fc085-f2f4-40f6-8b96-565d131fd964-2022-01-25T152448.406Z","2022-01-25T15:24:48.406Z","Hearing Loss"
"TMEM237","HGNC:14432","Joubert syndrome 14","MONDO:0013745","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d6b843c9-8fc3-4d61-8195-29aed5e7d700-2021-04-26T121051.373Z","2021-04-26T12:10:51.373Z","Syndromic Disorders"
"TMEM43","HGNC:28472","arrhythmogenic right ventricular dysplasia 5","MONDO:0011459","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_675dc788-9749-413f-93ce-8c1fc3adbe84-2018-10-26T160000.000Z","2018-10-26T16:00:00.000Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"TMEM67","HGNC:28396","ciliopathy","MONDO:0005308","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8f380d4b-6d0b-4c09-a3ae-ec34bc8ecb8d-2021-07-14T160000.000Z","2021-07-14T16:00:00.000Z","Kidney Cystic and Ciliopathy Disorders"
"TMIE","HGNC:30800","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b025a472-0a48-469c-a5f3-70df12ade334-2017-09-29T040000.000Z","2017-09-29T04:00:00.000Z","Hearing Loss"
"TMPO","HGNC:11875","familial isolated dilated cardiomyopathy","MONDO:0015470","AD","SOP4","Refuted","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3211","2016-11-30T00:00:00","General Gene Curation"
"TMPO","HGNC:11875","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP5","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1e1bb21-c617-4aac-b9d8-1c2054d76c55-2018-08-01T171930.510Z","2018-08-01T17:19:30.510Z","Hypertrophic Cardiomyopathy"
"TMPRSS3","HGNC:11877","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ee13ba8c-7986-4e6c-8a39-4ee197ba4023-2017-08-22T160000.000Z","2017-08-22T16:00:00.000Z","Hearing Loss"
"TMTC2","HGNC:25440","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0e56b4d6-4947-4de5-a3a7-373145019239-2018-08-22T175707.847Z","2018-08-22T17:57:07.847Z","Hearing Loss"
"TNC","HGNC:5318","nonsyndromic genetic hearing loss","MONDO:0019497","AD","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fce4988a-fb20-4f95-b73a-799c47b67e3b-2018-03-20T160000.000Z","2018-03-20T16:00:00.000Z","Hearing Loss"
"TNFRSF13B","HGNC:18153","immunodeficiency, common variable, 2","MONDO:0009413","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3049236b-8132-4dfa-8cda-2a328962a0a4-2021-01-20T170000.000Z","2021-01-20T17:00:00.000Z","Antibody Deficiencies GCEP"
"TNFRSF13C","HGNC:17755","immunodeficiency, common variable, 4","MONDO:0013284","AR","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1408411b-9d28-4308-b2bc-dbada3660898-2021-04-13T003359.028Z","2021-04-13T00:33:59.028Z","Antibody Deficiencies GCEP"
"TNNC1","HGNC:11943","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP5","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5d832673-8acb-4a02-ae34-35e0d9981b70-2016-11-01T160000.000Z","2016-11-01T16:00:00.000Z","Hypertrophic Cardiomyopathy"
"TNNC1","HGNC:11943","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6ad71467-74c0-4a7c-932d-c5ca5747e59e-2020-10-09T160000.000Z","2020-10-09T16:00:00.000Z","Dilated Cardiomyopathy"
"TNNC1","HGNC:11943","arrhythmogenic right ventricular cardiomyopathy","MONDO:0016587","AD","SOP7","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bea34b8c-4260-4dce-bcb3-69be7eb1aa21-2019-09-13T160000.000Z","2019-09-13T16:00:00.000Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"TNNC2","HGNC:11944","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP5","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8760","2017-04-04T00:00:00","Hypertrophic Cardiomyopathy"
"TNNI3","HGNC:11947","arrhythmogenic right ventricular cardiomyopathy","MONDO:0016587","AD","SOP7","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_21c990ca-e407-4a21-a3e2-237700a75d43-2019-07-16T160000.000Z","2019-07-16T16:00:00.000Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"TNNI3","HGNC:11947","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4a7e6901-d478-44c4-bd03-2c344029d4bb-2017-09-05T160000.000Z","2017-09-05T16:00:00.000Z","Hypertrophic Cardiomyopathy"
"TNNI3","HGNC:11947","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_668087ea-0d2f-42c2-a291-f73400d34023-2020-10-09T160000.000Z","2020-10-09T16:00:00.000Z","Dilated Cardiomyopathy"
"TNNI3K","HGNC:19661","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f5ce5790-8940-4d7a-a85c-8682be86939d-2020-08-12T160000.000Z","2020-08-12T16:00:00.000Z","Dilated Cardiomyopathy"
"TNNT1","HGNC:11948","nemaline myopathy 5","MONDO:0011539","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8f993d88-c2f6-42c8-8c2e-c1bb63e1416a-2020-05-07T160000.000Z","2020-05-07T16:00:00.000Z","Congenital Myopathies"
"TNNT1","HGNC:11948","nemaline myopathy","MONDO:0018958","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b5e1f9d1-b21e-46f6-94ce-10cb551ea92a-2020-06-22T141002.152Z","2020-06-22T14:10:02.152Z","Congenital Myopathies"
"TNNT2","HGNC:11949","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_20fbdfad-b2d2-45f1-9658-e2e3e02cb413-2020-10-09T160000.000Z","2020-10-09T16:00:00.000Z","Dilated Cardiomyopathy"
"TNNT2","HGNC:11949","arrhythmogenic right ventricular cardiomyopathy","MONDO:0016587","AD","SOP7","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d2bde3ff-f75f-40c3-a8fe-10a72e883b3c-2019-07-16T160000.000Z","2019-07-16T16:00:00.000Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"TNNT2","HGNC:11949","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ef922dc4-4e41-422b-ac3d-605fea375005-2021-02-04T170000.000Z","2021-02-04T17:00:00.000Z","Hypertrophic Cardiomyopathy"
"TNNT3","HGNC:11950","nemaline myopathy","MONDO:0018958","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9617fa6c-fcb4-460a-be4b-2e437267f608-2020-02-24T141842.425Z","2020-02-24T14:18:42.425Z","Congenital Myopathies"
"TNPO3","HGNC:17103","muscular dystrophy, limb-girdle, autosomal dominant","MONDO:0015151","AD","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9cd2cbd3-46da-490c-9765-40b52750dded-2021-06-15T185556.261Z","2021-06-15T18:55:56.261Z","Limb Girdle Muscular Dystrophy"
"TNRC6B","HGNC:29190","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a806c490-788f-49b6-b437-6970f5888c07-2021-01-06T170000.000Z","2021-01-06T17:00:00.000Z","Intellectual Disability and Autism"
"TOP2B","HGNC:11990","B-cell immunodeficiency, distal limb anomalies, and urogenital malformations","MONDO:0012243","AD","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_677a64c1-b005-44f6-9846-a7f371222667-2021-10-19T125736.122Z","2021-10-19T12:57:36.122Z","Antibody Deficiencies GCEP"
"TP53","HGNC:11998","familial ovarian cancer","MONDO:0016248","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9991","2018-01-10T00:00:00","Breast/Ovarian Cancer"
"TP53","HGNC:11998","Li-Fraumeni syndrome 1","MONDO:0007903","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_78494aba-bb52-4b33-bf1d-ebbb5374df4b-2020-05-14T005523.974Z","2020-05-14T00:55:23.974Z","Hereditary Cancer"
"TPK1","HGNC:17358","Leigh syndrome","MONDO:0009723","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_74e89426-cb27-4474-b892-dc303a9de644-2021-01-14T212800.773Z","2021-01-14T21:28:00.773Z","Mitochondrial Diseases"
"TPM1","HGNC:12010","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8771","2016-12-20T16:00:00","Hypertrophic Cardiomyopathy"
"TPM1","HGNC:12010","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1173d239-23cf-4c9c-9ea5-f95d9356e6c7-2020-11-13T170000.000Z","2020-11-13T17:00:00.000Z","Dilated Cardiomyopathy"
"TPM1","HGNC:12010","arrhythmogenic right ventricular cardiomyopathy","MONDO:0016587","AD","SOP7","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8e69d885-a5c6-48de-bb65-0943a6c2268d-2019-09-13T160000.000Z","2019-09-13T16:00:00.000Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"TPM2","HGNC:12011","TPM2-related myopathy","MONDO:0100196","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f137b6cf-247a-4af0-b41f-6cb976239175-2021-01-04T170000.000Z","2021-01-04T17:00:00.000Z","Congenital Myopathies"
"TPM3","HGNC:12012","TPM3-related myopathy","MONDO:0100108","SD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2d76d08c-446b-42d6-ab9c-064fa1b4433f-2020-11-03T212439.729Z","2020-11-03T21:24:39.729Z","Congenital Myopathies"
"TPP1","HGNC:2073","neuronal ceroid lipofuscinosis","MONDO:0016295","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9b2f3b20-fb9a-4b5e-ad8e-e03be5ebb8e5-2020-09-26T005342.102Z","2020-09-26T00:53:42.102Z","Epilepsy"
"TPRN","HGNC:26894","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a4dce399-9aeb-452e-a917-3603eb09d11f-2017-09-12T040000.000Z","2017-09-12T04:00:00.000Z","Hearing Loss"
"TRAPPC9","HGNC:30832","intellectual disability-obesity-brain malformations-facial dysmorphism syndrome","MONDO:0018123","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_456bfabf-5cad-4a08-bf21-3611a6fbf9b1-2020-08-15T160000.000Z","2020-08-15T16:00:00.000Z","Intellectual Disability and Autism"
"TRDN","HGNC:12261","long QT syndrome","MONDO:0002442","AR","SOP7","Strong","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1278bd6a-6ac7-4556-87ea-f860027b2da5-2020-04-24T160000.000Z","2020-04-24T16:00:00.000Z","Long QT Syndrome"
"TRDN","HGNC:12261","catecholaminergic polymorphic ventricular tachycardia","MONDO:0017990","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a86167e8-9010-488d-b5bb-1f29e805bd91-2021-01-20T170000.000Z","2021-01-20T17:00:00.000Z","Catecholaminergic Polymorphic Ventricular Tachycardia"
"TRIM32","HGNC:16380","autosomal recessive limb-girdle muscular dystrophy","MONDO:0015152","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fbabe4ea-579e-4d98-a4b7-5ff84ee7f245-2020-11-05T210106.630Z","2020-11-05T21:01:06.630Z","Limb Girdle Muscular Dystrophy"
"TRIM37","HGNC:7523","mulibrey nanism","MONDO:0009664","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0faa569d-4e0c-4809-a1b2-a93d460751e8-2020-05-01T160000.000Z","2020-05-01T16:00:00.000Z","Peroxisomal Disorders"
"TRIM63","HGNC:16007","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d9f35d3c-2d30-4947-9d10-87d21405586e-2018-08-01T163316.590Z","2018-08-01T16:33:16.590Z","Hypertrophic Cardiomyopathy"
"TRIO","HGNC:12303","syndromic intellectual disability","MONDO:0000508","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ff3b6c9b-4c51-4414-b92c-20e45758ab61-2021-11-18T192046.961Z","2021-11-18T19:20:46.961Z","Intellectual Disability and Autism"
"TRIOBP","HGNC:17009","hearing loss, autosomal recessive","MONDO:0019588","AR","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9543","2017-06-06T00:00:00","Hearing Loss"
"TRMU","HGNC:25481","Leigh syndrome","MONDO:0009723","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d1d9d958-be13-4018-ab9c-305788171d1e-2021-01-21T004755.799Z","2021-01-21T00:47:55.799Z","Mitochondrial Diseases"
"TRPM4","HGNC:17993","Brugada syndrome","MONDO:0015263","AD","SOP5","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10164","2017-11-21T00:00:00","Brugada Syndrome"
"TRPV4","HGNC:18083","brachyolmia","MONDO:0015262","AD","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1507b13c-d089-47e8-88cb-b3b4399581a6-2021-12-15T200032.687Z","2021-12-15T20:00:32.687Z","Skeletal Disorders"
"TRPV4","HGNC:18083","spondyloepimetaphyseal dysplasia, Maroteaux type","MONDO:0008473","AD","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_17fcb720-754a-429a-b1f8-90db6d423a89-2021-05-19T160000.000Z","2021-05-19T16:00:00.000Z","Skeletal Disorders"
"TRPV4","HGNC:18083","metatropic dysplasia","MONDO:0007986","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_70f8ac2b-5570-4672-b0ee-2f3a342ccd44-2020-12-08T170000.000Z","2020-12-08T17:00:00.000Z","Skeletal Disorders"
"TRPV4","HGNC:18083","neuromuscular disease","MONDO:0019056","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b89b03c3-24c7-4424-989c-abd65eb2b7ec-2021-12-14T145310.482Z","2021-12-14T14:53:10.482Z","Charcot-Marie-Tooth"
"TRPV4","HGNC:18083","spondylometaphyseal dysplasia, Kozlowski type","MONDO:0008477","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d93031fa-8ea5-465a-a903-6e7ae36a5faa-2021-06-07T160000.000Z","2021-06-07T16:00:00.000Z","Skeletal Disorders"
"TSC1","HGNC:12362","tuberous sclerosis","MONDO:0001734","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_61b07bb0-1385-4344-8b6c-571f6a271000-2019-01-23T170000.000Z","2019-01-23T17:00:00.000Z","General Gene Curation"
"TSC2","HGNC:12363","tuberous sclerosis","MONDO:0001734","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0b0a33ff-44ca-497c-8499-cc1f50cead93-2019-01-23T170000.000Z","2019-01-23T17:00:00.000Z","General Gene Curation"
"TSFM","HGNC:12367","Leigh syndrome","MONDO:0009723","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e3d30a3f-a054-4812-9b97-116a8834fcb1-2020-02-12T195529.785Z","2020-02-12T19:55:29.785Z","Mitochondrial Diseases"
"TSHZ1","HGNC:10669","aural atresia, congenital","MONDO:0011921","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cfbe0bb6-f9c6-447b-bec9-911af6a67566-2020-08-25T130420.457Z","2020-08-25T13:04:20.457Z","Syndromic Disorders"
"TSPAN7","HGNC:11854","non-syndromic X-linked intellectual disability","MONDO:0019181","XL","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2716e7b3-e038-421a-b584-55f6797502a4-2020-12-02T170000.000Z","2020-12-02T17:00:00.000Z","Intellectual Disability and Autism"
"TSPEAR","HGNC:1268","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f0928b06-d3bb-41fe-8222-d7f0e6c0a25a-2017-09-26T040000.000Z","2017-09-26T04:00:00.000Z","Hearing Loss"
"TTC19","HGNC:26006","Leigh syndrome","MONDO:0009723","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8dc9dcb6-1f63-41b1-80f1-a0f2a87b5ec4-2019-09-19T160132.570Z","2019-09-19T16:01:32.570Z","Mitochondrial Diseases"
"TTC21B","HGNC:25660","nephronophthisis 12","MONDO:0013442","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_60f93fe0-145f-47a7-9ecf-613b1b1dfa7f-2021-11-10T170000.000Z","2021-11-10T17:00:00.000Z","Kidney Cystic and Ciliopathy Disorders"
"TTC7A","HGNC:19750","multiple intestinal atresia","MONDO:0009465","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_80cadac5-067c-49e7-a021-ee4eec83984a-2021-10-21T184517.744Z","2021-10-21T18:45:17.744Z","SCID-CID"
"TTN","HGNC:12403","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1ec53217-814e-44b3-a7b7-0f18311c20f3-2020-11-06T182152.992Z","2020-11-06T18:21:52.992Z","Dilated Cardiomyopathy"
"TTN","HGNC:12403","arrhythmogenic right ventricular cardiomyopathy","MONDO:0016587","AD","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a93ab74d-c9fa-4e74-b849-c8c6e8366050-2019-08-06T160000.000Z","2019-08-06T16:00:00.000Z","Arrhythmogenic Right Ventricular Cardiomyopathy"
"TTN","HGNC:12403","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP5","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c17e22eb-c6fc-487d-bcf6-001bb85fdabd-2016-12-12T170000.000Z","2016-12-12T17:00:00.000Z","Hypertrophic Cardiomyopathy"
"TTR","HGNC:12405","hereditary ATTR amyloidosis","MONDO:0017132","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8a189cf4-767c-405c-80dc-4aa1727f6f73-2017-12-11T050000.000Z","2017-12-11T05:00:00.000Z","Hypertrophic Cardiomyopathy"
"TUBA4A","HGNC:12407","amyotrophic lateral sclerosis type 22","MONDO:0014531","AD","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7349d6e4-f351-4a8a-80f6-af62d3e716e5-2021-09-14T191334.954Z","2021-09-14T19:13:34.954Z","Amyotrophic Lateral Sclerosis Spectrum Disorders"
"TUBB1","HGNC:16257","autosomal dominant macrothrombocytopenia TUBB1-related","MONDO:0013141","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dbf068c4-8e07-4861-8eee-8e7d9572b122-2019-10-23T160000.000Z","2019-10-23T16:00:00.000Z","Hemostasis Thrombosis"
"TUBB2B","HGNC:30829","complex cortical dysplasia with other brain malformations","MONDO:0000904","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_81ced164-4ef1-4256-a727-84e79930efcc-2020-04-26T040000.000Z","2020-04-26T04:00:00.000Z","Brain Malformations"
"TUBB4B","HGNC:20771","Leber congenital amaurosis with early-onset deafness","MONDO:0060650","AD","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3b80d55d-0060-4b1c-849b-648011337400-2018-06-26T160000.000Z","2018-06-26T16:00:00.000Z","Hearing Loss"
"TUSC3","HGNC:30242","intellectual disability","MONDO:0001071","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_db38ed95-d1fe-43d6-bf80-c5e3f24f7d1b-2020-04-07T160000.000Z","2020-04-07T16:00:00.000Z","Intellectual Disability and Autism"
"TWIST1","HGNC:12428","Sweeney-Cox syndrome","MONDO:0060592","AD","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_14ba10ad-ebb5-491f-b4d6-639890ab7ab9-2021-03-26T213222.762Z","2021-03-26T21:32:22.762Z","Craniofacial Malformations"
"TWIST1","HGNC:12428","Saethre-Chotzen syndrome","MONDO:0007042","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1730a1bb-49c2-4c11-8c45-e8747d8fb91d-2021-01-28T180000.000Z","2021-01-28T18:00:00.000Z","Craniofacial Malformations"
"TWIST1","HGNC:12428","TWIST1-related craniosynostosis","MONDO:0007399","AD","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bda425f8-b760-4484-9336-b3e572d402ab-2021-06-10T160000.000Z","2021-06-10T16:00:00.000Z","Craniofacial Malformations"
"TYR","HGNC:12442","oculocutaneous albinism type 1","MONDO:0018135","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c9b52af2-1674-4f3d-9d7f-398a5f7f6875-2020-08-28T160000.000Z","2020-08-28T16:00:00.000Z","Aminoacidopathy"
"UBE2A","HGNC:12472","syndromic X-linked intellectual disability Nascimento type","MONDO:0010461","XL","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_94765cdb-fe12-4098-b28e-20cd58744271-2018-07-13T134934.109Z","2018-07-13T13:49:34.109Z","Intellectual Disability and Autism"
"UBE3A","HGNC:12496","Angelman syndrome","MONDO:0007113","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_df25de82-ea9a-4d86-8b42-6587a39650e3-2018-05-02T132344.716Z","2018-05-02T13:23:44.716Z","Rett and Angelman-like Disorders"
"UBE3B","HGNC:13478","oculocerebrofacial syndrome, Kaufman type","MONDO:0009485","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5604d13c-a46a-4a83-87ec-e4e94bbed3f0-2021-07-30T130354.346Z","2021-07-30T13:03:54.346Z","Syndromic Disorders"
"UBQLN2","HGNC:12509","amyotrophic lateral sclerosis type 15","MONDO:0010459","XL","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_17c06f6e-6fe1-4a61-bc35-026416e31dbb-2021-04-13T194634.543Z","2021-04-13T19:46:34.543Z","Amyotrophic Lateral Sclerosis Spectrum Disorders"
"UMOD","HGNC:12559","autosomal dominant medullary cystic kidney disease with hyperuricemia","MONDO:0019511","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_39233b4e-a491-47b4-8407-2e15dda89221-2021-02-08T214008.425Z","2021-02-08T21:40:08.425Z","Kidney Cystic and Ciliopathy Disorders"
"UNC80","HGNC:26582","hypotonia, infantile, with psychomotor retardation and characteristic facies 2","MONDO:0014777","AR","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7639160a-1761-4dcb-98de-2aeb61b2b080-2021-07-30T134337.292Z","2021-07-30T13:43:37.292Z","Syndromic Disorders"
"UNG","HGNC:12572","hyper-IgM syndrome type 5","MONDO:0011971","AR","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_336745e2-39bc-429c-8b0d-fd73216522a5-2021-08-17T160000.000Z","2021-08-17T16:00:00.000Z","Antibody Deficiencies GCEP"
"UPF3B","HGNC:20439","X-linked complex neurodevelopmental disorder","MONDO:0100148","XL","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1caf030-ef58-4f8f-ba40-aabbf81cf6b1-2019-07-03T160000.000Z","2019-07-03T16:00:00.000Z","Intellectual Disability and Autism"
"UQCRQ","HGNC:29594","Leigh syndrome","MONDO:0009723","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9bf205a2-6eb3-40aa-b3dd-54c19ce6e6f7-2019-10-16T144656.909Z","2019-10-16T14:46:56.909Z","Mitochondrial Diseases"
"UROC1","HGNC:26444","urocanic aciduria","MONDO:0010167","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_af2ff293-39ce-46b7-af58-01e3685f4334-2020-11-13T170000.000Z","2020-11-13T17:00:00.000Z","Aminoacidopathy"
"USH1C","HGNC:12597","Usher syndrome type 1","MONDO:0010168","AR","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5664","2017-02-15T00:00:00","Hearing Loss"
"USH1C","HGNC:12597","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f4194490-1b41-4d6d-be63-4a2a8827bb85-2018-06-11T040000.000Z","2018-06-11T04:00:00.000Z","Hearing Loss"
"USH1G","HGNC:16356","Usher syndrome type 1","MONDO:0010168","AR","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5660","2017-02-15T00:00:00","Hearing Loss"
"USH1G","HGNC:16356","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_02c62d06-b496-4a48-a514-56a772fae071-2019-05-21T160000.000Z","2019-05-21T16:00:00.000Z","Hearing Loss"
"USH2A","HGNC:12601","Usher syndrome type 2","MONDO:0016484","AR","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5661","2017-02-15T00:00:00","Hearing Loss"
"USP7","HGNC:12630","Hao-Fountain syndrome","MONDO:0014805","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7e4961fa-f972-4e82-ac29-a511ff954529-2021-09-03T182145.545Z","2021-09-03T18:21:45.545Z","Syndromic Disorders"
"VAPB","HGNC:12649","amyotrophic lateral sclerosis type 8","MONDO:0012077","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_da78d57d-1525-47b3-a649-743186d28eff-2021-12-15T183034.352Z","2021-12-15T18:30:34.352Z","Amyotrophic Lateral Sclerosis Spectrum Disorders"
"VCAN","HGNC:2464","Wagner disease","MONDO:0007740","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d1ea2623-463f-40f1-befb-5dfde7abc784-2021-07-26T183919.943Z","2021-07-26T18:39:19.943Z","Retina"
"VCL","HGNC:12665","hypertrophic cardiomyopathy","MONDO:0005045","AD","SOP8","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_27365fd2-1203-4e2b-8830-3277e965d8bc-2021-06-17T142636.354Z","2021-06-17T14:26:36.354Z","Hypertrophic Cardiomyopathy"
"VCL","HGNC:12665","dilated cardiomyopathy","MONDO:0005021","AD","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2d46699a-5f8c-460d-9233-bec4e2ecf560-2020-11-06T182645.766Z","2020-11-06T18:26:45.766Z","Dilated Cardiomyopathy"
"VCP","HGNC:12666","inclusion body myopathy with Paget disease of bone and frontotemporal dementia","MONDO:0000507","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6ea2bc4d-3b58-4b59-a5bc-9d8a96c452cb-2021-12-23T223510.433Z","2021-12-23T22:35:10.433Z","Amyotrophic Lateral Sclerosis Spectrum Disorders"
"VHL","HGNC:12687","von Hippel-Lindau disease","MONDO:0008667","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_30c04ced-b74d-465a-8d7d-eb822109b7f1-2020-05-14T004116.004Z","2020-05-14T00:41:16.004Z","Hereditary Cancer"
"VIPAS39","HGNC:20347","arthrogryposis, renal dysfunction, and cholestasis 2","MONDO:0013255","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b87d2443-a34d-41b1-8712-bcd346e3cf52-2020-12-16T170000.000Z","2020-12-16T17:00:00.000Z","Hemostasis Thrombosis"
"VKORC1","HGNC:23663","vitamin K-dependent clotting factors, combined deficiency of, type 2","MONDO:0011837","AR","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_84145ffe-9835-4a3a-a2ae-6d0c6bd34007-2020-06-24T160000.000Z","2020-06-24T16:00:00.000Z","Hemostasis Thrombosis"
"VPS13B","HGNC:2183","Cohen syndrome","MONDO:0008999","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ccfc68bc-9f00-4565-b2c7-70ad9f8e2002-2018-11-13T153457.342Z","2018-11-13T15:34:57.342Z","Intellectual Disability and Autism"
"VPS13D","HGNC:23595","Leigh syndrome","MONDO:0009723","AR","SOP7","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7f179add-fcdb-4ea0-bc3c-506f825d2dac-2021-06-14T143234.435Z","2021-06-14T14:32:34.435Z","Mitochondrial Diseases"
"VPS33B","HGNC:12712","arthrogryposis, renal dysfunction, and cholestasis 1","MONDO:0008822","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d38d685c-9aee-4660-9228-4119a4fd583d-2021-03-24T160534.056Z","2021-03-24T16:05:34.056Z","Hemostasis Thrombosis"
"VPS35","HGNC:13487","Parkinson disease","MONDO:0005180","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b0e546d6-8a44-4e9d-83aa-f781ec4ec166-2021-11-03T134517.796Z","2021-11-03T13:45:17.796Z","Parkinson's disease"
"VPS8","HGNC:29122","arthrogryposis multiplex congenita","MONDO:0015168","AR","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5463","2016-11-24T00:00:00","General Gene Curation"
"VWF","HGNC:12726","hereditary von Willebrand disease","MONDO:0019565","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4899c76e-7d5e-4b00-a47f-7e1f1b0ba664-2020-09-23T160000.000Z","2020-09-23T16:00:00.000Z","Hemostasis Thrombosis"
"VWF","HGNC:12726","von Willebrand disease type 2B","MONDO:0015629","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ecfe8bc1-5a4b-4d41-80d1-217af5b5b77f-2020-09-23T160000.000Z","2020-09-23T16:00:00.000Z","Hemostasis Thrombosis"
"WAS","HGNC:12731","X-linked severe congenital neutropenia","MONDO:0010294","XL","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_49c66050-ab36-4359-8d78-b7ba5bef80d2-2021-11-18T171012.085Z","2021-11-18T17:10:12.085Z","SCID-CID"
"WAS","HGNC:12731","Wiskott-Aldrich syndrome","MONDO:0010518","XL","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a936b3ba-f1d0-4f14-bd56-14f64ad4de3a-2018-10-12T205425.459Z","2018-10-12T20:54:25.459Z","Hereditary Cancer"
"WBP2","HGNC:12738","hearing loss, autosomal recessive","MONDO:0019588","AR","SOP6","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_baa7931c-1d6a-4260-9816-fbca764c5a0e-2018-12-09T170000.000Z","2018-12-09T17:00:00.000Z","Hearing Loss"
"WDR45","HGNC:28912","X-linked complex neurodevelopmental disorder","MONDO:0100148","XL","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_85a54036-4d36-414d-8d26-944b9763a039-2019-06-28T160000.000Z","2019-06-28T16:00:00.000Z","Epilepsy"
"WDR62","HGNC:24502","microcephaly 2, primary, autosomal recessive, with or without cortical malformations","MONDO:0011435","AR","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bdbcb9de-2ded-46a0-a6d0-16b34ea22008-2020-05-26T160000.000Z","2020-05-26T16:00:00.000Z","Brain Malformations"
"WFS1","HGNC:12762","Wolfram-like syndrome","MONDO:0013673","AD","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_17637c9d-03fb-496a-a00c-ae2431f441e8-2018-04-17T040000.000Z","2018-04-17T04:00:00.000Z","Hearing Loss"
"WFS1","HGNC:12762","Wolfram syndrome","MONDO:0018105","AR","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1e81eeda-4dd0-431c-ad52-90304fb761c8-2018-09-11T185409.174Z","2018-09-11T18:54:09.174Z","Hearing Loss"
"WHRN","HGNC:16361","Usher syndrome type 2D","MONDO:0012662","AR","SOP4","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8151","2017-05-10T00:00:00","Hearing Loss"
"WHRN","HGNC:16361","nonsyndromic genetic hearing loss","MONDO:0019497","AR","SOP6","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3188ec93-954a-4daa-b99d-7c5fccad8e1a-2018-12-26T170000.000Z","2018-12-26T17:00:00.000Z","Hearing Loss"
"WNT5A","HGNC:12784","autosomal dominant Robinow syndrome","MONDO:0008389","AD","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0fb2940f-f0e0-442c-beb8-72fc959d5a43-2021-02-03T142016.299Z","2021-02-03T14:20:16.299Z","Syndromic Disorders"
"WRAP53","HGNC:25522","dyskeratosis congenita","MONDO:0015780","AR","SOP4","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3207","2017-01-25T00:00:00","General Gene Curation"
"WRN","HGNC:12791","Werner syndrome","MONDO:0010196","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d9c04f29-bc94-40c5-95d7-d25d21cd387f-2018-10-09T170000.000Z","2018-10-09T17:00:00.000Z","Hereditary Cancer"
"WT1","HGNC:12796","Wilms tumor 1","MONDO:0008679","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_65010002-ff97-4dc0-a89f-6c77abf0982a-2020-07-30T205501.047Z","2020-07-30T20:55:01.047Z","Hereditary Cancer"
"WT1","HGNC:12796","Denys-Drash syndrome","MONDO:0008682","AD","SOP8","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cccc7a42-a49c-4a8d-8b9e-f16b81e9ee07-2021-07-27T210557.993Z","2021-07-27T21:05:57.993Z","Hereditary Cancer"
"XPA","HGNC:12814","xeroderma pigmentosum group A","MONDO:0010210","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5cd298eb-1e1a-4283-851e-2dd24059ba22-2018-11-02T213651.734Z","2018-11-02T21:36:51.734Z","Hereditary Cancer"
"XPC","HGNC:12816","xeroderma pigmentosum group C","MONDO:0010211","AR","SOP6","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8352d38c-7fb3-4a82-8f8b-7cd08fded1f4-2018-11-02T214221.860Z","2018-11-02T21:42:21.860Z","Hereditary Cancer"
"XPNPEP3","HGNC:28052","nephronophthisis-like nephropathy 1","MONDO:0013163","AR","SOP8","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c1fd65c6-6010-4ee7-bb1c-e347c539127c-2021-06-23T150426.493Z","2021-06-23T15:04:26.493Z","Kidney Cystic and Ciliopathy Disorders"
"XRCC2","HGNC:12829","hereditary breast carcinoma","MONDO:0016419","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8706","2017-05-10T00:00:00","Breast/Ovarian Cancer"
"XRCC2","HGNC:12829","familial ovarian cancer","MONDO:0016248","AD","SOP4","No Known Disease Relationship","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8707","2017-04-26T00:00:00","Breast/Ovarian Cancer"
"XRCC4","HGNC:12831","hereditary nonpolyposis colon cancer","MONDO:0018630","AD","SOP4","Limited","https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9865","2017-05-08T00:00:00","Colon Cancer"
"YARS1","HGNC:12840","Charcot-Marie-Tooth disease","MONDO:0015626","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9c326f90-be08-4bb3-9593-b2df48f29ca1-2020-04-28T160000.000Z","2020-04-28T16:00:00.000Z","Charcot-Marie-Tooth"
"ZC4H2","HGNC:24931","X-linked syndromic intellectual disability","MONDO:0020119","XL","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_64ba9cd6-bdfd-4b85-9bdd-1b317715230d-2020-10-21T002026.894Z","2020-10-21T00:20:26.894Z","Intellectual Disability and Autism"
"ZDHHC15","HGNC:20342","complex neurodevelopmental disorder","MONDO:0100038","XL","SOP8","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a2519945-2acd-4484-9811-487ff5189da9-2020-07-30T160000.000Z","2020-07-30T16:00:00.000Z","Intellectual Disability and Autism"
"ZDHHC9","HGNC:18475","syndromic X-linked intellectual disability Raymond type","MONDO:0010427","XL","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2156b925-1ee6-4edb-a514-3650aa5b780e-2020-05-19T160000.000Z","2020-05-19T16:00:00.000Z","Intellectual Disability and Autism"
"ZEB2","HGNC:14881","Mowat-Wilson syndrome","MONDO:0009341","AD","SOP5","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cb06ff0d-1cc6-494c-9ce5-f7cb26f34620-2018-05-24T123443.951Z","2018-05-24T12:34:43.951Z","Intellectual Disability and Autism"
"ZNF292","HGNC:18410","complex neurodevelopmental disorder","MONDO:0100038","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dba438b7-23f9-4c15-a8aa-f70431a193e2-2020-05-06T160000.000Z","2020-05-06T16:00:00.000Z","Intellectual Disability and Autism"
"ZNF41","HGNC:13107","non-syndromic X-linked intellectual disability","MONDO:0019181","XL","SOP7","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6d705685-78a3-4925-8a1b-e00d39d63f87-2021-03-16T171235.415Z","2021-03-16T17:12:35.415Z","Intellectual Disability and Autism"
"ZNF462","HGNC:21684","weiss-kruszka syndrome","MONDO:0032836","AD","SOP7","Definitive","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9fb3ee56-12be-4418-bd85-56e7958ac601-2020-08-25T131051.689Z","2020-08-25T13:10:51.689Z","Syndromic Disorders"
"ZNF674","HGNC:17625","X-linked intellectual disability","MONDO:0100284","XL","SOP8","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5105ab37-4f59-44dc-a8b1-f28e6ed3b704-2021-05-04T170000.000Z","2021-05-04T17:00:00.000Z","Intellectual Disability and Autism"
"ZNF711","HGNC:13128","X-linked complex neurodevelopmental disorder","MONDO:0100148","XL","SOP7","Moderate","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_80a6e42d-f8ce-4bce-8bb4-579b78c94d21-2020-11-03T170000.000Z","2020-11-03T17:00:00.000Z","Intellectual Disability and Autism"
"ZNF81","HGNC:13156","X-linked intellectual disability","MONDO:0100284","XL","SOP8","Disputed","https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a3ada757-6500-46a1-a89e-42668bbdb934-2021-01-26T170000.000Z","2021-01-26T17:00:00.000Z","Intellectual Disability and Autism"
